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Abstract
MmyJ is a protein encoded in the methylenomycin antibiotic gene cluster in Strep-
tomyces coelicolor A3(2). It was identified as a novel member of the ArsR family of
transcription repressors. In depth bioinformatic analyses were carried out to compare this
to other members of the ArsR family, leading to high confidence of its classification. An
expression system was engineered to investigate MmyJ in vitro, leading to the discovery
of the presence of a covalently bonded dimer, which is unusual for ArsR family proteins
and as such was thought to be an artefact of purification. A C49S mutant was then also
engineered without the capacity to form covalent dimers, such that the two variants could
be investigated side by side. Work was carried out to investigate the stability of MmyJ, and
it was found that its secondary structure denatured above temperatures of 40oC and that
the protein is only robust to a single freeze/thaw cycle. Electrophoretic mobility shift assays
were then used to prove that MmyJ binds specifically to a 13-1-13 semi conserved inverted
repeat overlapping the -35 region of both mmyJ and mmr promoters. This indicates that
MmyJ not only regulates its own expression, but also that of Mmr, an eﬄux pump that
removes methylenomycin A from the cell upon biosynthesis. It was also demonstrated
that methylenomycin A caused complete dissociation of the MmyJ:DNA complex when
present in a 20 times molar excess, hence suggesting that the methylenomycin A resistance
mechanism is triggered in the presence of methylenomycin A. This is the first reported
instance of an ArsR family protein sensing a non-metallic ligand. Structural insights into
MmyJ were also sought, with a homology model produced by Phyre2 analysis complimented
by circular dichroism analysis of recombinant MmyJ. X-ray diffraction data were obtained
to a resolution of 2.1 A˚ over 300o, but the phase of these data has yet to be determined,
so the crystal structure has not yet been solved.
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1.1 Microbial Transcription Factors
1.1.1 Transcriptional Regulation
The ability to regulate the transcription of genes is vital to bacteria; organisms must adapt to
local environmental conditions in a way that allows them to survive whilst also inhibiting
the growth of competing species. This has driven the evolution of a myriad of systems,
including ones to take advantage of a nutrient-rich environment as well as ones that respond
to extra-cellular threats via the production of secondary metabolites. However, it would be
inefficient and very wasteful if all of these genes were expressed at once and would likely result
in multiple systems within the cells actively competing against each other; for example, proteins
designed to import specific ions into the cell may end up operating alongside other proteins
exporting the same ions back out again. Hence, these systems must be regulated in real time
in accordance with the changing needs of the organism.
Some systems use post-transcriptional modification as a form of regulation, inhibiting the
processes between transcription of mRNA from the genomic DNA and translation into proteins
[1]. However, most regulation in bacteria occurs prior to this at the transcriptional level,
with systems evolving to inhibit transcription of genes into mRNA until such a time that the
eventual products of these genes are required [2]. One such method of transcriptional regulation
is through the presence of transcription factors: proteins which bind to a specific DNA sequence
near the promotor region for the gene or operon to be regulated and either activate or repress
the recruitment of RNA polymerase, hence regulating the level of transcription [3]. The amount
of regulation can then be altered as cellular conditions change, triggering the release of the DNA
by the transcription factor as conditions within the cell vary.
Once a transcription factor:DNA complex has been formed, either to promote or inhibit
gene expression, a mechanism for dissociating this complex as required must be present. This
allows alteration of gene expression levels to match the requirements of the cell, depending on
the environment it is in. There are two main ways of doing this: either by having a second reg-
ulator system that controls expression of the transcription factor, or by activating/deactivating
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transcription factors already present in the cell as required. In other words, either the synthesis
or activity of the transcription factors can be regulated [4]. In the second case, it is common
for the transcription factor:DNA complex to be stabilised or disrupted by binding to a cognate
ligand. An example of this kind of transcription factor is the Escherichia coli protein Fur which,
in the presence of Fe2+, forms a complex with these ions that then associates to a specific region
of DNA upstream of the genes responsible for the uptake of iron into the cell. This prevents
RNA polymerase from binding and hence represses the expression of this system. Likewise,
when cellular concentrations of iron fall, the Fe2+ ligand dissociates from Fur, which in turn
dissociates from the DNA, allowing the expression of the iron uptake system in order to raise
cellular concentrations of Fe2+ to the required level [5].
A second example of regulation of transcription factors by a binding ligand is ArsR, which
regulates the expression of the gene arsA, encoding for an oxyanion eﬄux pump found on the
R773 plasmid of Escherichia coli [6]. Unlike Fur, which is classed as a co-repressor due to the
requirement of a binding ligand to initiate repression, ArsR is a transcriptional repressor which
naturally forms a DNA complex until disrupted by an associating ligand. Once expressed, it
binds to the promoter region of arsA, thus preventing RNA polymerase from transcribing the
arsA gene. ArsR is responsive to arsenite and antimonite ions, which, upon binding, change
the conformation of the transcription factor such that it dissociates from the DNA, allowing
transcription of arsA and controlling the amount of arsenite and antimonite within the cell [7].
1.1.2 Inducible Expression Systems
The ability of transcriptional factors to regulate gene expression has led to their development
into genetically engineered inducible expression systems used to control the expression of desired
proteins in laboratory conditions. One common example of this is the lac system, originally
identified as regulating lactose transport and metabolism in E. coli strain K-12 [8]. This
regulatory system is responsive to, and induced by, allolactose, a metabolite of lactose, triggering
the release of LacI, a transcriptional repressor, from the lac operon, as illustrated in Figure 1.1
[9]. In this way, the lac system can be incorporated into engineered plasmids in order to
overproduce a desired protein, with its associated gene replacing the genes downstream of the
lac operator such that expression is inhibited. IPTG (Isopropyl β-D-1-thiogalactopyranoside),
2
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(a) Repression
(b) Induction
(c) Allolactose (d) IPTG
Figure 1.1: Illustration of transcriptional repression by LacI. (a) Expression of lacZ, lacY and
lacA genes is repressed due to inhibition of RNA polymerase by LacI:lac complex. (b) Upon
formation, the LacI:allolactose complex dissociates from lac, allowing recruitment of RNA
polymerase and expression of downstream genes. (c) and (d) show structures of allolactose
and IPTG respectively.
which is a functional analogue of allolactose, also binds to LacI [10] and can be added to cell
cultures in order to trigger expression of the desired gene and overproduction of the protein
of interest as it readily enters the cells when present at concentrations of the order of 1 µM
[11]. Extra regulation of this expression system may be added by the incorporation of RNA
polymerase from T7 bacteriophage regulated by an additional lac operon, giving a double tier
regulation of the expression system by controlling the expression of RNA polymerase as well as
inhibiting the polymerase binding site [12, 13]. This system is explored further in Section 3.1.1.
1.1.3 The Helix-Turn-Helix Superfamily
Transcription factors can be divided into several structural superfamilies. One such superfamily
is defined by a characteristic Helix-Turn-Helix (HTH) motif, from which the family takes its
3
1.1 Microbial Transcription Factors 1 INTRODUCTION
name. This superfamily was initially defined after it was noted that several regulatory proteins,
namely CAP [14] and Cro [15, 16] from E. coli and λ repressor [17] from bacteriophage lambda,
shared a similar amino acid sequence of between 20 and 25 residues that was found to be
required for DNA binding. It was observed that these three proteins have a common tertiary
structure in the DNA bound state, with one α-helix fitting completely into the major groove of
the binding site while the preceding helix (nearer the N terminus) lies near the DNA backbone
above the groove [18]. The α-helix in the groove is commonly classified as the recognition helix
[19], with the other helix often thought to stabilise the bond to the DNA, although it can also
play a role in recognition [19].
From the initial recognition of three proteins with this feature, it was noted that the relative
orientation of the two helices is strongly conserved [20], such that between CAP and Cro the
average deviation of the 24 overlapping backbone carbons was found to be just 1.1 A˚ [21].
Along with the similarity of the amino acid sequences themselves, this led to the hypothesis
that these three proteins were part of a much larger family of transcriptional regulators with
similar characteristics, recognising the Helix-Turn-Helix as a recurring motif with two helices
linked by three amino acids [22].
Since this initial classification, the HTH superfamily has grown considerably. It is defined
in the NCBI database [23] as “A large family of mostly alpha-helical protein domains with a
characteristic fold; most members function as sequence-specific DNA binding domains, such
as in transcription regulators. This superfamily also includes the winged helix-turn-helix do-
mains.” [24]. A simple search of the database on 27th August 2015 for proteins with the term
“helix turn helix DNA-binding” in their name or description returned over 4.4 million hits,
mostly of bacterial origin but also from archaea, eukaryotes and viruses, demonstrating how
many proteins have been classified as being part of this superfamily over the intervening 30
years since the motif was initially recognised. The HTH superfamily has also been divided into
many subfamilies with more defined and conserved structures and functions. Several examples
of such families found in prokaryotes are detailed in Table 1.1 [25, 26].
Figure 1.2 shows an example of an HTH transcription factor bound to DNA, visualised
using Pymol [42]. The structure displayed is the bacteriophage 434 repressor R1-69 bound to
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Family Action HTH Location Function Regulated
AraC [27] Activator C-terminal Sugar metabolism
ArsR [28] Repressor Central Metal homeostasis
AsnC [29] Activator/Repressor N-terminal Amino acid metabolism
Crp [30] Activator/Repressor C-terminal Cellular processes
DeoR [31] Repressor N-terminal Sugar metabolism
GntR [32] Repressor N-terminal Cellular processes
IclR [33] Repressor/Activator N-terminal Carbon metabolism
LacI [34] Repressor N-terminal Carbon metabolism
LuxR [35] Activator C-terminal Quorum sensing
LysR [36] Activator/Repressor N-terminal Cellular processes
MarR [37] Activator/Repressor Central Antibiotic resistance
MerR [38] Repressor N-terminal Metal homeostasis
NtrC [39] Activator C-terminal Nitrogen assimilation
OmpR [40] Activator C-terminal Metal homeostasis
TetR [25] Repressor C-terminal Antibiotic resistance
Table 1.1: Examples of families of prokaryotic proteins belonging to the HTH superfamily. In
each case, the typical action is listed (where both activator and repressor are listed, the first
is the primary function of the family), along with the location of the HTH motif within the
peptide chain. The function that is typically regulated by the family is also listed.
a 20 base pair DNA fragment using data from [41], entry number 1RPE on the PDB [43]. It
can be seen that it forms a homodimer, with each monomer interacting with the DNA strand
via helices α2 and α3, with α3 being the recognition helix embedded within the major groove
of the DNA sequence. Also, in accordance with observations of [22], the turn between α2 and
α3 is comprised of three amino acids, here Gly25, Thr26 and Thr27, allowing for the almost
perpendicular arrangement of the two binding helices, as shown explicitly in Figure 1.2b.
An example of how the interaction of a HTH transcription factor with a ligand can alter
the protein’s structure, disrupting DNA binding, is shown in Figure 1.3. In this instance, the
(a) (b)
Figure 1.2: Representation of the HTH transcription factor R1-69 dimer bound to a 20 base
pair DNA fragment (PDB entry 1RPE, data from [41]). (a) Shows complete dimeric complex
with both dimers coloured blue to red from N terminal to C terminal. (b) Shows just the HTH
domain and DNA major groove, with the three residues comprising the turn labelled explicitly.
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Figure 1.3: Crystal stucture of SimR in complex with both SD8 and DNA, viewed from two
different directions. Two monomers of SimR are present, coloured grey and green, with the
recognition helix of the HTH DNA binding domain coloured purple on both monomers. SD8 is
shown in red and DNA in orange. Taken from [45].
crystal structure of SimR, a TetR family transcriptional repressor produced by Streptomyces
antibioticus, is shown bound to both Simocyclinone D8 (SD8) and DNA. The TetR family
of transcriptional repressors is defined by a 47 residue domain, containing a HTH motif and
surrounding residues, which is highly conserved across TetR, QacR, CprB and EthR, both in
sequence and three dimensional structure. This has allowed the identification of over 2,000
members of this family through the screening of protein and genomic databases [25]. In the
system illustrated, the SD8 ligand is a DNA gyrase inhibitor native to S. antibioticus which
is exported from the cell by SimX, the expression of which SimR regulates. Hence this is
an example of a self-resistance mechanism to SD8; a secondary metabolite with antibiotic
properties [44]. It can clearly be seen that the distance between the recognition helices of the
two monomers, coloured purple in Figure 1.3, is altered by 4.9 A˚ upon receiving the SD8 ligand.
This conformational change is enough to disrupt the binding of SimR to the DNA, and thus it
is released, allowing transcription of SimX and export of SD8 from the cell.
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1.2 The ArsR Family
1.2.1 Brief History
As previously described, ArsR is a arsenite and antimonite sensing transcriptional repressor
found on E. coli plasmid R773 [46] that regulates the expression of arsA [7]. Whilst investigating
similarities between ArsA and other eﬄux pump systems, it was noted that ArsR was “weakly
but significantly similar to CadC” [47], a transcription factor that is part of a regulation
system for Cd2+ ions located on Staphylococcus aureus plasmid pI258 [48, 49], hinting at the
classification of a new family of metal sensing transcription factors. Interestingly, this plasmid
also contained an ortholologue of the ArsA system (including ArsR) [47].
The later identification of SmtB, a Zn binding transcription factor encoded in Synechococcus
PCC7942, as being structurally similar to ArsR [52, 53], added another protein to the classi-
fication. This group was then named the ArsR family of metalloregulatory proteins, defined
as containing a highly conserved ELCVCDL region proposed to be the metal binding domain
[54]. It is interesting to note that ArsR was not initially thought to have a canonical HTH
DNA binding domain [47], although further investigation led to its putative identification [55].
This was later refined to exclude the adjacent cysteines, which were identified as part of the
previously described metal binding site [54].
Since the definition of the ArsR family (sometimes called the ArsR-SmtB family), many
more proteins have been added to the classification. In 2006 there were 1024 genetic sequences
encoding for ArsR family proteins identified in the Pfam database [50, 56], with a range of
Site Motif Pattern and Location Classifier
α3 One or more of (i) CXCXXC, (ii) CXC or (iii) CXXD in α3 ArsR1
α3N As α3 + potential N-terminal ligands CadC
α3N-2 As α3 + C between α2 & α3 helices + N-terminal Cys ArsR2
α4C CXXXC in α4 + C-terminal ligands CmtR
α5 DXHX(10)HXX(E/H) in α5 SmtB
α5C As α5 + C-terminal His NmtR
α5-3 As α3 + HX(6)DX(5)EHX(7)HH spanning α5 & C-terminal region KmtR
α5-4 CC at α5 + C-terminal Cys ArsR3
Table 1.2: Description of 8 distinct metal sensing sites found in ArsR family transcription
factors. Helices (α2-5) are numbered according to those in SmtB (see Section 1.2.5). Classifiers
are proteins from which the motif is defined, with other candidate proteins mapped against these
for assignment into one of the listed categories [50, 51]. ArsR1,2,3 refer to ArsR orthologues
from E. coli, Corynebacterium glutamicum and Acidithiobacillus ferrooxidans respectively.
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Figure 1.4: Summary of the seven major classes of soluble metal sensing transcription factors
found in bacteria. In each case the founding member of the family is shown as well as a schematic
of how the family typically interacts with DNA. Other example members are also shown along
with a list of metals known to be sensed by different members of each family. Note: Fur and
NikR members can act as DNA-binding activators when bound to iron and nickel respectively,
and MerR family members can cause repression when unbound. Taken from [51].
classifying features allowing the family to be broken down into 8 smaller sub-groups containing
different sensory motifs [50]. These sub groups are detailed in Table 1.2 [57, 51]. The defining
factors of the ArsR family have been expanded since the initial definition of the conserved
ELCVCDL motif [54], although cysteines are still the key residues in most motifs. This
expansion has led to the classification of the ArsR family as one of the seven major structural
bacterial families of soluble metal sensing proteins, which are summarised in Figure 1.4 [51]. Of
the other families, Fur has already been described as a ligand sensing repressor, regulating the
uptake of iron into E. coli ; likewise DxtR and NikR perform similar functions. Also, the CsoR
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and CopY families are similar in function to ArsR, although these families are more regimented,
consisting of orthologues of only a few individual proteins. Of the seven families shown, MerR is
the only one which typically remains bound to DNA regardless of ligand binding, however it still
undergoes a conformational change. In this case, the DNA strand changes conformation with
the transcription factor and is twisted, which allows RNA polymerase access to the regulated
promoter. There are also examples of Mer family proteins, such as SoxR, acting as oxidation
switches and changing conformation if oxidised, with no ligand interaction required [58].
1.2.2 Dimerisation of ArsR
It was concluded early into the investigation of ArsR that it functions as a dimer, as determined
by carrying out mobility shift assays of wild type mixed with chimeric forms of ArsR. These
chimeras were made by fusing a large protein, in this case BlaM, to residues at codon 91 and
143, giving the ArsR-BlaM50 and ArsR-BlaM102 chimeras respectively. In experiments with
the 102 variant, three bands appeared on mobility shift assays (see Section 5.1.3): the native
dimer, the chimeric dimer and the native/chimeric dimer, as shown in Figure 1.5 [59]. The same
could not be said for the chimeric ArsR-BlaM50 protein, which did not exhibit dimerisation with
Figure 1.5: Evidence of ArsR dimerisation. Mobility Shift Assay with bands evident of four
differently shifted DNA fragments being present. Band (1) corresponds to free DNA, whereas
bands (2)-(4) correspond to DNA in complex with (2) ArsR dimer, (3) ArsR/ArsR-BlaM102
dimer and (4) ArsR-BlaM102 dimer. Taken from [59].
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the wild type form of ArsR. This is taken to be indicative that either the DNA binding domain
or dimer interface of ArsR include at least the amino acids between codon 91 and 143, as these
are not present in ArsR-Blam50. For these assays, the DNA used was the 153 bp EcoRI-DraI
fragment of plasmid pJHW1 containing the ars operon (this plasmid was engineered to include
the arsR gene and ars operon from R773 [7]), and so these data also show that the ArsR DNA
binding site lies near to the ars operon.
The conclusion that ArsR forms homodimers was later confirmed by the observation of
an elution peak corresponding to a mass of 26 kDa, double the ArsR monomer mass of
13 kDa [7], when purified by size exclusion chromatography (see Section 4.2.1) [60]. Later
work revealed that this homodimerisation was indeed essential for the function of ArsR after
truncated mutations were created and mixed with full length ArsR. In order to ensure that the
truncation process itself was not responsible for any alteration in DNA association, the DNA
binding domain from GAL4 was fused to the truncated forms of ArsR. This assay proved that
dimerisation was required for DNA binding, as well as indicating that the dimer interface lay
somewhere between residues 9 and 89 of the 117 amino acid monomer [61].
1.2.3 Interactions with DNA
A 15 base pair (bp) region of DNA on the R773 plasmid, close to the arsR operon, was identified
as being protected by DNase I footprinting and was found to contain an imperfect symmetrical
dyad within its sequence [59]. As this protected region spans the -64 to -40 bases with respect
to the transcriptional origin of arsR, and RNA polymerase is known to occupy bases from -50 to
+22 [62], it was concluded that this protected region was the ArsR binding site. However, it was
thought that the dimer formed by ArsR did not directly interact with the dyad [60], despite it
being a typical target for DNA binding proteins [63, 64]. This was the result of high resolution
techniques, which identified ArsR as binding specifically to just two sets of 4 bases: TCAT
and TTTG, separated by 7 bp; a result that was likewise found on a homologous chromosomal
arsR system in E. coli [60]. However, it was found that another homologue of ArsR from
Staphylococcus xylosus did not contain this sequence, instead containing five protected regions
of DNA, two of which contained dyad symmetry directly overlapping the arsR promoter site in
this case [65].
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Further study with SmtB found that this protein interacts with four distinct sites around
the smt operator: two forming an imperfect 6-2-6 inverted repeating DNA sequence (dyad) and
the other containing a 7-2-7 dyad 10 bps distant from the first pair [66]. Another difference is
that while it had been shown that ArsR bound to the same DNA strand [59], SmtB was found
to bind to both strands of the helix, with one part of each dyad appearing on each strand [66].
It was hypothesised that SmtB formed two distinct dimers and bound to both pairs of inverted
repeats located around the smtA operator [66], with later evidence indicating that this may in
fact be part of a monomer-dimer-tetramer system [67]. It was also found that CzrA, a zinc- and
cobalt-sensing ArsR family protein, forms multimeric complexes as well, with four dimers bound
across a 48 bp region near the czr operator containing multiple TGAA sequences. [68]. CadC
was also found to bind as two distinct dimers to two sites around the cad operator, although
binding to one of the sites was dependant on the concentration of NaCl present [69, 70].
Data from the above binding sites were collated and compared to define typical 12-2-12 DNA
sequences to which SmtB-like (bind to different strands) and ArsR-like (bind to same strand)
members of the ArsR family bind, as shown in Figure 1.6a and 1.6b [28]. Figure 1.6c shows
the location of the DNA binding sites with respect to the genes encoding for both the ArsR
family protein and the associated resistance system for ArsR and SmtB. The 12-2-12 region is
either directly overlapping the promoter site or is between it and the resistance gene, blocking
expression by RNA polymerase. It is also worth noting that many regulators are self-regulating,
5 - aATAxxTGAacaxxtatTCAxaTxtt - 3
(a)
5 - TAxAxTCAAAtaxxtaTTTGaxTxTA - 3
(b)
(c)
Figure 1.6: Conserved 12-2-12 DNA sequences to which (a) SmtB- and (b) ArsR-like members
of the ArsR family bind, classified with regard to whether the protein binds to both strands of
DNA or just one. Capitalised bases are more conserved than lower case bases [28]. (c) Locations
of DNA binding sites for SmtB and ArsR, indicated by →←, in relation to the promoters for
the genes whose transcription they regulate. Based on [28].
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with the gene encoding for both it and the protein it regulates being divergent within the gene
cluster, such that when the ArsR family protein binds to DNA it inhibits the promoter regions
for both genes. This is thought to be the case for approximately two thirds of ArsR family
proteins [71].
1.2.4 Ligand Interactions
It is well documented that members of the ArsR family can sense a range of metal ions, with
some ArsR proteins capable of binding several different metal ions, whilst others can bind
only one [51]. The range of metals that have been demonstrated to bind to ArsR proteins are
shown in Table 1.3, along with examples of which family members bind each metal. No obvious
groupings can be formed of proteins which bind similar metals, or metals that are bound by
a similar group of proteins. However, in general, it is thought that family members with an
α3-based metal binding site are responsible for sensing heavy metal pollutants in the cellular
environment, whereas those with an α5-based site tend to sense biologically required metal ions
[28]. As such, α5 sites typically have less sensitivity to their metal ligands, as a small amount
of the ion is not detrimental (and is often vital) to the cell’s survival, whereas α3 sites have a
much stronger affinity so that the system can detect even minute amounts of pollutant heavy
metal ions [51].
An ensemble of 554 of the previously mentioned 1024 ArsR sequences was created using
CLANS [79]; excluding the most distant relatives [57], a tree diagram of which can be seen in
Figure 1.7. It is apparent that there is no distinct grouping of the different sensing sites and
Metal Sensor Example
Antimony ArsR [46]
Arsenic ArsR [46]
Bismuth ArsR [7]
Cadmium AztR [53], BxmR [72], CadC [47], CmtR [73]
Cobalt CzrA [74], KmtR [57], NmtR [75]
Copper BxmR [72]
Lead AztR [76], CadC [77], CmtR [73]
Nickel KmtR [57], NmtR [75]
Silver BxmR [72]
Zinc AztR [76], BxmR [72], CadC [77], CzrA [74], SmtB [52], ZiaR [78]
Table 1.3: List of metal ions known to be sensed by different ArsR family member proteins,
along with examples to which each binds. NB: CzrA is also known as ZntR in the literature
[28].
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Figure 1.7: Tree diagram of the 554 closest ArsR family sequences from the Pfam database [56].
“??” indicates categorisation of ArsR proteins that do not contain any of the patterns indicated
in Table 1.2. Main bacterial phyla are shown in parenthesis, with elipses indicating sequences
that are present in other phyla. Modified from [57].
that proteins from the same phylum that have the same sensing site can appear in different
groups. It is, therefore, difficult to conclude that all family members with, for example, high
similarity to ArsR will bind arsenite and antimonite. There is not a one to one correlation
between metal binding sites and the sequence groups that are assigned here.
The issue is complicated further by the identification of a sub-group of the ArsR family that
regulate genes that are not involved in the regulation of metal ions within the cell. Two examples
of this sub group are EcaR, from Erwinia caratovora, and HlyU, thought to regulate expression
of haemolysin (HlyA) in Vibrio cholerae. These have both been shown to specifically bind to
DNA in their own operator regions, but neither of which could be dissociated from the DNA by
the addition of any of the metal ions ArsR proteins are known to bind to [57]. As each of these
proteins contains a cysteine in both α2 and α4, it is thought that this could indicate another
binding motif additional to those shown in Table 1.2, the α2α4 motif, predicting non-metal
sensors [51].
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1.2.5 Structural Properties
It has been alluded to several times thus far, especially in Section 1.2.1, that ArsR family
proteins have a strong helical character, beyond the two helices needed for the HTH DNA
binding domain. This was first demonstrated when the crystal structure of SmtB was solved,
identifying five α-helices and a double stranded β-sheet, arranged as an α1-α2-α3-αR-β1-β2-α5
fold, where αR designates the recognition helix of the HTH domain, along with α3 [80]. The
full dimeric structure is shown in Figure 1.8, visualising data from PDB entry 1SMT [80] using
Pymol [42].
It can be seen from Figure 1.8 that the dimeric interface of SmtB forms via interactions
between the pairs of α1 and α5 helices, resulting in a configuration with both recognition helices
presented on the same side of the dimer for DNA binding. The α3-turn-αR sub-structure can
also be directly compared to the typical HTH structure shown in Figure 1.2 (comprising α2 and
α3 in that instance). From this structure, it can also be seen how the different metal binding
sites identified in Table 1.2 lead to different mechanisms of action. For instance, it is easy to
see that a metal ion binding to the α3 helix would directly interfere with DNA binding [81],
whereas binding to α5 would alter the dynamics of the dimer interface, resulting in a shift
in conformation with a direct impact on DNA affinity [80]. From this and later structures,
the ArsR family have sometimes been assigned as winged HTH in character (a subgroup of
HTH transcription factors [82]) due to the positioning of the β-sheet with respect to the DNA
binding domain. However, it is often the case that winged HTH proteins also interact with
Figure 1.8: Crystal structure of SmtB visualised in Pymol using data from [80]. α-helices and
β-sheets are numbered starting at the N terminal, with green and cyan representing different
monomers.
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Figure 1.9: Overlay of crystal structure of Zn2 SmtB dimer (purple and blue) with apo-SmtB
dimer (green and gold). Right hand monomers are aligned to each other, resulting in an
observable shift in relative position of the recognition helix of the second Zn bound monomer
by 4.8 A˚. Zinc binding sites also clearly highlighted in α5-helices. Taken from [84].
minor grooves of DNA through their β-sheets, whereas this is only the case for a few ArsR
proteins [83], hence the ArsR family can perhaps be thought to exist between the HTH and
winged HTH groups.
Figure 1.9 shows an overlay of the crystal structure of zinc bound SmtB with the apo-form,
clearly demonstrating the structural shift leading to a reduction in DNA affinity [84]. It can be
seen that upon binding two zinc ions to the α5 helices the relative position between αR helices
is altered by 4.8 A˚, enough to cause misalignment between the two recognition helices and the
Figure 1.10: Overlay of NMR structure of DNA-bound CzrA (red) and crystal structure of
Zn(II) bound CzrA (blue), viewed from two different perspectives. Bold and pale colouring
indicates the individual monomers in the dimeric complexes, and Zn(II) is illustrated as gold
spheres. Green arrows illustrate the conformational change in the two structures. Taken
from [81].
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major grooves of the target DNA.
The functional shift in conformation of α5-binding ArsR proteins can be seen more explicitly
in Figure 1.10, which shows structural data for CzrA obtained by solution Nuclear Magnetic
Resonance (NMR) when bound to DNA as well as the crystal structure of Zn(II) CzrA [81]. In
this instance, the binding of Zn2+ to the two α5 helices draws these helices closer together and
also deeper into the centre of the complex, as shown by the top green arrow. This then leads
to further conformational change, resulting in a shift in the relative position of the two HTH
domains to a more open conformation, similar to that seen in SmtB in Figure 1.9. Again, this
shift in conformation causes misalignment between the two HTH motifs and the major grooves
of the DNA target, reducing binding affinity and causing dissociation with DNA upon Zn(II)
binding. In this case, the global backbone root mean squared deviation (RMSD) between the
two structures is 2.8 A˚ [81]. However, it is noted that a quantitative comparison at this level
may be invalid due to the possible inherent deviation between the DNA and Zn(II) bound
structures as they were determined by different techniques. Further work has been carried out
to provide a more accurate comparison via molecular dynamics simulations [85].
While no direct structural comparisons of DNA-/metal-bound α3 sites have been reported
in the literature,1 an NMR structure showing cadmium bound to the α4C site in CmtR has
been published [86]. It has been demonstrated that this metal site does indeed include cysteine
residues in the recognition helix of CmtR, as well as Cys102 in the C terminal region. This
locks the recognition helix and C terminus into close proximity, reducing the mobility of the
protein such that it cannot adopt a conformation amenable to DNA binding. This is displayed
in Figure 1.11, demonstrating a similar yet distinct method of action when compared to binding
of the α5 site in other family members.
Another insight into ArsR family structure can be gained from the crystal structures of
two HlyU orthologues: HlyU-Vv from Vibrio vulnificus CMCP6 [87] and HlyU-Vc from Vibrio
cholerae N16961 [83]. It was found that the dimeric interface in HlyU-Vv differed slightly from
that of SmtB by the addition of an extra polar interaction between the α5-helices, as well as
deviations in length and orientation [87]. It was also noted that the distance between α1 and
1It should be noted that apo- and metal-bound CadC structures have been reported [77], but these are with
Zn(II) bound to the α5 site, rather than either Cd(II) or Pb(II) bound to the α3 site.
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Figure 1.11: Illustration of reduced flexibility in CmtR upon binding of cadmium ions to α4C
binding site. Apo-CmtR structure set results from molecular dynamics simulations using the
CYANA algorithm based on NOE measurements of Cd-CmtR, whereas the Cd-CmtR structures
themselves are the 30 lowest energy backbone conformations experimentally determined by
NMR. Taken from [86].
Figure 1.12: Model of DNA binding by HlyU-Vv, indicating that a 15o bend of the DNA is
required to align with the two recognition helices. The two monomers of HlyU-Vv are coloured
green and purple. Taken from [87].
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αR in HlyU-Vv was larger than in SmtB, with the distance between αR helices reduced to 30 A˚
compared to 34 A˚ in SmtB [83]. This indicated that DNA would have to bend by approximately
15o for binding by HlyU-Vv, as shown in Figure 1.12. With this being the case, it is easy to
see how, if the predicted α2α4 cysteine ligand binding model is correct, any further interactions
and stresses around the recognition helix α4 would lead to DNA dissociation.
HlyU does not contain any typical ArsR metal binding sites, instead having cysteines present
in α2 and αR/4 as previously mentioned, and has been shown to be non-responsive to any metal
ligand known to bind to ArsR family members [57]. Work carried out on HlyU-Vc has identified
that Cys38 in helix α2 can be modified to sulfenic acid, hinting at the possibility that this protein
operates as a redox switch [83], similar to the MerR family protein SoxR [58] and the ArsR
family protein BigR (see below). It is interesting to note that the αR-helices in HlyU-Vc are
even closer together than those in HlyU-Vv, only 27 A˚ apart, meaning a DNA bend of 68o is
required for major groove alignment. This is possible in HlyU-Vc as it brings the two β-sheets
into contact with the minor grooves, making HlyU-Vc one of the ArsR family proteins that can
Figure 1.13: Model of crystal structure of HlyU-Vc interacting with DNA, with purple and pink
representing the individual monomers. It can be seen that the β-sheets of the dimer align with
the minor grooves of the DNA, stabilising the bond despite the 68o bend required to align the
major grooves with the recognition helices. Taken from [83].
18
1.2 The ArsR Family 1 INTRODUCTION
(a)
(b)
Figure 1.14: Crystal structure of BigR. (a) Monomer, with disulphide bridge highlighted as
yellow sticks. Red shows the reduced form while blue shows the oxidised form. (b) Dimer in
both reduced (red) and oxidised (blue) form, with the difference in distance between recognition
helices highlighted. As with other ArsR family proteins, this difference is on the order of 4 A˚.
In this alignment, the α1 helices of both forms have been superimposed. Modified from [88].
truly be classified as winged HTH, as seen in Figure 1.13.
Finally, BigR is another example of a winged HTH ArsR family protein which has in this
case been shown conclusively to act as a redox switch [88]. It has been demonstrated that the
formation of a disulphide bridge between C42 and C108 locks the protein in a conformation
which is not amenable to interactions with DNA, as demonstrated in the solved crystal struc-
tures shown in Figure 1.14. Hence it can be seen that when the cell experiences hypoxia, the
BigR dimer will dissociate from DNA, allowing transcription of the regulated genes which, in
this case, encode for a hydrogen sulphide detoxification mechanism.
All of the structures presented here indicate that while there are certain consistent elements
to the structures of ArsR family proteins, there are also characteristics specific to each of the
family members whose structure has been solved. This adds weight to the previous assignment
of at least 8 sub groups being present within the family, as predicted by database analysis
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in [50].
1.3 A Novel ArsR-like Protein Regulating Antibiotic Export?
1.3.1 The Methylenomycin Gene Cluster
Methylenomycin (Mm) A was first characterised in 1974 as an antibiotic produced by Strepto-
myces violaceoruber SANK 95570, active against both Gram-positive and Gram-negative species
[89], although their mechanism of action is still unknown. Further work into the biosynthetic
pathway also led to the identification of Methylenomycin C [90], the structure of which, along
with MmA, is shown in Figure 1.15. It was found that the Methylenomycins were produced by
Streptomyces coelicolor A3(2) by genes on the SCP1 plasmid, making them the first antibiotic
compound whose synthesis and resistance was entirely plasmid determined [91, 92].
These species were found to be resistant to the Mm they produced via the Mmr protein
[93, 94], later found to operate as a membrane integral eﬄux pump through comparison with the
known eﬄux protein Tcr, which provides resistance to tetracycline in E. coli [95]. The mmr gene
was found to be embedded within a cluster of biosynthetic genes, leading to the possibility that
the genes encoding the resistance mechanism may only be transcribed during biosynthesis of
MmA [96]. Plasmid SCP1 has been sequenced in its entirety [97], allowing the Methylenomycin
gene cluster to be fully annotated, a schematic of which is shown in Figure 1.16a. It has been
noted that there is an imperfect inverted repeat within the intergenic region between the mmr
gene and its divergent neighbour, mmyJ, suspected of being a possible transcription factor
binding site [95]. Further investigation indicated that this region, shown in Figure 1.16b, was
indeed protected from RNA polymerase. As it captures the promoter regions for both mmyJ
and mmr genes, it was suspected that the protecting protein was a transcriptional repressor,
Figure 1.15: Structures of Methylenomycin A [89] and C [90].
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(a)
(b)
Figure 1.16: (a) Methylenomycin gene cluster from SCP1 plasmid. This cluster is pictured in
accordance to orientation previously described in the literature [96], even though the sequenced
genome was orientated the other way around [97]. Taken from [99]. (b) Promoter regions
of mmyJ and mmr. Straight arrows indicate repeated sequences, with dots highlighting
mismatches. Colons mark every tenth base pair and wavy arrows indicate mRNA transcription
origins. Sequence originally reported in [95]. Modified from [100].
encoded by the mmyJ gene. It is also known that mmr transcription begins upon production
of MmA [98], and so we propose here that MmyJ is a transcriptional regulator, sensitive to
MmA.
1.3.2 MmyJ: A Novel ArsR Family Protein
MmyJ is encoded by a relatively short gene (336 bp) divergent to mmr and separated by just
218 bps. This position, along with the previously discussed protected region of the intergenic
DNA containing the promoter sequences for both mmyJ and mmr, indicates that MmyJ could
be a self-regulating transcription factor, which also regulates expression of the Mmr eﬄux pump.
MmyJ is a 111 amino acid/12.1 kDa protein, encoded for by the mmyJ gene as displayed
in Figure 1.17. An analysis of the resulting amino acid sequence by NCBI’s pBLAST (protein
Basic Local Alignment Search Tool) [101] returned an ArsR-like classification (see Chapter 2
for more information). Through observation of the amino acid sequence shown in Figure 1.17,
however, it can be seen that this classification is slightly surprising, as there is only a single
cysteine present in the protein at residue 49, and, as previously discussed, cysteine residues
typically form the main ligand site in ArsR proteins. Interestingly, based on predicted protein
structure (Chapter 2), this cysteine lies on the edge of the α3 helix, deviating from the observed
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1 GTG GCG GCA CGG ATC ACG ACA GAG CGC ATC ACC GAC CAT CCG GAC GCT GAC
M A A R I T T E R I T D H P D A D
52 GCC ATC ACC CTC CAG GGC GTC CTG GAC GCG CTG GTC GAT CCG GTG CGC CGC
A I T L Q G V L D A L V D P V R R
103 AGC ATC GTC CGG CAG CTG GCT AAG GCA CCC GAG GAC ATC GCC TGC GGC ACC
S I V R Q L A K A P E D I A C G T
154 TTC GAC ATC ACC GTC TCC CGC TCG ACC GGC ACT CAC CAC TTC AAG GTG TTG
F D I T V S R S T G T H H F K V L
205 CGC CAG GCC GGG ATC ATC AGG CAG TAC TAC ATC GGC ACC TCG AAG ATG AAC
R Q A G I I R Q Y Y I G T S K M N
256 ACG CTT CGC ACC GAT GAT CTC GAT CAG GCC TTC CCC GGC CTG CTC ACC GCG
T L R T D D L D Q A F P G L L T A
307 ATC GTC GAC GCC GCG GCC AGG GAG AGC TGA AAA AAA AAA AAA AAA AAA AAA
I V D A A A R E S - AAA AAA AAA AAA AAA AAA AAA
Figure 1.17: Genetic sequence and corresponding amino acid sequence for MmyJ [97].
pattern of suspected non-metal binding ArsR proteins containing the α2α4 motif. However, as
this system is regulating Mm production, and is not proposed to involve metal sensing, it is
possible that cysteine residues are not needed if MmA or one of its biosynthetic intermediates
is sensed by MmyJ. If this is the case it would be the first reported instance of an ArsR family
protein sensing a non-metallic ligand.
1.4 Project Aims & Objectives
The main aim of this project is to investigate MmyJ and determine its structure and function,
and hence conclude whether it is truly a novel ArsR-like transcriptional repressor and is the
first instance of an ArsR family protein known to bind an organic molecule, rather than a
metallic ligand. An in depth bioinformatics analysis will be carried out, alongside experimental
work with expressed protein and amplified fragments of the mmr-mmyJ intergenic region to
determine binding characteristics. Work will also be carried out into identifying the binding
ligand and/or conditions that cause dissociation of MmyJ from DNA if it is proven to be
a transcription factor. Also, attempts will be made to confirm that the identified imperfect
inverted repeat surrounding the mmyJ/mmr promoter regions is in fact the binding site of
MmyJ, confirming its role as a transcriptional repressor of itself as well as mmr. Once the DNA
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target region and ligand have been identified, surface plasmon resonance (SPR) will be used to
determine the binding kinetics of the interactions.
As well as the above functional investigation, work will be carried out to determine MmyJ’s
structure by solution and solid state NMR, as well as X-Ray crystallography if conditions can
be determined that lead to crystallisation of the protein. From this, work will then be carried
out, if possible, to observe the structure of MmyJ when bound to both DNA and its ligand,
with the hope that direct comparisons between these structures and that of apo-MmyJ will lead
to insights into the specific residues needed for each interaction. Data acquired through NMR
will also be used to complement the analysis by SPR, investigating the link between residue
mobility and binding kinetics at the interaction sites.
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2 Bioinformatic Analysis of MmyJ
Before characterising MmyJ by experimental means, bioinformatic studies were carried out to
investigate MmyJ and determine its similarities and differences to other ArsR proteins.
2.1 MmyJ - Basic Properties
The amino acid sequence for MmyJ is shown in Figure 2.1. This was first determined by forming
a cosmid library based on the linear plasmid SCP1 from S. coelicolor A3(2), sequencing it and
translating the coding sequences (CDS) from these cosmids. Specifically, cosmid C73 contains
the entire methylenomycin pathway [99]. As can be seen, the resulting protein corresponding
to the mmyJ gene is 111 amino acids long, with a corresponding mass of 12135.8 Da. The
amino acid composition can be seen in Figure 2.1b. This sequence was then entered into
the ProtParam [102] web tool in order to calculate basic physical properties of the protein,
relevant for later work. One such property calculated was the extinction coefficient, found
to be 2980±300 M−1cm−1, corresponding to an absorbance at 280 nm of 0.246±0.02 when
at a concentration of 1 g/L.2 This allowed the concentration of MmyJ to be determined when
produced in the laboratory (although a modification to 0.281±0.03 was required for recombinant
MmyJ with histidine tag, as described in Section 3). Also, the computations indicated that
2Calculated uncertainty of 10% in approximation of extinction coefficient is due to lack of Trp residues [102].
10 20 30 40 50 60
MAARITTERI TDHPDADAIT LOGVLDALVD PVRRSIVROL AKAPEDIACG TFDITVSRST
70 80 90 100 110 h
GTHHFKVLRQ AGIIRQYYIG TSKMNTLRTD DLDQAFPGLL TAIVDAAARE S
(a)
(b)
Figure 2.1: (a) Amino acid sequence and (b) amino acid composition of MmyJ, determined by
coding sequence (CDS) analysis.
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MmyJ may be unstable, with a calculated instability index of 45.39, and so measures were
taken when expressed to improve stability, such as ensuring the protein was kept in solution
containing 10% glycerol (see Chapter 3 for more information regarding protein handling after
expression).
2.2 Motif Recognition & Alignment
2.2.1 BLAST Analysis & Classification
Initial classification of MmyJ as an ArsR protein was carried out by entering the protein
sequence shown in Figure 2.1 into BLAST (Basic Local Alignment Search Tool) [101]. Figure 2.2
shows the conserved domains detected using the BLASTp algorithm3 to compare the amino
acid sequence of MmyJ to the NCBI nr database4 [103, 104, 105, 23]. It can immediately be seen
that there is a specific hit identifying residues 25-83 as an ArsR helix-turn-helix (HTH) motif.
The motif was assigned with an expected value of 1.10 × 10−6, giving the result moderately
high significance (expected value indicates the likelihood that the motif is recognised purely
by chance rather than there being a true assignment). However, the lowest expected value
belongs to the assignment of the general ArsR identification of residues 8-103, with a value
of 8.43 × 10−10, and so even if the exact assignment of the HTH ARSR motif is incorrect, it
is highly likely that MmyJ is still an ArsR family protein. The other non-specific hits, the
second possible HTH ARSR and HTH 5 domains, have expected values of 1.19 × 10−9 and
9.9 × 10−7 respectively, offering alternative assignments in the case of the specific hit proving
to be inaccurate. The closeness in expectation values of these possibilities implies that while
it is likely that there is a HTH motif within the area identified as being ArsR-like, its precise
location perhaps cannot be determined by this method.
3BLASTp is a form of BLAST optimised for comparing protein sequences.
4The nr, or non-redundant, database contains sequences from GenBank translations as well as Refseq, PDB,
SwissProt, PIR and PRF databases with duplicate sequences removed.
Figure 2.2: Graphical summary of conserved domains within MmyJ, identified using NCBI
BLASTp.
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(a) (b) (c) (d)
Figure 2.3: Crystal structure of SmtB viewed in Cn3D. The isolated monomer is shown in (a),
with pink balls in (b), (c) and (d) representing putative DNA binding sites, dimeric interfaces
and Zn2+ binding sites respectively [80].
However, it is still worth looking closer at the specific hit indicated in Figure 2.2, as part of
this assignment includes the identification of 20 putative DNA binding sites out of the 24 that
are thought to be conserved as part of the motif, specifically those identified in SmtB [80, 23].
Figure 2.3 displays the position of these putative DNA binding sites on the structure of SmtB,
along with dimer interface region and Zn2+ binding sites. The predicted structure of MmyJ is
compared to SmtB in Section 2.3, and so it is discussed there whether the highlighted DNA,
dimer and Zn2+ binding sites could share common features to that of MmyJ.
Another aspect of the BLAST output is statistical analysis of the degree of overlap, identity
and similarity between a queried sequence and the closest protein sequences in the database,
with the default being the top 100 matched; the top 10 of which are shown in Table 2.1. While
some caution should be taken when using this analysis (for example if the 5 residues on the
N-terminal of the query sequence match the 5 residues on the C-terminal on a sequence in the
database, the analysis will return 100% identity but only for a small degree of overlap), it is
possible to extract useful information. In this instance, it was discovered that of the 100 closest
protein sequences in the database, 80 were classified as ArsR proteins, with all others being
hypothetical proteins with no assigned function at the time of analysis, further cementing
the conclusion that MmyJ is indeed an ArsR protein. Of these 80 sequence alignments, all
but one had 50% or higher identity over 90 or more amino acids of the MmyJ sequence. The
average identity over all 80 sequences was 58.87% over 90 or more amino acids, with the average
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Description and Species % ID % Cover Accension #
ArsR family transcriptional regulator 92 100 WP 030742020.1
Streptomyces NRRL S-31
hypothetical protein 75 99 WP 030742020.1
Streptomyces 351MFTsu5.1
ArsR family transcriptional regulator 72 94 WP 020419963.1
Amycolatopsis (Multispecies)
ArsR family transcriptional regulator 72 90 WP 052868623.1
Streptomyces niger
ArsR family transcriptional regulator 70 100 WP 030286058.1
Streptomyces (Multispecies)
hypothetical protein SBI 00765 70 83 ADI03886.1
Streptomyces bingchenggensis BCW-1
ArsR family transcriptional regulator 70 95 WP 037721374.1
Streptomyces mirabilis
ArsR family transcriptional regulator 69 96 WP 035791758.1
Kitasatospora mediocidica
ArsR family transcriptional regulator 68 88 WP 007625248.1
Gordonia soli
hypothetical protein 68 90 ADC45569.1
Streptomyces nanchangensis
Table 2.1: Top ten hits when comparing the sequence of MmyJ to the nr database using
BLASTp, listed by percentage identity (ID). All can be seen to have high identity and cover.
The top two hits are thought to be orthologues of MmyJ (see Section 2.4).
similarity (allowing for substitution of amino acids for others with similar properties) found
to be 76.08% over the same range. This indicates a very high degree of homology with a
significant number of ArsR proteins. It is also worth noting that all of the expected values for
the alignments included in the above analysis were of the order 10−31 or lower and so it can
confidently be stated that these represent true alignments statistically.
2.2.2 Prosite Comparison with other ArsR Family Proteins
In order to further compare MmyJ to similar proteins, the sequences of SmtB, ArsR and 7 other
ArsR family proteins were selected from those mentioned in [51], details of which can be seen
in Table 2.2. These proteins were selected as they are produced by a range of species, with 4
produced by Gram-negative and 5 by Gram-positive organisms, as well as sensing a range of
metals, binding between 0 and 4 of the 10 metals known to bind to ArsR proteins. In this way
it was hoped to attempt a broad comparison across the ArsR family.
Amino acid sequences for the proteins shown in Table 2.2 were obtained from the GenBank
database [110] hosted by NCBI. These, along with the sequence for MmyJ, were then entered
into ExPASy’s ScanProsite tool [107], which compares user defined sequences with a database
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Name Organism GenBank ID Metals Sensed [51]
SmtB Synechococcus elongatus PCC 7942 (-) CAA45872.1 Zn
ArsR Acinetobacter baumannii (-) AFC76435.1 As, Sb
ZiaR Bacillus thuringiensis Bt407 (+) AFV16327.1 Zn
BxmR Oscillatoria brevis (-) BAD11074.1 Cu, Ag, Cd, Zn
CadC Staphylococcus aureus (+) AEH58925.1 Cd, Pb, Zn
CzrA Bacillus amyloliquefaciens (+) TA208 YP 005541188.1 Zn, Co
HlyU Vibrio cholerae (-) CAA47336.1 None
KmtR Mycobacterium tuberculosis H37Rv (+) NP 215342.1 Ni, Co
CmtR Mycobacterium tuberculosis H37Rv (+) CCP44766.1 Cd, Pb
Table 2.2: Details of proteins included in a test set of ArsR family proteins for comparison with
MmyJ. (+) and (-) at the end of each species denotes its response to the Gram staining test,
as listed in [106]. Note: the organism listed corresponds to the orthologue of each protein as
listed in Figure 2.4.
>MmyJ .............................MAARITTERITDHPDADAITLQGVL
>SmtB ..............MTKPVLQDGETVVCQGTHAAIASELQAIAPEVAQSLAEFF
>ArsR ..........................................MSENMDQINFFK
>ZiaR ...........MAGNKVETPQETCSQTIIHEEVVEQVKQTIPTDESLSKVAELF
>BxmR MSPKSAVNGAISQPHQENDTPTCDRAHLVDCSRVGDIQTQVLNTAKAQRMAEFF
>CadC ..................MTKDMCEVTYIHEDKVNRAKKDLAKQNPMDVAKVFK
>CzrA .........................MTEFHESGNKNDPAVDLDEETLFLVAQTF
>HlyU .........................................EMEKNSAKAVVLL
>KmtR ................................MYADSGPDPLPDDQVCLVVEVF
>CmtR .......................................MLTCEMRESALARLG
>MmyJ DALVDPVRRSIVRQLAKAPEDIACGTFDITVSRSTGTHHFKVLRQAGIIRQYYI
>SmtB AVLADPNRLRLLSLLARSELCVGDLAQAIGVSESAVSHQLRSLRNLRLVSYRKQ
>ArsR CLADETRFNIVMLVLGNNEQCVCDLTEKLELSQPKISRHLALLRSSGLLQDRRQ
>ZiaR KVLGDRTRTRILHALFEAEMCVCDLAYLLGMTQSSISHQLRVLKQAKLVKNRKE
>BxmR SLLGDANRLRLVSVLAKQELCVCDLAATLGMSESAVSHQLRAMRAMRLVSYRKV
>CadC ALSDDTRVKIAYVLSLEGELCVCDVANIIESSTATASHHLRLLKNLGIAKYRKE
>CzrA KALCDPTRIRILHLLSQGEHAVNDIAEKLNLLQSTVSHQLRFLKNLRLVKSRRE
>HlyU KAMANERRLQILCMLLDNELSVGELSSRLELSQSALSQHLAWLRRDGLVNTRKE
>KmtR RMLADATRVQVLWSLADREMSVNELAEQVGKPAPSVSQHLAKLRMARLVRTRRD
>CmtR RALADPTRCRILVALLDGVCYPGQLAAHLGLTRSNVSNHLSCLRGCGLVVATYE
>MmyJ GTSKMNTLRTDDLDQAFPGLLTAIVDAAARES......................
>SmtB GRHVYYQLQDHHIVALYQNALDHLQECR..........................
>ArsR GQWVYYSLNPNLPTWCIEVLNTVKNSDLQPKVAPSFQQINSYCE..........
>ZiaR GKVVYYSLADQHVIHIFEQAFEHVNEEE..........................
>BxmR GRQVFYSLLDRHVLELYRAVAEHLDEES..........................
>CadC GKVVYYSLDDEHVKQLVEKAFLYQREVASIG.......................
>CzrA GTSIYYSPEDEHVLDVLQQMIHHTRHD...........................
>HlyU AQTVFYTLSSTEVKAMIELLHRLYCQAN..........................
>KmtR GTTIFYRLENEHVRQLVIDAVFNAEHAGPGIPRHHRAAGGLQSVAKASATKDVG
>CmtR GRQVRYALADSHLARALGELVQVVLAVDTDQPCVAERAASGEAVEMTGS.....
Domain (HTH ArsR Type)
DNA_Bind (H-T-H Motif)
Metal Binding Site (Incomplete)
Figure 2.4: Predicted domains, motifs and metal sites in MmyJ, SmtB, ArsR and 7 other
selected ArsR family protein sequences. Red residues indicate predicted metal binding sites
thought by the algorithm to be incomplete. Analysis was carried out using ScanProsite [107]
and the PROSITE database [108, 109].
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[108] according to PROSITE methodology [109] in order to identify motifs and functional sites.
The result of this analysis can be seen in Figure 2.4, and clearly there is a conserved motif
between all 10 protein sequences: namely that identified as DNA Bind (H-T-H Motif). Whilst
all test proteins are also identified as containing the generic HTH ArsR Type Domain, the
length of this varies between proteins, as does the position of the DNA binding motif within
this generic domain. As such, it is concluded that the DNA binding motif is the key part of
the ArsR domain as defined by PROSITE, and hence this is used as further evidence of MmyJ
being identified as an ArsR type protein. It is interesting to note that all metal sites predicted
to be part of an ArsR motif by PROSITE are absent in the amino acid sequence of MmyJ,
possibly indicating that it is not a metal binding protein. However, the same can be said for
HlyU, KmtR and CmtR and, while HlyU has been shown not to bind to metal ions, KmtR and
CmtR are both known to be metal binders, hence no adequate conclusion can be drawn from
their predicted absence from MmyJ.
By comparing this PROSITE analysis to the previous one done with BLAST, it can be seen
that the HTH ArsR domain, identified by BLAST, corresponds to just a section of the HTH
ArsR Type domain, identified by PROSITE, although it also contains the entire DNA Bind
(H-T-H Motif) sequence, indicating a high level of confidence in the presence of an ArsR
type HTH domain within MmyJ. However, the two analyses are slightly contradictory in their
prediction of DNA binding sites - only 10 of the 20 identified by BLAST in Figure 2.2 coincide
with the HTH motif as identified by PROSITE, demonstrating how these analyses cannot be
simply taken at face value.
2.2.3 MEME Analysis
The amino acid sequences identified as comprising an ArsR family DNA binding HTH motif by
PROSITE were extraced and analysed further using the MEME online tool [111]. The result
of this analysis can be seen in Figure 2.5. While there are no instances of a single amino acid
being conserved across all 10 proteins, there are at least several points where amino acid type
is conserved, for example residues 8, 19 and 22 being conserved as hydrophobic.
It is apparent from Figure 2.5 that, while MmyJ has the highest p-value (equivalent to the
expected value previously explained for BLAST) and therefore can be thought of as the least
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Figure 2.5: Graphical output showing conservation of amino acids (both individually and
grouped by types) from the MEME online tool [111]. Blue indicates hydrophobic residues,
green indicates polar, non-charged, non-aliphatic residues, magenta indicates acidic residues
and red indicates positively charged residues. Pink, orange, yellow and turquoise indicate
ungrouped residues. Grey indicates that residues are not identified as being part of the motif.
Proteins are ranked in order of ascending p-value.
likely protein sequence out of the 10 submitted to actually contain this motif, there is still a
high degree of alignment between it and the other proteins tested. It is logical that there is
some variation within this motif as each protein is likely to bind to a different sequence of DNA
and, as such, it is still felt that MmyJ contains this motif with a high significance. Hence, it
can be concluded that MmyJ is an ArsR family protein and does appear to contain a typical
HTH DNA binding domain.
2.3 Homology Modelling
Having established with confidence that MmyJ is an ArsR-type protein, homology modelling
was carried out to approximate its 3D structure.
2.3.1 Monomer
The amino acid sequence for MmyJ was entered into the Phyre2 web portal [112]. This algorithm
finds homologues using PSI-BLAST5 [113], before constructing models based on structural
information found for these homologues and iterating these models until the resulting structure
is of sufficiently high quality. Figure 2.6 shows the best predicted 3D structure of MmyJ from
5PSI-BLAST differs from the previously used BLASTp algorithm in that it uses position specific scoring
matrices, unique to each sequence comparison, rather than the pre-defined scoring matrices traditionally used
in BLAST. This increases sensitivity of the search but also increases computation time.
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Figure 2.6: Phyre2 homology model of MmyJ based on template c2lkpB, the solution structure
of NmtR. This structure models 93 residues (84% of MmyJ sequence) with a confidence of
99.9% or higher. Chain is coloured such that N terminus is blue and C terminus is red. Helices
are numbered 1-5.
this system, comprising 5 α-helices, numbered from N to C terminal, and a single antiparallel
β-sheet. In this way, the ArsR HTH motif, and hence suspected DNA binding site, incorporates
helices α3 and α4 plus the turn between them. This model is based on the NMR structure of
NmtR which, incidentally, was not included in the original test set but is a nickel and cobalt
binding transcriptional repressor found in Mycobacterium tuberculosis, similar to KmtR but
with a different binding environment [51].
Figure 2.7 displays the structure and disorder confidence levels associated with the model
shown in Figure 2.6. It can be seen that, for the most part, the only regions with high
Figure 2.7: Confidence levels in prediction of secondary structure (helices labelled as in
Figure 2.6) and local disorder of MmyJ homology model based on template c2lkpB. Residue text
colour indicates hydrophobic (green), small/polar (orange), charged (red) or aromatic/cysteine
(purple) nature.
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Figure 2.8: Superposition of the c2lkpB model with the 6 other models with a TM-score of 0.7
or higher when compared to c2lkpB. These models were based on templates c1r22B (SmtB),
d1r1ta, d1r1ua, c4omzG (NolR), c3jthA (HlyU) and c3cuoB (YgaV). RMSD of all models is
between 1.484 and 1.995 A˚
disorder/low structure confidence are the ends of the molecule (typically the most flexible
part of a protein), with a single point of high disorder within the turn between helices 3 and 4,
although as this is the suspected DNA binding site, a degree of flexibility is expected.
Finally, Figure 2.8 displays a superposition of the 6 other models produced by the Phyre2
algorithm with a confidence of 99.9% that are also classified as ‘Highly Similar’ to the c2lpB
model by having a TM-score (measuring the degree of similarity between tertiary protein
structures on a scale of 0 to 1 [114]) of 0.7 or higher when compared to this best predicted
structure. As expected from the confidence levels of the c2lpB model, it can be seen that the
highest level of degeneracy is at the ends of the structure, with good agreement between the
models demonstrated for the majority of α-helical residues.
2.3.2 Dimeric Interface
In order to model the expected hydrogen bonded homodimer, the pdb file generated by Phyre2
for MmyJ was uploaded to the HADDOCK web portal [115, 116]. The resulting docking model
can be seen in Figure 2.9 and it is apparent that there is significant deviation around the N
terminal region from Figure 2.6, with a longer disordered region and helix α1 appearing much
shorter. However, as the Phyre model had high confidence of disorder in this region, there is
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Figure 2.9: Predicted MmyJ dimer modelled by HADDOCK [115, 116]. Each individual chain
is coloured blue to red from N to C terminus as in Figure 2.6.
no concern over this issue. The Root Mean Squared Deviation (RMSD) between this predicted
dimer model and the Phyre2 monomer was calculated using PyMOL [42] as shown below
RMSD =
√∑
dii
2
N
(2.1)
where dii is the distance between the i
th atoms in each sequence and N is the number of atoms
matched in each structure. In this case, the RMSD between the Phyre2 monomeric model and
HADDOCK dimeric model was calculated to be 2.132 A˚ across 88 atoms (excluding outliers).
It is thought that this could be a demonstration of the conformational change required to bind
to DNA, although structural data would ideally be needed to confirm this assumption.
It is interesting to note that the dimeric interface predicted by HADDOCK matches the
approximate interface locations predicted initially by BLAST based on SmtB (see Figure 2.3),
with helices 1 and 5 providing the majority of the dimer interface, leaving helices 3 and 4
(thought to be the ArsR HTH domain) exposed on the edge of the dimer for each monomer.
2.3.3 Alignment with ArsR Structures
Following on from the previously mentioned RMSD calculation between the predicted MmyJ
monomer and dimer, two structures solved by solution NMR and two solved by X-ray crystal-
lography were obtained for other ArsR family proteins from the PDB so that a similar alignment
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(a) SmtB (b) NmtR
(c) CzrA (d) RHA00566
Figure 2.10: Alignments of four solved ArsR family structures with HADDOCK model of MmyJ
dimer. In all figures the MmyJ dimer is coloured lime green and turquoise for the two individual
monomers, while the compared structure is shown as a single colour.
Name PDB ID Structure Type Citation RMSD (wrt MmyJ)
SmtB 1R1T XRD (1.70 A˚) [84] 4.542 A˚ over 139 atoms
NmtR 2LKP Solution NMR [117] 4.318 A˚ over 131 atoms
CzrA 2KJB Solution NMR [81] 5.106 A˚ over 155 atoms
RHA00566 3F6O XRD (1.90 A˚) [118] 7.339 A˚ over 136 atoms
Table 2.3: Details of protein structures compared to predicted MmyJ dimer in Figure 2.10.
Structures are either characterised by X-Ray Diffraction (XRD) or Nuclear Magnetic Resonance
(NMR) experiments. RMSD calculated as shown in Equation 2.1.
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could be carried out against those. Again, this was done in Pymol with RMSD values calculated
as before. Figure 2.10 illustrates these alignments, with details of the structures used shown in
Table 2.3.
While the RMSD values shown in Table 2.3 are higher than those between the solved
structures (for example the RMSD between SmtB and NmtR was found to be just 2.285 A˚ over
178 atoms), this is understandable given that the MmyJ structure is only a predicted model.
However, it is still thought that these RMSD values are low enough to indicate a good match,
giving confidence in the HADDOCK structure. Also, through visual inspection of the overlay of
the solved structures with that predicted of MmyJ, it is clear that the dimeric interface appears
to have been predicted correctly and that the ArsR HTH regions are in similar positions, further
indicating that this simulation is likely a good prediction of the MmyJ structure.
2.4 MmyJ Orthologues
Methylenomycin-related gene clusters have been identified in two other Streptomyces species via
NCBI BLAST [101]: S. sp. NRRL S-31 [119] and S. sp. 251MFTsu5.1 [120]. Protein sequences
encoded within these clusters were previously identified as the two hits from BLASTp analysis
with the highest percentage identity to MmyJ and, as such, are thought to be examples of
orthologues of MmyJ. When comparing the mmr and mmyJ genes and associated intergenic
region of these other clusters it was noted that the orthologues were both 123 amino acids
Figure 2.11: Phyre2 models of original MmyJ sequence (green) and N-terminal extended version
(red) annotated with the extra 12 amino acids incorporated.
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MmyJ (ext) MVERHATRRRTAVAARITTERITDHPDADAITLQGVLDALVDPVRRSIVRQLAKAPEDIA 60
NRRL_S-31 MAGQHSTRRRTTVAARITTERITDHPEADAINLQGVLDALVDPVRRSIVRQLAQAPEDIA 60
351MFTsu5.1 ---MCSGTGRHEVTARTAEERITDHPDAQDITLQGVLEALADPVRRSIVRQIAGAADERK 57
: * *:** : *******:*: *.*****:**.**********:* *.::
MmyJ (ext) CGTFDITVSRSTGTHHFKVLRQAGIIRQYYIGTSKMNTLRTDDLDQAFPGLLTAIVDAAA 120
NRRL_S-31 CGTFDITVSRSTGTHHFKVLRQAGIIRQYYVGTSKMNALRIDDLEQAFPGLLTAIVNAAA 120
351MFTsu5.1 CGTFDISVTRSTGTHHFRVLRQSGIIRQYYMGTSKMNILRRDDLDRAFPGLLDAVVEAAN 117
******:*:********:****:*******:****** ** ***::****** *:*:**
MmyJ (ext) RES--- 123
NRRL_S-31 RET--- 123
351MFTsu5.1 REVARR 123
**
Figure 2.12: ClustalW2 alignment of the extended version of MmyJ from S. coelicolor A3(2)
compared with orthologues from S. sp. NRRL S-31 and S. sp. 351MFTsu5.1. Amino acids
not previously included in MmyJ analyses are underlined. Asterisks indicate fully conserved
residues, colons indicate conservation between groups of strongly similar properties and periods
indicate conservation between groups of weakly similar properties. Strongly similar and weakly
similar are defined as scoring greater than, or less than or equal to 0.5 in the Gonnet PAM 250
matrix [121]. Colours indicate grouping of amino acids as small or hydrophobic (red), acidic
(blue), basic (pink) or containing a hydroxyl, sulfhydryl or amino side chain (green).
long; 12 amino acids longer than MmyJ. After further inspection of the S. coelicolor A3(2)
methylenomycin gene cluster, it was noticed that there was a second possible start codon for
MmyJ, which would make it 123 amino acids long as in the orthologous systems. Figure 2.11
shows the possible extended version of MmyJ, along with a new Phyre2 homology model with
the extra 12 N-terminal amino acids included. It can be seen that these extra amino acids are
predicted to have no impact on the overall fold of the protein, with the only differences being
apparent in helix 1, which is now slightly shorter, and the disordered N-terminal region, which
is now longer. As such, it is not thought to be important whether these extra amino acids are
included, and so all previous analyses are still expected to be valid.
Figure 2.12 shows the protein sequence of MmyJ from S. coelicolor A3(2) aligned with the
two orthologues from S. sp. NRRL S-31 and S. sp. 251MFTsu5.1 using ClustalW2 [122]. It
can be seen that there is a high degree of similarity between the three orthologues, with 65%
identity across all three amino acid chains. Including those amino acids deemed to have strongly
similar properties, the three orthologues can be said to have 80% similarity in total, strongly
suggesting that they are indeed true orthologues.
It is interesting to note that the ArsR HTH DNA binding domain, previously identified in
MmyJ by PROSITE (transposed now to amino acids 59 to 82 due to the additional 12 amino
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acids at the N terminus), is one of the highest conserved regions of the three protein sequences,
with 79% identity and 92% similarity across all three orthologues. The region contains only 2
residues not deemed to be at least strongly similar according to the Gonnet PAM 250 similarity
matrix [121]. This leads to the expectation that, should MmyJ truly behave as an ArsR protein
as thought and inhibit the expression of the eﬄux pump protein Mmr until required by binding
to the DNA between the mmr and mmyJ genes, then it can be assumed that the DNA target
region should also be highly conserved across all three orthologues.
2.5 Target DNA Sequence
Under the assumption that the DNA target region for MmyJ lies in the intergenic region between
mmr and mmyJ, and that it is conserved across all three orthologues, the three intergenic
regions were submitted to MEME for analysis, with motifs discovered shown in Figure 2.13
[111]. While the blue and green motifs have e-values higher than 0.05, and can therefore be
dismissed as insignificant, the red motif with and e-value of 3.8e-11 can be assumed to have
quite high significance and, therefore, it is likely that the DNA binding target lies in this region.
(a)
(b) Red motif; e-value 3.8e-11
(c) Blue motif; e-value 9.1e+1 (d) Green motif; e-value 4.8e+2
Figure 2.13: Results of MEME analysis of intergenic region between mmr and mmyJ genes in
S. coelicolor A3(2) and analogous systems. Motifs highlighted in (a) are expanded and labelled
by colour as motifs (b) - (d).
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(a)
(b)
Figure 2.14: (a) Sets of semi-conserved inverted palindromic sequences identified as protected
via DNA fingerprinting [100]. mmyJ and mmr signify the start of the transcription start sites
for each gene. Base numbers correspond to 1 being the start of the intergenic region with
colons indicating groups of 10 nucleotides from this start point. Sequence reversed compared to
Figure 1.16. Purple line identifies start codon of possible extended 123 residue version of MmyJ.
Orange line corresponds to motif shown in (b), identified by MEME as being common across all
three mmr -mmyJ orthologues when weighted towards the semi-conserved palindromic regions
identified in [100]. This motif was returned with an e-value of 5.7e-19.
DNA fingerprinting techniques have previously identified a protected area of the mmr -mmyJ
intergenic region [100] containing a semi-conserved inverted palindromic repeat sequence of the
type usually associated with DNA-binding proteins [18, 123]. This region is illustrated in
Figure 2.14a. It can be seen that there are several possible sets of semi-conserved inverted
palindromic repeats to which MmyJ could bind, all of which are around the -35 promoter sites
for both mmr and mmyJ. This implies that binding at any of these palindromic sites would
block the promoter region and, therefore, inhibit production of both MmyJ and Mmr proteins.
It is worth noting at this point that an investigation of this region of the gene cluster was
undertaken to see if there was any significance in the placement of the two possible start codons
for MmyJ with regard to the promoter site. In this way it was hoped that it could be confirmed
whether MmyJ is comprised of the 111 amino acids originally thought, or whether the 123
amino acid extended version is the true sequence. It was found that the ATG start point for
the extended version lies within the previously identified -10 site in Figure 2.14a, as shown by
sequence underlined in purple. As the origin of transcription of MmyJ has previously been
confirmed [99], it can be concluded that the extra 12 amino acids are not incorporated into the
protein, and as such that MmyJ is indeed 111 residues long as originally thought.
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In order to further investigate these DNA binding sites, the previous MEME analysis
was re-run with the total possible palindromic region (as indicated by the blue arrows in
Figure 2.14a) added as a fourth sequence, thereby weighting the analysis towards this region. In
this way, it was hoped that a motif would be recognised that incorporates one whole palindromic
sequence, be it the blue, red or green one indicated in Figure 2.14a. This analysis produced
a similar motif pattern to that shown in Figure 2.13, but the main motif recognised is shorter
than previously, with a lower e-value of 5.7e-19. This new motif is shown in Figure 2.14b [111]
and corresponds to bases 130 to 168 of the mmr -mmyJ intergentic region in S. coelicolor
A3(2). From the regions shown in Figure 2.14a, this can be seen to incorporate either the
red palindromic sequence (with half of the extra repeat) or the inner-most green palindromic
sequence. As ArsR family proteins typically bind to an imperfect 12-2-12 inverted sequence [28],
and the red palindromic sequence highlighted in Figure 2.14a and incorporated into the motif
shown in Figure 2.14b is a 13-1-13 semi-conserved inverted palindromic repeat, it is assumed
that this is the most likely DNA binding site and will be investigated further by experimentation
(see Chapter 5).
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3 Protein Overproduction & Purification
3.1 Protein Overproduction
In order to overproduce and purify His6-MmyJ from E. coli, the mmyJ gene was first cloned
into a suitable expression vector with an inducible promoter.
3.1.1 Cloning mmyJ
There were several factors to consider when choosing an appropriate expression vector. Firstly,
the vector would need to have a fusion tag included so that the recombinant protein could
easily be purified. Due to the high affinity of histidine for metal ions, including nickel (see
Section 3.1.3), it was decided that a histidine tag would be an appropriate choice. The
Champion™ pET Directional TOPO® Expression Kit from Invitrogen™ [124] was chosen due
to the ease of using the TOPO cloning method to insert the desired gene into the expression
vector. As the vectors in these kits offer a choice of either 6xHis or His-Patch (HP) Thioredoxin
tag, consideration had to be given to the type of tag used. Due to the mmyJ gene being only
336 bp long, the 6xHis tag (96 bp) was chosen over HP Thioredoxin (330 bp) so that the overall
increase in length of the complete fusion protein compared to MmyJ was minimised, in order
to reduce the risk of non-native protein folding.
Secondly, it was decided that a cleavage site should be included to allow the removal of
the histidine tag, if required, for further experimentation. Again, the range of TOPO cloning
kits offered a choice between enterokinase or tobacco etch virus (TEV) cleavage sites. As TEV
was already used by another group in the laboratory, and so would be easily available, it was
decided that this would be the more suitable choice. This combination of 6xHis tag and TEV
cleavage site meant that the pET151/D-TOPO™ plasmid would be a sensible choice for this
work.
The plasmid map from the kit’s manual is shown in Figure 3.1, with the inclusion of an
ampicillin resistance gene that can be used as a selection marker. It can be seen, that as well as
the 6xHis tag, a V5 epitope is included which, together with the TEV cleavage site, brings the
total tag length to 96 bp, corresponding to approximately a third of the length of the mmyJ
gene. After TEV protease cleavage there would only be 6 amino acids extra added to the
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(a)
(b)
Figure 3.1: (a) pET151 plasmid map and (b) DNA sequence of 6xHis tag (and corresponding
amino acid sequence) including preceeding lac operator, taken from [124]. Complete vector
sequence is available from http://www.invitrogen.com.
N-terminus of the recombinant MmyJ, which was expected to have a negligible effect on the
protein fold, even if there was an effect from the full length tag.
The mmyJ gene was amplified for insertion into the pET151 vector by PCR using Roche
High Fidelity Polymerase and oligonucleotide pair 2 (see Section 8.1.3). The resulting PCR
product was inserted into the pET151 plasmid in accordance with the instructions in [124],
which was then transformed into E. coli Top10 cells. A colony was picked and a glycerol stock
was prepared. The plasmid was extracted from a culture inoculated with this glycerol stock
and 20 µL was sent for sequencing by GATC with the standard T7 primer (oligonucleotide 1).
Figure 3.2 shows the resulting sequencing data, along with the expected sequence for the pET151
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pET151mmyJ 1 -----------------------------------------------atg
MmyJ-Top10-T7 1 gaattcctctagaatattttgtttaactttaagaaggagatatacatatg
pET151mmyJ 4 catcatcaccatcaccatggtaagcctatccctaaccctctcctcggtct
MmyJ-Top10-T7 51 catcatcaccatcaccatggtaagcctatccctaaccctctcctcggtct
pET151mmyJ 54 cgattctacggaaaacctgtattttcagggaattgatcccttcaccgtgg
MmyJ-Top10-T7 101 cgattctacggaaaacctgtattttcagggaattgatcccttcaccgtgg
pET151mmyJ 104 cggcacggatcacgacagagcgcatcaccgaccatccggacgctgacgcc
MmyJ-Top10-T7 151 cggcacggatcacgacagagcgcatcaccgaccatccggacgctgacgcc
pET151mmyJ 154 atcaccctccagggcgtcctggacgcgctggtcgatccggtgcgccgcag
MmyJ-Top10-T7 201 atcaccctccagggcgtcctggacgcgctggtcgatccggtgcgccgcag
pET151mmyJ 204 catcgtccggcagctggctaaggcacccgaggacatcgcctgcggcacct
MmyJ-Top10-T7 251 catcgtccggcagctggctaaggcacccgaggacatcgcctgcggcacct
pET151mmyJ 254 tcgacatcaccgtctcccgctcgaccggcactcaccacttcaaggtgttg
MmyJ-Top10-T7 301 tcgacatcaccgtctcccgctcgaccggcactcaccacttcaaggtgttg
pET151mmyJ 304 cgccaggccgggatcatcaggcagtactacatcggcacctcgaagatgaa
MmyJ-Top10-T7 351 cgccaggccgggatcatcaggcagtactacatcggcacctcgaagatgaa
pET151mmyJ 354 cacgcttcgcaccgatgatctcgatcaggccttccccggcctgctcaccg
MmyJ-Top10-T7 401 cacgcttcgcaccgatgatctcgatcaggccttccccggcctgctcaccg
pET151mmyJ 404 cgatcgtcgacgccgcggccagggagagctgaccggccaccgctcgcccg
MmyJ-Top10-T7 451 cgatcgtcgacgccgcggccagggagagctgaccggccaccgctcgcccg
pET151mmyJ 454 cacggcgctccaaagggcgagctcagatccggctgctaacaaagcccgaa
MmyJ-Top10-T7 501 cacggcgctccaaagggcgagctcagatccggctgctaacaaagcccgaa
pET151mmyJ 504 aggaagctgagttggctgctgccaccgctgagcaataactagcataaccc
MmyJ-Top10-T7 551 aggaagctgagttggctgctgccaccgctgagcaataactagcataaccc
pET151mmyJ 554 cttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaac
MmyJ-Top10-T7 601 cttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaac
pET151mmyJ 604 tatatccggatatcccgcaagaggcccggcagtaccggcataaccaagcc
MmyJ-Top10-T7 651 tatatccggatatcccgcaagaggcccggcagtaccggcataaccaagcc
pET151mmyJ 654 tatgcctacagcatccagggtgacggtgccgaggatgacgatgagcgcat
MmyJ-Top10-T7 701 tatgcctacagcatccagggtgacggtgccgaggatgacgatgagcgcat
pET151mmyJ 704 tgttagatttcatacacggtgcctgactgcgttagcaatttaactgtgat
MmyJ-Top10-T7 751 tgttagatttcatacacggtgcctgactgcgttagcaatttaactgtgat
pET151mmyJ 754 aaactaccgcattaaagctagcttatcgatgataagctgtcaaacatgag
MmyJ-Top10-T7 801 aaactaccgcattaaagctagcttatcgatgataagctgtcaaacatgag
pET151mmyJ 804 aattaattcttgaagacgaaagggcctcgtgatacgcctatttttatagg
MmyJ-Top10-T7 851 aattaattcttgaagacgaaagggcctcgtgatacgcctatttttatagg
(Figure Continued Overleaf)
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pET151mmyJ 854 ttaatgtcatgataataatggtttcttagacgtcaggtggcacttttcgg
MmyJ-Top10-T7 901 ttaatgtcatgataataatggtttcttagacgtcaggtggcacttttcgg
pET151mmyJ 904 ggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaa
MmyJ-Top10-T7 951 ggaaatgtgcgcggaacccctatttgtttatttttctaaatacattcaaa
pET151mmyJ 954 tatgtatccgctcatgagacaataaccctgataaatgcttcaataatatt
MmyJ-Top10-T7 1001 tatgtatccgctcatgagacaataaccctgataaatgcttcaataatatt
pET151mmyJ 1004 gaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattccc
MmyJ-Top10-T7 1051 gaaaaaggaagagtatgagtattcaacatttccgtgtcgcccttattccc
pET151mmyJ 1054 ttttttgcggcattttgccttcctgtttttgctcacccagaaacgctggt
MmyJ-Top10-T7 1101 ttttttgcggcattttgccttcctgtttttgctcacccagaaacgctggt
pET151mmyJ 1104 gaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcg
MmyJ-Top10-T7 1151 gaaagtaaa-----------------------------------------
pET151mmyJ 1154 aactggatctcaacagcggtaagatccttgagagttttcgccccgaagaa
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1204 cgttttccaatgatgagcacttttaaagttctgctatgtggcgcggtatt
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1254 atcccgtgttgacgccgggcaagagcaactcggtcgccgcatacactatt
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1304 ctcagaatgacttggttgagtactcaccagtcacagaaaagcatcttacg
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1354 gatggcatgacagtaagagaattatgcagtgctgccataaccatgagtga
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1404 taacactgcggccaacttacttctgacaacgatcggaggaccgaaggagc
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1454 taaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgt
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1504 tgggaaccggagctgaatgaagccataccaaacgacgagcgtgacaccac
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1554 gatgcctgcagcaatggcaacaacgttgcgcaaactattaactggcgaac
MmyJ-Top10-T7 --------------------------------------------------
pET151mmyJ 1604 tacttactctagcttcccggcaacaattaatagactggatggaggcggat
MmyJ-Top10-T7 --------------------------------------------------
Figure 3.2: Sequenced pET151-mmyJ plasmid. Inserted mmyJ gene runs from base 100 to
435 inclusive. ‘pET151mmyJ’ is the designed construct, and ‘MmyJ-Top10-T7’ is the result of
sequencing the constructed plasmid extracted from transformed Top10 cells. Yellow highlight
indicates agreement between sequences. Only the first 1653 bases of the pET151 plasmid are
shown here.
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plasmid with mmyJ gene inserted. As can be seen, the sequenced plasmid and predicted
construct align perfectly with the inserted gene sequenced in its entirety. It can therefore
be concluded that the mmyJ gene had been successfully cloned into the pET151/D-TOPO
plasmid.
3.1.2 Overproduction of MmyJ
BL21 star cells carry the DE3 bacteriophage λ lysogen containing the gene for T7 RNA
polymerase, required for transcription of the cloned gene in pET plasmids. This is under the
control of a lac promoter, meaning that, in theory, no T7 RNA polymerase is produced by the
cells until IPTG induction. However, studies have shown that the λDE3 lysogen can produce
small amounts of T7 RNA polymerase even without IPTG present [125]. In order to prevent
premature expression of proteins that may hinder the growth of the BL21 star cell culture, a
second lac operator is included in pET TOPO plasmids downstream of the T7 promoter, adding
a second degree of regulation to the expression system when in BL21 star [13, 12].
The pET151-mmyJ plasmid was transformed into BL21 star cells and the 6xHis tagged
MmyJ, from here on referred to as His6-MmyJ, was expressed. As BL21 star is known to
reduce in efficiency over time due to homologous recombination by RecA [126], fresh BL21 star
cells were regularly transformed with pET151-mmyJ plasmid to maintain optimal expression
levels when used to inoculate cultures.
3.1.3 Chromatographic Purification
In order to purify His6-MmyJ from the Cell Free Extract (CFE), a Fast Protein Liquid Chro-
matography (FPLC) instrument was used to perform Immobilised Metal Ion Chromatography
(IMAC).
FPLC works by drawing from one or more reservoirs of buffer in order to flow proteins in so-
lution (liquid phase) through a column containing an immobilised resin (stationary phase) [127].
Buffer conditions can then be altered so as to separate proteins in the column either by
size/shape, charge, hydrophobicity, function, or interaction with ligands [128]. Thus, proteins
can be purified by, for example, size exclusion chromatography, immobilised metal affinity
chromatography (IMAC) or anion/cation exchange through the use of specifically designed
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(a) (b)
Figure 3.3: (a) Demonstration of binding of polyhistidine tag to the Ni2+ ion in
nickel-nitrilotriacetic acid (Ni-NTA) molecule immobilised on a matrix, modified from [135].
(b) Structure of imidazole, which competitively binds to the Ni2+ over the polyhistidine tag,
causing elution of the immobilised protein.
pre-packed columns containing micron-scale gel beads with varying properties [129]. FPLC
varies only slightly from High Pressure Liquid Chromatography (HPLC), with the main dif-
ferences being that FPLC operates at lower pressure and is capable of running larger samples
ranging from 100 µL to 150 mL or more, whereas a typical HPLC system handles samples
of 100 µL at most. Also, FPLC systems have simpler detectors, typically only operating at
wavelengths relevant to protein purification (i.e. 254 nm and 280 nm) [130]. This makes FPLC
a valuable tool in the bulk purification of expressed proteins from a large liquid culture, easily
able to purify upwards of 10 mg of protein from 50 mL of CFE.
IMAC relies on the interactions between metal ions immobilised on a chelating ligand
and amino acid residues, specifically histidine, tryptophan and cysteine [131], and was first
proposed in 1975 under the name Metal-Chelate Affinity Chromatography [132]. The chelating
ligand used can be optimised for different types of tags or antibodies, leading to a breadth
of purification options [133]. Once bound to the chelating ligand, the tagged protein can
then be eluted by competitive binding with certain salts or small molecules, depending on the
chelating ligand used. In all IMAC purifications carried out here, the chelating ligand was
nitrilotriacetic acid (NTA) bound to Ni2+, with imidazole being used to elute the purified
protein by competitively binding to the nickel ions [134], as detailed in Figure 3.3.
It has already been mentioned that the pET plasmid was selected with metal affinity
chromatography in mind, specifically the affinity between histidine and Ni2+, allowing IMAC
to be performed. Various elution methods were trialled so as to best separate weakly binding
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contaminants such as the E. coli protein SlyD, a 29 kDa protein with a high natural affinity to
nickel [136] which could cause false results in later experiments due to the similarity between its
mass and that of potential His6-MmyJ dimers. Sodium Dodecyl Sulphate Poly-Acrylamide Gel
Electrophoresis (SDS-PAGE) was used to observe the proteins in chosen fractions from each
FPLC purification.
3.1.4 Optimising Protein Elution from Ni2+ Columns
The first elution method attempted was a simple switch between wash/binding buffer and
elution buffer. These first experiments also had 20 mM imidazole added to the wash/binding
(a)
(b)
Figure 3.4: (a) FPLC UV absorption trace at 280 nm of His6-MmyJ purification with
corresponding % elution buffer, using wash/binding buffer with 20 mM imidazole and eluting in
one step. (b) 15% SDS-PAGE gel showing proteins present in collected fractions. Lane numbers
correspond to volumes at positions indicated by numbers on UV trace.
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buffer in order to prevent non-specific binding by contaminants such as SlyD, in accordance
with the manual supplied with the HisTrap columns [137].
The FPLC trace for this purification, as well as the SDS-PAGE gel of fractions taken, can be
seen in Figure 3.4. This purification was done with a larger than normal CFE: approximately
100 mL, and so the experiment was paused after 50 mL so that the Superloop™ could be refilled.
Hence the gel has two lanes corresponding to the non-binding proteins; one from each run of
the Superloop™ for completeness. It is immediately apparent that the overproduced protein is
present in the elution lanes, meaning that it was present in the CFE. As all membrane proteins
had previously been removed from the CFE by pelleting by centrifuge, it can therefore be
concluded that MmyJ is soluble6. However, eluting in this manner has retained some impurities
in the purified fraction, as indicated by faint bands higher up in lane 4 in Figure 3.4b (in
which there is slight leakage into the ladder from the lane 1). Also, a noticeable amount of
overproduced protein is eluted with the non-binding proteins (lanes 1 and 2) and when washing
the column to remove any last impurities from it before elution (lane 3).
It is worth noting that, as demonstrated in Figure 3.4b, the band for His6-MmyJ was
consistently lower than expected for all gels run. Mass spectrometry results (see Section 3.3)
confirm that the bands do correspond to MmyJ, and so it must be concluded that the deviation
from the ladder is due to the shape of the protein affecting how it migrates through the gel.
In an attempt to maximise the yield of overproduced His6-MmyJ, the next stragegy at-
tempted was to reduce the amount of imidazole in the wash/binding buffer to 10 mM and to
elute by stepwise increments in percentage of elution buffer. In this way the actual concentration
of imidazole in mM can be calculated as:
[Imidazole] = (10× (100−% Elution Buffer) + 200× (% Elution Buffer))÷ 100 (3.1)
The results of this run can be seen in Figure 3.5, showing that there are still significant impurity
bands in the eluted fractions. Figure 3.5b also indicates that reducing the imidazole content
of the wash/binding buffer to 10 mM still leads to partial elution of His6-MmyJ when washing
the column as there is a band present in lane 2. It is also worth noting that this strategy led to
6If this was not the case then further work to extract the protein from the pelleted cell debris and insoluble
proteins after lysis would be required.
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(a)
(b)
Figure 3.5: (a) FPLC UV absorption trace at 280 nm of His6-MmyJ purification with
corresponding % elution buffer, using wash/binding buffer with 10 mM imidazole and eluting
in several steps. (b) 15% SDS-PAGE gel showing proteins present in collected fractions. Lane
numbers correspond to volumes at positions indicated by numbers on UV trace.
excessive dilution of the eluted protein, as it was present in each of the peaks in varying degrees,
and so the fractions needed re-combining and concentrating in order to carry out further work.
Finally, there is a distinct drop in absorption when elution is halted by switching back to 100%
wash/binding buffer, corresponding to the absorption at 280 nm by imidazole.
The third attempt at optimising the elution protocol is shown in Figure 3.6. In this instance
the elution was carried out by gradually increasing the percentage of elution buffer from 0 to
100% over the course of two hours. Also, there was no imidazole present in the wash/binding
buffer, meaning the concentration of imidazole in Figure 3.6a can simply be found by multiplying
the percentage elution buffer by 2.
It can be seen from Figure 3.6a that the elution profile is more complex in this instance, hence
the comparatively large number of samples taken around the largest peak in order to determine
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(a)
(b)
Figure 3.6: (a) FPLC UV absorption trace at 280 nm of His6-MmyJ purification with
corresponding % elution buffer, using wash/binding buffer without imidazole and eluting
continuously over 2 hours. (b) 15% SDS-PAGE gel showing proteins present in collected
fractions. Lane numbers correspond to volumes at positions indicated by numbers on UV
trace.
the proteins present via SDS-PAGE. The results seen in this gel (Figure 3.6b) surprisingly
show that the largest peak, corresponding to lane 4, contains very little of the overproduced
His6-MmyJ. This peak at low imidazole levels corresponds to the bulk of protein impurities
that bound non-specifically to the HisTrap column, whereas His6-MmyJ does not start to elute
until the shoulder of this largest peak, as shown in lane 5, which as such still contains several
impurities. However, lane 6 shows very pure protein eluted at higher imidazole concentrations,
with the corresponding peak being over a smaller volume than the collection of peaks seen
when eluting in a step-wise fashion. It was decided that, even though a large proportion of
His6-MmyJ eluted alongside impurities, this could be kept and re-purified if needed. Also,
the second elution peak containing pure His6-MmyJ was of a higher purity using this elution
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method than the others attempted. As such, all His6-MmyJ was purified using this method.
It should be noted that many elution peaks corresponding to His6-MmyJ seem small com-
pared to the amount of protein evident in the associated SDS-PAGE gels. This is due to the
absence of tryptophan residues in MmyJ, drastically reducing the amount of absorption at
280 nm. It can be thought that a small peak can indicate pure protein, as even a small amount
of impurities containing tryptophan would lead to much higher absorption peaks.
3.1.5 TEV Protease Expression and Cleavage of MmyJ Tag
Rosetta (DE3) pLysS cells containing an expression vector for His6-tagged TEV solubilised
through fusion with superfolded green fluorescent protein (sGFP) were obtained from the Dixon
Group, who had previously obtained the cells line from the Moreman group at the Complex
Carbohydrate Research Centre, University of Georgia (USA). Despite the advantages of BL21
star over Rosetta (DE3) pLysS cells, which do not contain a second lac operator regulating T7
RNA polymerase production, it was decided to keep the plasmid in this strain. This was due to
previously reported overproduction levels of the sGFP-TEV-His6 fusion protein in this system
being more than adequate for the requirements of these experiments [138, 139]. The expression
vector can be seen in Figure 3.7.
An 800 mL LB culture of the Rosetta cells containing this sGFP-TEV-His6 expression vector
was grown with protein expression and purification carried out as previous. The FPLC trace
Figure 3.7: Expression vector for sGFP-TEV-His6, taken from [139]. Linker sequence between
sGFP and TEV is defined as GSKGP. Plasmid incorporates ampicillin resistance marker and
IPTG inducible expression system.
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(a)
(b)
Figure 3.8: (a) FPLC UV absorption trace at 280 nm of TEV purification with corresponding
% elution buffer, using wash/binding buffer without imidazole and eluting in a single step.
(b) 15% SDS-PAGE gel showing proteins present in collected fractions. Lane numbers
correspond to volumes at positions indicated by numbers on UV trace.
at 280 nm for the purified TEV, with accompanying SDS-PAGE gel, can be seen in Figure 3.8.
A simple one step elution was used in this instance as it was deemed that any other protein
impurities retained would be removed along with the TEV and 6xHis tags after cleavage. It
is worth noting that, as with His6-MmyJ, there is a discrepancy in Figure 3.8b between the
indicated molecular weight of the purified protein and the ladder. In this instance it was easy
to see that the band was indeed sGFP-TEV-His6 as the band was visibly green before staining.
The eluted TEV was then stored at 4oC.
His tag cleavage was carried out according to [140]. IMAC FPLC was then performed
on the sample again, as shown in Figure 3.9, with some cleaved MmyJ passing through the
column (demonstrated by a weak band in lane 3 in Figure 3.9b), although the majority of the
cleaved protein was retained by the column due to non-specific binding, along with the TEV
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(a)
(b)
(c)
Figure 3.9: (a) FPLC UV absorption trace at 280 nm of purification of MmyJ from cleaved
6xHis tags and sGFP-TEV-His6 protease, using wash/binding buffer with no imidazole. Cleaved
MmyJ was eluted using 20 mM imidazole (10% elution buffer) due to non-specific binding to
the His-Trap column. (b) 15% SDS-PAGE gel showing proteins present in fractions after TEV
cleavage. Lanes 1 and 2 correspond to His6-MmyJ samples before and after TEV was added,
demonstrating reduction in molecular weight due to loss of tags, with further lane numbers
corresponding to volumes at positions indicated on UV trace. (c) 15% SDS-PAGE gel showing
another purification of cleaved MmyJ. Lanes 1 and 2 correspond to pre- and post-cleavage
respectively. The red arrow corresponds to the decrease in mass due to the removal of the His
tag, and the blue arrow indicates a similar decrease in mass of what was thought to be an
impurity.
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protease, cleaved 6xHis tags and impurities. A low amount of elution buffer (corresponding to
20 mM imidazole) was then used to elute the MmyJ. TEV, tags and impurities were then eluted
using 200 mM imidazole as shown in Figure 3.9a and 3.9b. Figure 3.9c explicitly shows the
result of running another sample of His6-MmyJ on an SDS-PAGE gel before and after cleavage.
While it is obvious that the reduction in mass associated with the main bands between lanes
1 and 2 is due to the cleavage of the His tag from His6-MmyJ, it was surprising to see that a
similar decrease was also apparent in the fainter band at around 30 kDa. This was previously
suspected to be an impurity such as SlyD, but the fact that it was cleaved indicates that this
band corresponds to a dimer of His6-MmyJ.
Whilst MmyJ is expected to form dimers, ArsR family dimers have always been reported to
be hydrogen bonded [51], whereas for this dimer to have survived denaturing by the SDS within
the gel it must be covalently bonded. What is interesting to note is that this band was thought
to be an impurity as it was not always apparent; indeed it cannot be seen in Figure 3.4b. It was
realised when quantifying different His6-MmyJ preparations that the suspected dimeric band
only appeared in high concentration samples. Hence, it was suspected that this covalent bond
arose from the close proximity of His6-MmyJ monomers when forced into concentrations higher
than would be occur naturally, and thus could disrupt the biological function of MmyJ, causing
difficulties in later experiments.
3.2 Site Directed Mutagenesis
3.2.1 Determination of Disulphide Bridge Formation
In order to investigate the suspected covalent bonding of His6-MmyJ dimers, Dithiothreitol
(DTT) was used as a reducing agent to disrupt any disulphide bridges that may be forming
between monomers, as it was suspected that this would be the most logical reason for their
formation. A 100 mM DTT solution was prepared and 0.3 µL was added to 100 µL 0.3 mM pure
His6-MmyJ, giving a 1:1 molar ratio. This was performed twice, with one mixture being left
at room temperature and another being incubated at 90oC for an hour to encourage unfolding.
Negative controls of His6-MmyJwith dH2O added in the same quantities as DTT solution
were also prepared and incubated accordingly. After incubation, a 25 µL sample from each
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Figure 3.10: Native PAGE gel of His6-MmyJ DTT assay investigating covalent dimer formation.
Lanes 1 and 2 correspond to samples left at room temperature, and lanes 3 and 4 correspond
to samples incubated at 90oC for an hour.
temperature was run against the negative controls on a Native-PAGE (i.e. non-denaturing) gel
in order to see whether the addition of DTT had affected the suspected dimers. Figure 3.10
shows the result of this assay, from which it can be concluded that the addition of DTT clearly
disrupts dimer formation as the bands associated with the dimer are completely removed. What
is also apparent is that the dimer is not only robust to the denaturing properties of SDS (as
seen in Figure 3.9), but is also resistant to thermal degradation. As it would be expected
that the combination of the presence of SDS and incubation at temperatures this high would
disrupt hydrogen bonded secondary structure, it can be concluded that this is a covalent dimer
of His6-MmyJ. It was thought that a disulphide bridge between monomers was the cause of the
dimer formation, likely between two cysteine sites. After inspection of the amino acid sequence
for His6-MmyJ, it was found that the protein only contains one cysteine residue at position 49,
and so it was proposed that mutating this residue could prevent disulphide bridge formation.
It is worth noting that, according to the previously reported homology model, this single
cysteine lies at the start of the α3 helix, as shown in Figure 3.11. As such it could have a role in
Figure 3.11: Previously shown homology model of MmyJ with the side chain of C49 shown
explicitly on the outer edge at the start of the α3-helix.
54
3.2 Site Directed Mutagenesis 3 PROTEIN OVERPRODUCTION & PURIFICATION
stabilising the MmyJ:DNA complexes once formed, especially as it is on the outside of the helix
in a position where it could conceivably interact with DNA. For this reason, it was decided that
should the mutation be successful, work would continue with both the wild type and mutated
MmyJ to ensure that functional investigations were not hindered by this mutation.
3.2.2 Mutation of C49
Site directed mutagenesis was performed to mutate the single cysteine at residue 49 into a serine,
thus removing the possibility of disulphide bridge formation. This required the replacement of
the TGC codon with AGC, hence only a single point mutation of t145a was needed. A single
colony grew after transformation with the mutated plasmid, and a glycerol stock was created. A
liquid culture was grown and the plasmid was extracted and sent for sequencing. The sequencing
data can be seen in Figure 3.12, where it can be seen that the t145a mutation of the mmyJ
gene required was successful.
3.2.3 Overproduction of His6-MmyJ C49S and DTT Assay
BL21 star cells were transformed with the C49S plasmid and His6-MmyJ C49S was then
overproduced in LB media in the same manner as the wild type protein. This was then purified
using a new HisTrap column to avoid cross contamination. The FPLC trace and associated
SDS-PAGE gel can be seen in Figure 3.13. As this initial run was only to test the mutated
plasmid, ensuring there were no other substitutions elsewhere that could disrupt expression of
the mutated mmyJ gene, the overproduced protein was purified in a simple stepwise elution,
leaving some impurities in the sample visible as faint bands in Figure 3.13b. It is apparent that
the gene was indeed over expressed and the corresponding His tagged protein was overproduced
but, as before, the band appears much lower on the gel than one would expect. Again this is
suspected to be due to the shape of His6-MmyJ, and further analysis by mass spectrometry can
be seen in Section 3.3.
The same DTT assay was carried out with His6-MmyJ C49S as with the previously expressed
wild type His6-MmyJ (previously shown in Figure 3.10). The results of this assay can be seen in
Figure 3.14. While there are still some higher molecular weight bands apparent due to impurities
previously mentioned, there is no apparent difference between the lanes with and without DTT
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pET151mmyJC49S --------------------------------------------------
MmyJC49S-T7forwa 1 gtggagaattcccctctagatattttgtttactttaagaaggagatatac
mmyJ --------------------------------------------------
pET151mmyJC49S 1 --atgcatcatcaccatcaccatggtaagcctatccctaaccctctcctc
MmyJC49S-T7forwa 51 atatgcatcatcaccatcaccatggtaagcctatccctaaccctctcctc
mmyJ --------------------------------------------------
pET151mmyJC49S 49 ggtctcgattctacggaaaacctgtattttcagggaattgatcccttcac
MmyJC49S-T7forwa 101 ggtctcgattctacggaaaacctgtattttcagggaattgatcccttcac
mmyJ --------------------------------------------------
pET151mmyJC49S 99 cgtggcggcacggatcacgacagagcgcatcaccgaccatccggacgctg
MmyJC49S-T7forwa 151 cgtggcggcacggatcacgacagagcgcatcaccgaccatccggacgctg
mmyJ 1 -gtggcggcacggatcacgacagagcgcatcaccgaccatccggacgctg
pET151mmyJC49S 149 acgccatcaccctccagggcgtcctggacgcgctggtcgatccggtgcgc
MmyJC49S-T7forwa 201 acgccatcaccctccagggcgtcctggacgcgctggtcgatccggtgcgc
mmyJ 50 acgccatcaccctccagggcgtcctggacgcgctggtcgatccggtgcgc
pET151mmyJC49S 199 cgcagcatcgtccggcagctggctaaggcacccgaggacatcgccagcgg
MmyJC49S-T7forwa 251 cgcagcatcgtccggcagctggctaaggcacccgaggacatcgccagcgg
mmyJ 100 cgcagcatcgtccggcagctggctaaggcacccgaggacatcgcctgcgg
pET151mmyJC49S 249 caccttcgacatcaccgtctcccgctcgaccggcactcaccacttcaagg
MmyJC49S-T7forwa 301 caccttcgacatcaccgtctcccgctcgaccggcactcaccacttcaagg
mmyJ 150 caccttcgacatcaccgtctcccgctcgaccggcactcaccacttcaagg
pET151mmyJC49S 299 tgttgcgccaggccgggatcatcaggcagtactacatcggcacctcgaag
MmyJC49S-T7forwa 351 tgttgcgccaggccgggatcatcaggcagtactacatcggcacctcgaag
mmyJ 200 tgttgcgccaggccgggatcatcaggcagtactacatcggcacctcgaag
pET151mmyJC49S 349 atgaacacgcttcgcaccgatgatctcgatcaggccttccccggcctgct
MmyJC49S-T7forwa 401 atgaacacgcttcgcaccgatgatctcgatcaggccttccccggcctgct
mmyJ 250 atgaacacgcttcgcaccgatgatctcgatcaggccttccccggcctgct
pET151mmyJC49S 399 caccgcgatcgtcgacgccgcggccagggagagctgaccggccaccgctc
MmyJC49S-T7forwa 451 caccgcgatcgtcgacgccgcggccagggagagctgaccggccaccgctc
mmyJ 300 caccgcgatcgtcgacgccgcggccagggagagctga-------------
pET151mmyJC49S 449 gcccgcacggcgctccaaagggcgagctcagatccggctgctaacaaagc
MmyJC49S-T7forwa 501 gcccgcacggcgctccaaagggcgagctcagatccggctgctaacaaagc
mmyJ --------------------------------------------------
pET151mmyJC49S 499 ccgaaaggaagctgagttggctgctgccaccgctgagcaataactagcat
MmyJC49S-T7forwa 551 ccgaaaggaagctgagttggctgctgccaccgctgagcaataactagcat
mmyJ --------------------------------------------------
pET151mmyJC49S 549 aaccccttggggcctctaaacgggtcttgaggggttttttgctgaaagga
MmyJC49S-T7forwa 601 aaccccttggggcctctaaacgggtcttgaggggttttttgctgaaagga
mmyJ --------------------------------------------------
pET151mmyJC49S 599 ggaactatatccggatatcccgcaagaggcccggcagtaccggcataacc
MmyJC49S-T7forwa 651 ggaactatatccggatatcccgcaagaggcccggcagtaccggcataacc
mmyJ --------------------------------------------------
(Figure Continued Overleaf)
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pET151mmyJC49S 649 aagcctatgcctacagcatccagggtgacggtgccgaggatgacgatgag
MmyJC49S-T7forwa 701 aagcctatgcctacagcatccagggtgacggtgccgaggatgacgatgag
mmyJ --------------------------------------------------
pET151mmyJC49S 699 cgcattgttagatttcatacacggtgcctgactgcgttagcaatttaact
MmyJC49S-T7forwa 751 cgcattgttagatttcatacacggtgcctgactgcgttagcaatttaact
mmyJ --------------------------------------------------
pET151mmyJC49S 749 gtgataaactaccgcattaaagctagcttatcgatgataagctgtcaaac
MmyJC49S-T7forwa 801 gtgataaactaccgcattaaagctagcttatcgatgataagctgtcaaac
mmyJ --------------------------------------------------
pET151mmyJC49S 799 atgagaattaattcttgaagacgaaagggcctcgtgatacgcctattttt
MmyJC49S-T7forwa 851 atgagaattaattcttgaagacgaaagggcctcgtgatacgcctattttt
mmyJ --------------------------------------------------
pET151mmyJC49S 849 ataggttaatgtcatgataataatggtttcttagacgtcaggtggcactt
MmyJC49S-T7forwa 901 ataggttaatgtcatgataataatggtttcttagacgtcaggtggcactt
mmyJ --------------------------------------------------
pET151mmyJC49S 899 ttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacat
MmyJC49S-T7forwa 951 ttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatacat
mmyJ --------------------------------------------------
pET151mmyJC49S 949 tcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaata
MmyJC49S-T7forwa 1001 tcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaata
mmyJ --------------------------------------------------
pET151mmyJC49S 999 atattgaaaaaggaagagtatgagtattcaacatttccgtgtcgccctta
MmyJC49S-T7forwa 1051 atattgaaaaaggaagagtatgagtattcaacatttccgtgtcgccctta
mmyJ --------------------------------------------------
pET151mmyJC49S 1049 ttcccttttttgcggcattttgccttcctgtttttgctcacccagaaacg
MmyJC49S-T7forwa 1101 ttcccttttttgcggcattttgccttcctgtttttgctcacccagaaacg
mmyJ --------------------------------------------------
pET151mmyJC49S 1099 ctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggtta
MmyJC49S-T7forwa 1151 ctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggtta
mmyJ --------------------------------------------------
pET151mmyJC49S 1149 catcgaactggatctcaacagcggtaagatccttgagagttttcgccccg
MmyJC49S-T7forwa 1201 catcgaactggatctcaacagcggtaagatccttgagagttttcgccccg
mmyJ --------------------------------------------------
pET151mmyJC49S 1199 aagaacgttttccaatgatgagcacttttaaagttctgctatgtggcgcg
MmyJC49S-T7forwa 1251 aagaacgttttccaatgatgagcacttttaa-------------------
mmyJ --------------------------------------------------
Figure 3.12: Sequenced plasmid containing single t145a mutation resulting in C49S mutant.
‘pET151mmyJC49S’ is the designed construct, ‘MmyJC49S-T7forwa’ is the result of sequencing
the constructed plasmid extracted from transformed Top10 cells and ‘mmyJ’ is the sequence
for the mmyJ gene, indicating the transformed base. Only the first 1248 bases of the pET151
plasmid are shown here.
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(a)
(b)
Figure 3.13: (a) FPLC UV absorption trace at 280 nm of His6-MmyJ C49S purification with
corresponding % elution buffer, using wash/binding buffer with 10 mM imidazole and eluting
in two steps. (b) 15% SDS-PAGE gel showing proteins present in collected fractions. Lane
numbers correspond to volumes at positions indicated by numbers on UV trace.
Figure 3.14: Native PAGE gel of His6-MmyJ C49S DTT assay investigating covalent dimer
formation. Samples were incubated at room temperature for an hour.
added. From this it can be concluded that there is no covalent dimer forming in this instance,
and thus also that it was in fact disulphide bonds between C49 on separate monomers causing
covalent dimers. Under the assumption that this covalent bond is not biologically relevant,
work was carried out throughout with both the wild type protein and C49S mutation.
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3.3 Mass Spectrometry Analyses
Mass Spectrometry (MS) was not routinely performed on each protein sample produced, how-
ever samples of His6-MmyJ C49S and TEV cleaved MmyJ C49S were submitted in order
to determine the molecular weight of the overproduced proteins. This was done to confirm
that the overproduced MmyJ C49S matched the expected mass, thereby confirming that the
peptide was intact. As the C49S mutant was created from the wild type expression vector, this
would also confirm by inference that the wild type MmyJ was also overproduced correctly. In
order to reduce the risk of uncontrolled fragmentation, and thus obtain a deconvoluted mass
peak corresponding to the full length protein, electrospray ionisation was utilised [141]. The
expected masses of His tagged and TEV cleaved MmyJ C49S are 15870.7573 and 12718.2474 Da
respectively, calculated from the molecular formulae generated by ProtParam [102].
Figure 3.15 shows mass spectra of His6-MmyJ C49S and TEV cleaved MmyJ C49S, where
(a)
(b)
Figure 3.15: Mass spectra of (a) His6-MmyJ C49S and (b) TEV cleaved MmyJ C49S. Expected
masses are 15870.7573 Da and 12718.2474 Da respectively.
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it can be seen that the deviations between expected and measured molecular weight for the
highest mass peaks are 0.0240 and 0.0339 respectively. These values can be converted to parts
per million (ppm) as follows:
Deviation (ppm) =
Expected Mass−Observed Mass
Expected Mass× 10−6 (3.2)
This gives deviations of 1.51 and 2.67 ppm for His tagged and TEV cleaved MmyJ respectively,
well within the 5 ppm accuracy of the instrument.
From this it can be concluded that both variations of MmyJ overproduced by cells containing
the engineered pET151 vectors do indeed contain the full length peptide chain. It is thought
that the peaks with an m/z value of approximately 11690 in both spectra are either the result
of fragmentation within the spectrometer or impurities within the instrument, as the purity of
the submitted samples was confirmed by SDS-PAGE.
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4 Stability Determination
As protein function is governed by its secondary and tertiary structure, it was desireable to
ensure that the purified His6-MmyJ was correctly folded, leading to further investigations into
its stability.
4.1 Thermal Stability
In order to first check that the purified His6-MmyJ was correctly folded and then investigate
its thermal stability, circular dichroism spectroscopy was employed.
4.1.1 Circular Dichroism Spectroscopy
Circular Dichroism (CD) spectroscopy uses circularly polarised light to extract structural infor-
mation about chiral molecules [142]. In the case of proteins, this can lead to quantification of
the relative amount of α-helical, β-sheet or random coil character that comprise their secondary
structure [143].
Circularly polarised light differs from linearly polarised (where the electric field oscillates
only in one dimension perpendicular to the direction of travel of the light) in that the electric
field vector rotates around the direction of propagation with the same frequency as the light;
i.e. it takes one period of the base wavelength for the electric field vector to rotate through
a full 360o. This vector may rotate either clockwise or anti-clockwise along the direction of
propagation, defined as right-circularly polarised light (rpl) or left-circularly polarised light
(lpl) respectively. As rpl and lpl are enantiomeric, they will lead to slightly different absorption
behaviour when interacting with chiral molecules, and it is this difference in absorption A that
gives a CD signal as follows [144]:
CD = ∆A = Alpl −Arpl (4.1)
NB: This shift in absorption is on the order of 10−4 times the absolute absorption, and so
the light incident on the sample is modulated between rpl and lpl at the same frequency as the
frequency of the light itself to enhance the signal received.
In proteins, the interactions between electronic transitions in adjacent peptide groups leads
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Figure 4.1: CD spectra of poly-L-lysine in α-helical (black), β-sheet (red) and random coil
(green) conformations, demonstrating standard curves for those structures. Modified from
[145].
to signature CD spectra depending on the secondary structure of the protein [144]. Figure 4.1
demonstrates the typical spectra one would expect from proteins that are completely α-helical
(peak at 190 nm and double trough at 208 and 222 nm), β-sheet (peak at around 200 nm
and trough at around 217 nm) or random coil (trough at around 200 nm). Most CD signals
are measured in units of ellipticity θ for historical reasons, which can easily be converted to
absorption using the relation ∆A = θ/32.982, with θ measured in degrees [142].
4.1.2 Protein Folding
Due to the high absorbance of NaCl in the high UV range [146], wild type His6-MmyJ was pre-
pared straight from purification by eluting with a variation on IMAC elution buffer containing
NaHPO4 substituted for NaCl. A sample of this was then taken and diluted to 0.5 mg/mL. A
second sample was also prepared, this time of His6-MmyJ C49S which had been dialysed into
deionised water before being lyophilised and then resuspended in pH 6.5 phosphate buffer. The
resulting CD spectra for both samples can be seen in Figure 4.2.
By comparison to Figure 4.1, it can be seen that Figure 4.2 demonstrates that both the
wild type and C49S mutant of His6-MmyJ have a high degree of α-helical structure as the
spectra of both have the characteristic double trough at 208 and 222 nm as well as the peak at
around 190 nm. This concurs with the predicted structure determined by homology modelling
62
4.1 Thermal Stability 4 STABILITY DETERMINATION
Figure 4.2: Circular Dichroism spectra of re-suspended lyophilised His6-MmyJ C49S and native
wild type His6-MmyJ.
illustrated in Section 2.3, which classifies 65 of the total 111 amino acids as being in α-helices.
This can be compared to only 14 amino acids being part of β-sheets which are likely to be
responsible for causing the slight shift in α-helix peak closer to 200 nm.
Given the above analysis, it can be concluded that not only does recombinant His6-MmyJ fold
as expected, but also that the folding of His6-MmyJ is not affected by the introduction of the
C49S mutation. Also, it appears that the protein structure is robust to lyophilisation and
rehydration after dialysis into deionised water, which means that this can be used as a sample
preparation method in future if needed.
It is worth noting that the two spectra in Figure 4.2 were not taken on the same day and
different cuvettes were used. This, along with the previously stated fact that they were in
different buffers, is likely to have introduced minor changes in the profile of each sample, for
example the relative height of the peak around 190 nm compared to the depth of the double
trough, as well as a more pronounced shift in peak position for the wild type. It is not expected
that these differences are a reflection in different folding between the wild type and mutant and,
as this experiment was performed simply to see if the proteins were folded, it was not deemed
necessary to repeat it.
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4.1.3 Variable Temperature Assay
Once wild type and C49S His6-MmyJ samples had been shown to be correctly folded, further
work was undertaken to investigate the stability of the folded protein. The previously used
sample of His6-MmyJ C49S was re-used in order to investigate thermal stability. The instrument
was set to raise the temperature by 1oC per minute from 20oC to 60oC inclusive, with the
absorbance at 195 nm measured at each increment. As well as this, the instrument was set
to record a full spectrum from 185 nm to 300 nm at 5oC intervals, requiring an equilibration
(a)
(b)
Figure 4.3: Data showing results of thermal stability assay performed on His6-MmyJ C49S
sample. (a) Shows how the entire CD spectrum varies at 5oC intervals, and (b) shows variation
in CD signal at 195 nm when being heated and then cooled back down.
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period of 5 minutes, as well as 5 minutes to record 3 acquisitions as before. The data from
these experiments is shown in Figure 4.3.
Figure 4.3a revealed that the spectrum, and so the degree of folding, appears largely
unchanged between 20oC and 35oC, with the features characteristic of α-helical folded proteins
remaining the same. However, at 40oC it can be seen that the peak around 190 nm and
the double trough at 208 and 222 nm all reduce drastically in amplitude, with these features
disappearing from 45oC upwards, explicitly showing that His6-MmyJ C49S denatures at around
40oC. This can also be seen in Figure 4.3b, where the absorption value at 195 nm also rapidly
drops off at 40oC. It should be noted, however, that the absorption measurements, taken at the
same temperature as the whole spectra (i.e. every 5oC), are taken at the end of the 5 minute
equilibration period, and so the sharpness of the jump demonstrated in Figure 4.3b may have
been exaggerated by the amount of time sat at 40oC. This does not alter the fact that the protein
denatures at this temperature, but more implies that the line shape in Figure 4.3b would be
different. Specifically, if this experiment was repeated without the equilibration periods or
acquisition time for complete spectra, both of which were 5 minutes, the plot of absorption
at 195 nm against temperature would likely have a less pronounced jump at 40oC. As such, it
would probably follow the line of the curve that can be seen as the protein continues to denature
from 41oC to 50oC. Also shown is a plot of data taken by repeating the measurements at 195 nm
every minute as the sample was cooled back down to 20oC at the same rate, demonstrating
that, as one would expect, the protein does not refold once denatured.
It is thought that as this method primarily monitors the stability of secondary structure,
there would be no observable difference between the thermal stability of His6-MmyJ C49S
and the wild type protein. This is because the formation of a disulphide bridge between C49
residues in adjacent monomers is not thought to have any impact on the stability of α-helices
and β-sheets elsewhere in the covalent dimer and, as such, the CD spectra observed here for
the C49S mutant are expected to also reflect the behaviour of the wild type protein.
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4.2 Protein Aggregation
While attempting to identify the oligomeric state of His6-MmyJ in its native form, it was
noticed that the protein was aggregating, which is likely the reason many early experiments
into the function and structure of His6-MmyJ failed. Work was then performed to investigate
this aggregation phenomenon.
4.2.1 Gel Filtration Chromatography & Calibration
Gel filtration chromatography is a method for separating molecules in solution, based on their
size, by passing the solution through a column containing a porous matrix, typically made
of cross-linked beads [147]. Smaller molecules pass in between the beads whereas larger ones
cannot enter the matrix fully and so elute from the column quicker, thus retention time on the
column can be used to approximate the mass of molecules and fractions can be collected to
separate the molecules in solution. The mass range and resolution varies from column to column
depending on the polymers used to make the beads as well as bead and bed dimensions, pH
and buffer contents. Also, there is some variation with protein shape, as a globular protein will
pass through the column differently to an elongated protein of the same mass, but in this case
it was assumed that His6-MmyJ could be treated as globular, as supported by the previously
described Phyre2 model.
Calibration data for the gel filtration column used to investigate oligomerisation of His6-MmyJ
can be seen in Figure 4.4. This was repeated for both FPLC machines available and was found
to be near identical, so only the A¨KTApurifier 10 traces are shown. The peak for Blue Dextran
corresponds to the so-called dead volume Vo, corresponding to the elution volume required
for molecules too large to enter the matrix. Typically, data from gel filtration is shown with
elution volume Ve normalised against Vo to reduce any dependance on the system used, as is
done here.
It can clearly be seen from Figure 4.4a that the elution volume does increase with decreasing
molecular mass as expected, and from Figure 4.4b it can be seen that this follows an exponential
decay, in agreement with the predicted curve in the Technical Bulletin supplied with the
calibration kit.
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(a)
(b)
Figure 4.4: Calibration data for the Superdex™ 75 5/150 GL column on the A¨KTApurifier 10
system. (a) shows the UV chromatograms of the calibration solutions used while (b) shows how
the molecular mass affects elution volume. The trend line was fitted using OriginPro 9.1 64Bit.
4.2.2 Oligomeric State
A 50 µL sample of His6-MmyJ in IMAC wash binding buffer was run through the gel filtration
column. It was decided that the initial run should be done in this buffer with glycerol still
present, rather than the gel filtration buffer, for the sake of the stability of the protein. In
order to determine whether this would have any effect on the peak positions, another run was
performed with albumin and aprotinin added to the His6-MmyJ sample to observe any shifts
due to the inclusion of glycerol when compared to the calibration data. These data are shown
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Figure 4.5: UV A280 chromatograms of 50 µL samples of His6-MmyJ with and without
addition of calibration proteins to observe peak shift due to presence of glycerol. Monomeric
His6-MmyJ has a molecular weight of 15.9 kDa, and so dimeric His6-MmyJ is expected to have
a peak corresponding to approximately 32 kDa.
alongside the original calibration data in Figure 4.5.
The first thing to notice about the His6-MmyJ trace is that there is a large amount of
material eluted in the dead volume peak. It was initially considered that the two peaks were
the monomer and dimer of His6-MmyJ, and that they had simply been shifted by the different
buffer conditions. However, the second trace proves that this is not the case as while the
albumin and aprotinin peaks are shifted slightly compared to the calibration peaks, the degree
of difference is negligeable compared to the shift that would be needed for peaks of around
15 kDa and 30 kDa to appear where the two His6-MmyJ peaks are. Also, the dead volume
peak appears as a shoulder on the albumin peak at 66 kDa, demonstrating that it is not buffer
conditions that have caused this peak to appear where it is. Due to this, the idea that the
two peaks represented the monomer and dimer was discarded, and it was then assumed that
the right hand peak corresponded to the dimer and the left hand peak corresponded to an
unknown oligomeric state that was forming in solution from monomers and dimers, such that it
was larger than 70 kDa and hence above the resolving range of the column7. In this case there
7Both native and SDS-PAGE gels were attempted with fractions collected from both peaks but, due to small
initial sample size and the protein being diluted further upon elution, neither type of gel offered conclusive
visualisation of the contents of these peaks.
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Figure 4.6: A280 chromatograms of 50 µL samples of His6-MmyJ C49S with and without
addition of calibration proteins, run under identical conditions as previous wild type sample.
was no observed peak assigned to the monomer, and so it was assumed that His6-MmyJ does
not appear in its monomeric form while in a non-denaturing solution.
The experiment was then repeated with a sample of His6-MmyJ C49S prepared in the same
manner, as shown in Figure 4.6. As can be seen, the His6-MmyJ peaks appear to be in the same
place, and so the mutation appears not to have altered the formation of oligomers. However, the
dead volume peak is much larger, indicating that more protein has aggregated in this instance.
This was not expected as the C49S mutation was introduced to minimise what was thought to
be non-biologically relevant binding between monomers. Also, the dead volume peak is shifted
significantly this time between the samples with and without added calibration proteins, yet
the buffer conditions were identical for both runs, and so it can be inferred that this deviation
may simply be due to a systematic error within the apparatus. If this is indeed the case then
the minor aberrations apparent in Figure 4.5 may also be due to the same systematic error.
From this and other runs where dead volume peaks were shifted slightly (a total of 22 separate
experiments), the average shift in dead volume peak position was found to be ±0.0255 when
compared to the calibration value of Ve/Vo = 1. This error could be introduced into the system
at a number of points; for example if a small air bubble was injected into the column along
with the 50 µL sample, or if a slightly different length of tubing was used to attach the column
69
4.2 Protein Aggregation 4 STABILITY DETERMINATION
to the FPLC machine (although this was actively avoided by attempting to use the same piece
of tubing for each experiment).
With this uncertainty in mind, the gel filtration data was then used to approximate the
mass of the putative dimeric state corresponding to the right hand elution peak of both
Figures 4.5 and 4.6. The position of this peak was recorded over 16 identical samples to
give a mean peak position of 1.25±0.04, where the uncertainty is the standard deviation across
the 16 values. This is higher than the previously estimated systematic error, possibly due to
there being more concordance between the elution time of large molecules that never enter
the matrix, and so the actual deviation in elution time may in fact increase as molecule size
decreases. Nevertheless, using this value and standard error propagation techniques [148] [149],
along with the equation of the trend line from Figure 4.4b, the peaks were found to correspond
to an approximate mass of 53± 11 kDa. This is not the expected mass of a His6-MmyJ dimer,
which should be 31.8 kDa. This has led to some speculation that His6-MmyJ may form either a
trimer or tetramer (as masses of 45 kDa and 60 kDa do fall within the error boundaries of this
calculated value). However, despite there being some instances of tetrameric structures being
reported [150], almost all ArsR family proteins are reported to form homodimers [51], and so
more precise data would be needed to confidently describe the oligomeric state of His6-MmyJ.
4.2.3 Analytical Ultracentrifugation
In a further attempt to identify the two oligomeric states of His6-MmyJ apparent from gel filtra-
tion, a sample was prepared for Analytical Ultracentrifugation (AUC). This method sediments a
sample in solution by spinning at high speeds, leading to centrifugal forces of around 250,000×g
[151]. In this way, a gradient is formed throughout the sediment with larger molecules towards
the outside edge of the rotor. UV absorbance can then be used to obtain a profile of the
masses of the molecules present. Sedimentation velocity experiments measure sedimentation
coefficients from which the mass can be calculated for a range of molecules present, whereas
sedimentation equilibrium experiments accurately measure the molecular masses, but require
only a single species to be present.
A sample of His6-MmyJ C49S was prepared and submitted to the Birmingham Biophysical
Characterisation Facility (BBCF) for analysis. As it was uncertain how many different oligomers
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Figure 4.7: Data from AUC run of His6-MmyJ C49S. The top panel shows the raw UV
absorbance at 280 nm from 120 measurements, with the second panel showing the residuals
from the fit of the data. The calculated distribution of sedimentation coefficient is then shown
in the bottom panel, with major peaks identified by asterisks. The calculation was performed
using values of ρ = 1.0226 (density), η = 1.29984 × 10−2 (viscosity) and V¯ = 0.72024 (partial
specific volume) from Sedfit.
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Figure 4.8: Mass distribution of species present in AUC sample, calculated from sedimentation
coefficients according to instructions supplied with the data.
would be present, the sample was run in sedimentation velocity mode, sacrificing accuracy
for breadth of results. The raw data from this, including absorbance spectra for multiple
runs, quantification of residuals and distribution of sedimentation coefficients, can be seen in
Figure 4.7. This analysis was done according to the instructions supplied with the data from
the BBCF following a continuous distribution model [152]. It can be seen from the bottom
panel of Figure 4.7 that there are two major peaks (annotated with an asterisk), corresponding
to oligomers with different masses.
This distribution was then manipulated, again according to instructions supplied with the
data, to transform the sedimentation coefficient values into masses. A plot of the resulting
mass distribution can be seen in Figure 4.8. Using the full width at half maximum height as
an approximation of the errors in peak position, the left hand peak corresponds to a mass of
12.1 ± 5.4 kDa while the right hand peak corresponds to a mass of 124.2 ± 53.7 kDa. As the
monomer of His6-MmyJ has a mass of 15.9 kDa, it can be concluded that the narrow peak on the
left corresponds to the monomer, with the broad peak corresponding to the large aggregated
state which cannot be resolved by gel filtration as it is too large to enter the matrix. The
broadness of this peak also leads to the conclusion that there are several different oligomeric
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states included in this aggregate. What is unexpected, however, is that there is no peak
corresponding to a low order oligomer such as dimer, trimer or tetramer. This could be due to
buffer conditions preventing the formation of hydrogen bonds between monomers, which then
leads to the conclusion that the aggregate is likely formed by covalent bonds in order to still
be present. With this in mind, more work was then carried out to investigate the formation of
the aggregate using gel filtration.
4.2.4 Dynamic Equilibrium of Oligomeric States
In order to investigate the formation of the aggregated state, gel filtration experiments were
carried out on collected fractions of His6-MmyJ C49S. These fractions were then briefly cen-
trifuged in spin filters to re-concentrate the eluted molecules, 50 µL of which were then taken
and run through the gel filtration column a second time. Traces of these runs can be seen in
Figure 4.9.
It is interesting to note that during several gel filtration experiments, including calibration
runs, an extra peak was observed at high elution volume. As this must be a species much
smaller than 6.6 kDa in weight by comparison to the calibration peaks, it was decided that it
must be a small molecule, possibly an organic salt that had not fully dissolved, or free amino
Figure 4.9: Gel filtration chromatograms of His6-MmyJ C49S. The top panel shows the initial
run, from which fractions were collected of peaks 1-3. These were then re-concentrated and run
again, with these traces shown together in the bottom panel.
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acids resulting from protein degradation. It is possible that some residual imidazole was still
present in the sample, which does absorb at 280 nm and so could be responsible for the extra
absorption peak, or that some residual plasticizers had entered the samples from plasticware
used during preparation. For completeness sake it was included in the following analysis.
Figure 4.9 indicates that there is a dynamic equilibrium at play. The fraction collected from
the dead volume peak does not then give peaks at any other positions when re-run, except the
suspected small molecule, but the fraction from the oligomer peak of His6-MmyJ C49S does
give rise to a new dead volume peak, indicating that some of the oligomer had aggregated
during the re-concentration process. Also, there appears to be severe broadening between the
oligomer and dead-volume peaks, with a slight bump between the two, indicating another,
possibly intermediate, phase present. This is thought to be evidence of the oligomers directly
interacting with each other to form the higher order aggregates apparent in the AUC data.
As suspected, the small molecule peak did not vary between runs, although another peak did
become apparent at an even higher elution volume. However, these are not thought to be of
interest.
At this point it was realised that the observed His6-MmyJ aggregate could be formed by
Figure 4.10: Gel filtration UV chromatograms of two runs taken from the same sample of
His6-MmyJ, before and after boiling at 95
oC for 15 minutes. Region shaded yellow corresponds
to approximate error in V0.
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the interaction of hydrophobic regions of unfolded portions of the protein [153], which would
be a good explanation of why many preliminary structural and functional experiments had
failed. In order to investigate this possibility, a sample of His6-MmyJ was boiled at 95
oC for 15
minutes, with 50 µL taken before and after boiling to compare the traces. These data can be
seen in Figure 4.10. The absorption trace of the boiled protein matches the profile of the re-run
dead volume peak in Figure 4.9, from which it can be concluded that the species responsible
for the large dead volume peak observed in all gel filtration experiments so far is in fact from
aggregated His6-MmyJ after it has unfolded.
4.3 Concentration Stability
It was suspected that His6-MmyJ might aggregate when concentrated to levels required for
biophysical experiments, of the order of 10 mg/mL or approximately 600 µM - much higher
than biologically relevant concentrations which are typically of the order of 1 nM [154]. In
order to examine this possibility, an experiment was devised where the entire eluted amount
of His6-MmyJ from a 1 L culture, taken straight from the FPLC fraction collector after
purification, was placed in a 10 kDa cut-off Amicon Ultra-15 Centrifugal Filter Unit and spun at
2,500×g at 4oC, with 200 µL taken at 5 minute intervals and kept on ice. The concentration of
these fractions was then quantified on a Thermo Scientific NanoDrop Lite Spectrophotometer,
before 50 µL of each was run through the gel filtration column previously used. In this way
it was hoped that the ratio of intensity between the His6-MmyJ oligomeric peak and the dead
volume peak could be used to approximate the degree of unfolding, and hence determine whether
concentration was a factor in this process.
The UV absorption traces for each fraction can be seen in Figure 4.11a. The general trend
is that the peaks increase in both intensity and area as the protein gets more concentrated,
as should be expected, but it is not immediately apparent whether the dead volume peak is
increasing faster than the oligomeric peak. Figure 4.11b shows the estimated percentage folded
for each concentration (established for each time period by taking a mean of 3 readings on
the NanoDrop) by dividing both the area and maximum intensity of the oligomeric peak by
the total of both the dead volume and oligomeric peaks together (assuming that all signals in
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(a)
(b)
Figure 4.11: Results of investigating degree of unfolding as concentration is increased. (a) shows
gel filtration traces at each time step, and (b) shows estimated folded percentage based on both
peak area and intensity at different concentrations.
76
4.4 Cryo Stability 4 STABILITY DETERMINATION
each sample were purely from His6-MmyJ, whether it be in oligomeric or aggregated form).
The percentage folded remains fairly constant to concentrations above 10 mg/mL, which is the
highest concentration aimed for during biophysical work. Increasing concentration is therefore
not causing the protein to unfold and aggregate, so the problem likely lies elsewhere in the
preparation methods.
4.4 Cryo Stability
Stability under different freezing conditions was then investigated, with the aim of identifying
the cause of the observed unfolding and aggregation.
4.4.1 Robustness to Prolonged Periods of Freezing
In order to investigate the effect of freezing His6-MmyJ, 200 µL aliquots of freshly purified
protein were kept under different conditions for different lengths of time before being thawed so
CD analysis could be used as a gauge of how much the protein had unfolded. Figure 4.12 shows
the resulting spectra for samples kept at room temperature, 4oC, −20oC (with and without
flash freezing in liquid nitrogen) and −80oC (again, with and without flash freezing) for 3, 7,
19 and 28 days.
Figure 4.12 reveals that there is a degree of unfolding over time, demonstrated by a decrease
in the amplitude of the characteristic α-helical peak at around 190 nm and double trough at
208 and 222 nm. However, the amount of unfolding is still a lot less than if the protein was
boiled. What is also interesting to note is that, with the exception of the sample stored at
4oC for 7 days (which is thought to be an anomalous result, possibly due to poor cleaning of
the cuvette used), there is very little difference in the amount of unfolding for the different
storage conditions, even when comparing the protein that was simply left on the bench at room
temperature for a month with that stored at −80oC. This is surprising as it implies that the
protein is actually more stable than originally thought, and means that sample preparation
need not necessarily be done on ice for future biophysical experiments. However, if this is
the case then it still offers no explanation for why the protein was seen to be unfolding and
aggregating in both the AUC and gel filtration experiments. It was considered that perhaps
the protein was retaining some of its α-helical structure when mostly unfolded, leading to false
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(a) 3 Days (b) 7 Days
(c) 19 Days (d) 28 Days
Figure 4.12: CD spectra of samples stored at different temperatures, and with different freezing
conditions for those stored below 0oC, taken after the samples had been stored for (a) 3, (b) 7,
(c) 19 and (d) 29 days.
results in the CD spectra, but the previously demonstrated thermal stability assay clearly shows
that when unfolded His6-MmyJ loses all α-helical character. As such it can be concluded that
the previously observed unfolding and aggregation is simply not happening in these samples,
meaning there has to be another factor causing it.
4.4.2 Robustness to Repeated Freeze/Thaw Cycles
The next thing investigated was how the number of freeze/thaw cycles endured by the protein
affected its structure. As before, CD spectra were taken of 200 µL aliquots of the same batch
of protein after repeated freeze/thaws, as well as a baseline spectrum being taken before the
samples were frozen. Also, for this experiment only samples stored at −80oC with and without
flash freezing in liquid nitrogen were used. The results of this experiment can be seen in
Figure 4.13, and what is immediately apparent is that while freezing His6-MmyJ once has very
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(a) (b)
Figure 4.13: Spectra of samples of His6-MmyJ that have been frozen and thawed repeated times
at (a) −80oC only and (b) −80oC with flash freezing in liquid nitrogen.
little effect, freezing it a second time after it has thawed seems to almost completely unfold
the protein. This appears to be true whether the sample is frozen slowly or quickly in liquid
nitrogen. From this it can be concluded that the issues experienced in attempted biophysical
experiments were likely due to the protein experiencing multiple freeze/thaw cycles. This is
in fact very likely as the −20oC freezer that the His6-MmyJ was generally stored in until low
cryogenic stability was suspected has been noted to have problems closing due to a perished
door seal leading to a build up of ice. Due to this, many aliquoted samples within that freezer
will have inadvertently been frozen and thawed multiple times, hence causing disruption to
experiments.
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5 Function
Work began with purified recombinant MmyJ to investigate if it does indeed behave as a typical
ArsR family transcriptional repressor.
5.1 DNA Binding
The first step towards proving ArsR-like functionality was to establish whether MmyJ binds to
DNA and, if so, whether it binds specifically.
5.1.1 Proposed Binding Site
As previously mentioned in Sections 1.3.1 and 2.5, there is a region of DNA surrounding the
promotor regions of both the mmr and mmyJ genes that has been shown to be protected by
DNA fingerprinting [100], which was shown in Figure 2.14a. This region was found to contain
a semi-conserved inverted dyad sequence, similar to the sequences to which ArsR proteins
typically bind [28]. A comparison between this identified 13-1-13 dyad and the typical 12-2-12
motifs to which ArsR-like and SmtB-like family members are known to bind can be seen in
Figure 5.1 [28]. Even allowing for the base shift due to the different sizes of the motifs, it can
be seen that there is a greater alignment to the core ArsR-like motif than the SmtB-like motif.
The two halves of the repeated sequence can clearly be seen to align in the case of the ArsR-like
motif, whereas the SmtB-like motif is shifted to quite a large degree, with the centre points
of the two motifs separated by a considerable number of bases. Incidentally, there are several
other imperfect inverted dyad motifs within the same region, as highlighted in Figures 1.16b
and 2.14a. However, these are two pairs of 7-3-7 dyads and a single 25-0-25 sequence, which
aaaaaaaaaaaaaaArsR-like:aaaaa---TAxAxTCAAAtax-xtaTTTGaxTxTA---
aaaaaaaaaaaaaa13-1-13 Dyad:aaGACGGCTGTCAAA---C---TTTGATGGCCGTC
aaaaaaaaaaaaaaSmtB-like:aaaaaaAtAxxTGAacaxxtatTCAxaTxtt----------
aaaaaaaaaaaaaa13-1-13 Dyad:a --------GACGGCT-GTCAAACTTTGATGGCCGTC
Figure 5.1: Core DNA motifs recognised by ArsR-like and SmtB-like ArsR family proteins
[28] (see Section 1.2.3 for details) aligned with imperfect dyad reported in [100]. For the core
motifs, lower case letters indicate a lesser degree of conservation and ‘x’ indicates any base can
be present at this position. Common bases are highlighted yellow. Bases in red indicate the
non-repeated bases at the centre of the 12-2-12 and 13-1-13 sequences. Alignment performed
using ClustalW2 [122].
80
5.1 DNA Binding 5 FUNCTION
align less favourably with the known core sequences than the 13-1-13 dyad, and so are not
considered to be likely DNA targets for MmyJ.
Due to the similarity to the ArsR binding motif, the identified 13-1-13 repeat is considered
the most likely target DNA sequence for MmyJ binding, and will be the focus of the following
work.
5.1.2 Polymerase Chain Reaction Amplification of Intergenic Region
Polymerase Chain Reaction (PCR) amplification was used to amplify the 218 bp intergenic
region between the mmr and mmyJ transcription start sites in its entirety from cosmid C73,
containing the methylenomycin gene cluster from plasmid SCP1 [99]. Due to the shortness of
the amplification region, Taq polymerase (error rate approximately 1 in 1000) was used with
oligomer pair 4, listed in Section 8.1.3, which were designed using the Primer Design feature in
Clone Manager 9 [155]. Later, the same PCR protocol was used to amplify 110 bp fragments
of this intergenic region (bases 1-110 and 111-218) in order to locate the protein binding site,
using primer pairs 5 and 6 (also designed using Clone Manager 9 [155]). The products of
these amplifications can be seen in Figures 5.2a and 5.2b respectively. Both amplifications were
successful, and all primers bound specifically, with no non-specific binding evident, which would
lead to multiple undesired PCR products.
5.1.3 Electrophoretic Mobility Shift Assays
Electrophoretic Mobility Shift Assays (EMSAs), also called Gel Shift Assays, are a common
method of demonstrating the specific binding of proteins to DNA [156, 157]. As with many
(a) (b)
Figure 5.2: Products of PCR amplification of (a) entire 218 bp mmr -mmyJ intergenic region
and (b) 110 bp fragments of the intergenic region (bases 1-110 and 111-218). Both sets of PCR
products were run on 1.2 % agarose gels.
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other gel electrophoresis techniques, the distance a compound moves through the gel when a
voltage is applied varies with the charge and mass of the compound, with shape also having a
contributing effect [158]. In EMSAs, there is typically a lane containing a specific sequence of
DNA, as well as lanes containing the same DNA in a mixture with proteins that are suspected
to bind to it. If a protein does indeed bind to the DNA sequence then, as the protein:DNA
complex is larger and heavier than the unbound DNA, it would have reduced mobility and
travel less distance through the gel in a given time. In this way, shifts in band positions can be
observed between DNA and DNA/protein complexes if the protein binds to the DNA.
Likewise, this technique can be used when investigating ligands that cause the release of a
bound protein from DNA. If a protein is known to bind to a DNA sequence, a lane containing
this complex is run alongside lanes containing the complex plus ligands suspected of binding to
the protein. If one of these ligands does in fact bind, then the DNA will be released and the
band will be observed at the same position as the unbound DNA.
This process is illustrated in Figure 5.3, which simulates an experiment between two proteins
binding to the same DNA sequence. A shift due to the addition of Protein 2 is observed and
Figure 5.3: Simulation of EMSA in which the potential binding of two proteins to DNA is
demonstrated, along with a simulation of the addition of binding ligands to the resulting
protein/DNA complex. ‘+’ and ‘-’ indicate the potential applied across the gel.
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reveals protein-DNA binding. When ligands A or B are added, it can be seen that ligand B
prevents the band shift, and so implying that ligand B binds to protein 2 and causes it to release
the DNA to which it was bound. This is the general principle of how EMSAs work, although
there are of course some proteins that require a ligand to bind DNA, such as Fur, and so the
procedure would differ in those instances.
5.1.4 Evidence of DNA Binding by MmyJ
Initial EMSA attempts were carried out using a 10 µL mixture of DNA and MmyJ (dissolved in
IMAC wash/binding buffer) in an approximate 1:1 molar ratio. This was then added to 10 µL
of binding buffer from Roche DIG Kit [159]. This mixture was incubated for 15 minutes before
adding 5 µL non-denaturing loading dye, after which it was run on a 1% agarose gel containing
a DNA intercalent. An attempted EMSA using the full 218 bp intergenic region is represented
in Figure 5.4.
No binding is apparent with either the His tagged or cleaved MmyJ to the intergenic region as
there is no shift upon addition of either protein. In order to improve the chances of successfully
observing binding, further EMSAs were carried out on a 6% Native PAGE gel, using a recipe
and protocol that had previously worked well for other users in the laboratory. Furthermore,
upon investigation of the integenic region, it was noticed that it could be split in half; with one
half containing the suspected binding site between bases 131 and 180 (incorporating the full
possible binding site, not just the 13-1-13 inverted repeat) and the other proposed to be used
Figure 5.4: 1% Agarose EMSA investigating binding of both His tagged and cleaved MmyJ to
complete 218 bp intergenic region.
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Figure 5.5: 6% Native PAGE EMSA showing binding of His6-MmyJ to 110-mer corresponding
to bases 111-218 of the intergenic region. - and + indicate absence and presence of MmyJ.
as an innate negative control, assuming MmyJ-DNA binding is specific. As such, primers were
designed to divide the intergenic region, resulting in one 110-mer (bases 1-110) and one 108-mer
(bases 111-218). These regions are numbered such that base 1 is the first base of the intergenic
region, next to the mmr start codon. For simplicity, both will be classified as 110-mers for the
remainder of this discussion.
Figure 5.5 shows the gel resulting from running the assay with the 110-mers. A clear shift is
observed when His6-MmyJ is added to fragment 111-218, but not fragment 1-110, indicating that
His6-MmyJ does indeed bind to DNA and that the binding is specific. As further proof of this,
Figure 5.6 shows the SDS-PAGE gel from the purification of the sample of His6-MmyJ used
in this assay, from which the fractions corresponding to lane 4 were taken. The only bands
present correspond to the pure His6-MmyJ monomer and covalent dimer previously identified
in Section 3.1.5 (NB: the dimer band is expected due to this being the wild-type MmyJ, and so
the previously mentioned covalent binding is present). Hence, it can confidently be concluded
that the binding observed in Figure 5.5 is due to His6-MmyJ. It should be noted that although
Figure 5.6: 15% SDS-PAGE gel showing purification of His6-MmyJ sample used in EMSA
shown in Figure 5.5. Lanes as follows: 1. Non-binding proteins, 2. Column wash, 3. First
elution peak (His6-MmyJ + impurities), 4. Second elution peak (pure His6-MmyJ).
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the His tagged form of MmyJ was used for this assay, there is no indication that such a tag
alters the function of DNA binding proteins [160], and so it can be assumed that the DNA
binding exhibited is in no way due to the presence of the His tag.
To further locate the protein binding site within the DNA fragment, pairs of 50 bp long
oligonucleotides were designed and ordered from Sigma Aldrich. These oligonucleotides were
designed such that the second half of the intergenic region was repeated in overlapping 50 bp
blocks. In this way, there would be an additional overlapping oligonucleotide containing the
entire binding site if it lay at the end of one oligonucleotide or bridged two adjacent blocks of
50 bases. As such, the region was divided into oligonucleotides covering bases 101-150, 131-180,
151-200 and 169-218, listed as oligonucleotide pairs 7-10 in Section 8.1.3. After mixing the pairs
of complementary strands in a 1:1 molar ratio, these were then heated to 95oC and allowed to
cool naturally back to room temperature, thus annealing the individual oligonucleotides into
double stranded DNA.
Figure 5.7 shows the result of running an EMSA with the new 50-mers. A clear shift
appeared in lanes containing both the 101-150 and 131-180 fragments, while weak binding is
apparent in the lane containing the 151-200 fragment, and no binding in the lane containing
169-218. From this, it can be surmised that the protein binding site does indeed lie on the
boundary between bases 101-150 and 151-200, and is therefore captured in its entirety by bases
131-180. This pattern of weak and strong binding can be overlaid with the predicted target
sequence as shown in Figure 5.8; a modification of Figure 2.14a previously shown in Section 2.5.
With the DNA sequence annotated in this way, it can be seen that the 7-3-7 sequences,
Figure 5.7: 6% Native PAGE EMSA showing binding of His6-MmyJ to overlapping 50-mers
covering the second half of the mmr to mmyJ intergenic region. - and + correspond to absence
and presence of His6-MmyJ.
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Figure 5.8: As Figure 2.14a: Fragment of intergenic region containing promoter sites for mmr
and mmyJ, shown by black boxes. Colour coded arrows represent inverted repeats, with breaks
in the arrows indicating imperfections in the repeated sequence. Bold lines added below the
sequence correspond to 50-mers used in EMSA shown in Figure 5.7, with green indicating strong
binding between the DNA fragment and His6-MmyJ, orange indicating weak binding and red
indicating that no binding was apparent.
indicated by green arrows, cannot be the protein binding sites as the 151-200 fragment actually
contains one complete repeat and part of the other. Hence, if this was indeed the target
sequence of MmyJ, then there should be strong binding exhibited by this fragment and weaker
binding by the 101-150 fragment, which does not incorporate a single iteration of the full 7-3-7
sequence. Likewise, it cannot be the 25-0-25 sequence, shown by blue arrows, as if this was the
case then the 131-180 fragment would show stronger binding than either 101-150 or 151-200,
given that only the overlapping fragment contains the full 25-0-25 sequence, with the other
two fragments simply contain half of the sequence. Thus, only the 13-1-13 sequence, labelled
with red arrows, corresponds with the observed binding pattern, as 101-150 contains almost
the full sequence and 131-180 contains the full inverted repeat. The fact that 151-200 binds
weakly, despite containing the complete additional single copy of the repeated sequence as well
as part of the true inverted sequence, can be explained simply by the observation that these
two repeats are not antisense unlike the full inverted sequence between bases 132 and 158. As
it has been shown that MmyJ binds specifically to DNA, if one of the repeats is the wrong way
around then it does not match the specific requirements of the DNA binding site within MmyJ.
Bases Description
101-129 No part of 13-1-13 sequence
117-145 First half of 13-1-13 dyad
131-159 Full 13-1-13 imperfect dyad
147-176 Second half of 13-1-13 dyad plus additional repeated 13 bp
161-189 Just additional repeat of 13 bp sequence
Table 5.1: Description of 29-mers with regards to the parts of the 13-1-13 repeat they contain.
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5’ - GC...(29-mer sequence)...GCGAGGC...(29-mer complement)...GC - 3’
Figure 5.9: Design of self-annealing oligonucleotides [161]. Bases in blue form central loop and
locking ends for 29-mer when cooled slowly from 95oC.
Also, the absence of binding to the 169-218 fragment indicates that MmyJ requires at least one
complete half of the 13-1-13 repeat to bind.
Further work was then carried out using 29-mers, designed such that the binding of MmyJ
to parts of the 13-1-13 sequence could be investigated. These are listed as oligonucleotides 11-15
in Section 8.1.3 and described in Table 5.1. These oligonucleotides contain additional bases at
each end, as well as a loop section in their centre to promote self-annealing, with the 29 bp
sequence and its complement placed on either side of the loop, as illustrated in Figure 5.9 [161].
These self-annealing oligonucleotides were heated to 95oC before being allowed to cool naturally
to room temperature.
Figure 5.10 shows the corresponding EMSA using 1 µL of the self-annealed 29-mers diluted
by a factor of 100. Also, in this instance, 18 µL of MmyJ was used to try and maximise
interaction visibility. However, it can be seen that there is no clear binding, despite the
expectation that there should be at least weak binding to the 117-145, 147-176 and 161-189
fragments, and strong binding to the 131-159 fragment. There is a slight shadow possibly
indicating binding to the 131-159 fragment, but this is too faint to be conclusive and would
represent a much larger shift than seen before. The lack of apparent binding could be explained,
Figure 5.10: 6% Native PAGE EMSA using self-annealing 29-mers including parts of the 13-1-13
inverted dyad. - and + correspond to absence and presence of MmyJ respectively.
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however, if MmyJ requires some of the bases surrounding the 13-1-13 repeat to stabilise the
interaction with DNA. This could be the case if it proves to have a winged HTH structure or if
the αR-αR’ distance is shortened, requiring bending of the DNA to fully align with the major
grooves as discussed in the case of HlyU in Section 1.2.5.
5.2 Ligand Sensing and DNA Release
Once DNA binding had been proven, the next step in the investigation into the function of
MmyJ was to identify the binding ligand that would cause dissociation of the MmyJ:DNA
complex, allowing the transcription of the mmr gene.
5.2.1 Evidence of Ligand Interactions with MmyJ
As with the interactions with DNA, EMSAs were used to investigate possible ligands sensed
by MmyJ. Due to the absence of any genes indicating metalloregulatory function within the
methylenomycin gene cluster, it was thought that either methylenomycin A (MmA) itself or
one of its intermediates were likely ligands to which MmyJ would prove sensitive. Due to
previously demonstrated binding of MmyJ to the mmr promoter region, it would make sense
for the expression of mmr to be triggered by MmA or an intermediate being sensed by MmyJ,
hence activating the self-resistance mechanism.
Figure 5.11 shows the result of an EMSA using a mixture of Methylenomycin C, D1 and
Figure 5.11: 6% Native PAGE EMSA showing sensitivity of MmyJ to mixture of MmC, D1 and
D2 at different ligand concentrations, causing the DNA to be released. DMSO and ampicillin
are used as negative controls.
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Figure 5.12: Structures of Methylenomycins A [89], B [163], C [90], D1 and D2 as well as the
Pre-MmC Lactone [162].
D2 (where MmD1 and MmD2 are metabolic products of the saturation of the exomethylene
side group in MmC [162]), obtained from Gideon Idowu, another member of the Corre research
group. The structures of these intermediates are illustrated in Figure 5.12. As the MmC,D1,D2
mixture was suspended in Dimethyl Sulfoxide (DMSO), this is used as a negative control, along
with ampicillin at the same concentrations as MmC,D1,D2, to ensure that any observed binding
is specific to those compounds. It can be seen that while not sufficient to completely disrupt
the MmyJ-DNA complexes, 10 mg/mL (approximately 50 µM) of the mixed MmC,D1,D2 does
appear to reduce the amount of MmyJ bound to DNA, corresponding to approximately a
20 times molar excess. As this effect is reduced upon diluting the MmC,D1,D2 mixture to
1 mg/mL, and is not visible when diluted to 0.1 mg/mL, it can be concluded that one or more
of the compounds MmC, MmD1 and MmD2 is sensed by MmyJ, disrupting the MmyJ:DNA
complex. This is reinforced by the observation that neither DMSO nor ampicillin appear to
inhibit the MmyJ-DNA interaction in the same manner.
Further samples of pure MmA, MmC and Pre-MmC Lactone were likewise dissolved in
DMSO to a concentration of 10 mg/mL (50 µM) and tested. Figure 5.13 shows an EMSA
performed using 1 µL of each of these compounds, along with the previous mixed sample of
MmC,D1,D2. In this instance, streptomycin was used as a negative control, being an antibiotic
also produced by Streptomyces species [164]. It can be seen that the reduction in DNA binding
of MmyJ in the presence of pure MmC is comparable to the MmC,D1,D2 mix, implying that
if more than one compound in this mixture is indeed sensed by MmyJ, MmC is probably
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Figure 5.13: 6% Native PAGE EMSA showing sensing of MmA and MmC by MmyJ, causing
the release of DNA. All ligands were added at a concentration of 10 mg/mL, with DMSO and
streptomycin used as negative controls.
the dominant ligand. Interestingly, the addition of MmA almost completely disrupts the
MmyJ:DNA complex, proving that MmyJ is more sensitive to this compound, and hence it
is likely to be the most specific ligand of MmyJ. No sensitivity is exhibited to the Pre-MmC
lactone, nor streptomycin, indicating that the interaction observed is specific to MmA and, to
a lesser extent, MmC (which have a similar structure, as seen in Figure 5.12).
As a further study, the methylenomycin furan signalling molecules (MmFs) were also inves-
tigated as potential ligands to MmyJ. These are naturally produced by S. coelicolor A3(2) and
are known to induce methylenomycin production by association with the TetR transcriptional
repressor MmfR [99, 166]; their structures are shown in Figure 5.14. As they trigger the
biosynthesis of methylenomycin, it is logical to think that they may also trigger its resistance
mechanism, hence their inclusion in this investigation. Figure 5.15 shows an EMSA investigating
Figure 5.14: Structures of the 5 methylenomycin furan (MmF) signalling molecules [165].
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Figure 5.15: 6% Native PAGE EMSA investigating sensing of MmF compounds by MmyJ.
MmFs, which were obtained from the Challis Research Group and dissolved in DMSO to
10 mg/mL as before, with MmA used as a positive control. An apparent reduction in intensity of
the shifted band upon the addition of MmA could be observed, but not for the MmF compounds,
so they do not appear to be sensed by MmyJ. However, the results of this EMSA are slightly
inconsistent with previous assays, as upon closer inspection it can be seen that the DNA binding
of MmyJ in all lanes causes a drastically reduced shift when compared to Figures 5.7 and 5.13,
despite the same conditions being used. There is still some interaction occurring, as there is a
visible shift between the lane containing just DNA and the ones with MmyJ added, however
the interaction appears to involve a smaller shift and, therefore, potentially a lower mass of
protein. This could be the result of monomeric binding or partial proteolysis of MmyJ prior
to purification, or indeed it could be the opposite case that this EMSA demonstrates true
dimeric binding and previous results indicate a super-shift caused by the possible formation
of a tetramer (as SmtB is known to do [67]). Multiple repeats of this assay have since been
attempted using freshly expressed and purified protein, as well as freshly extracted MmA, with
no improvement in clarity. As the observed MmA sensing in this case is not as efficient as
previous assays, despite being used in the same molar ratio with MmyJ, the results of this
experiment would need validating by further experimentation.
The same issue is also apparent in assays carried out at the same time investigating the
sensitivity of MmyJ to metal ions known to bind to ArsR family proteins, as can be seen in
Figure 5.16, which is also inconclusive. In this instance, the metal salts listed in Table 5.2
were dissolved in dH2O to a concentration of 10 mg/mL. However, the shift of the MmyJ:DNA
complex is again reduced and the positive control, (this time a mixture of MmA and MmC,
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Figure 5.16: 6% Native PAGE EMSA investigating sensitivity of MmyJ to metal ions known
to bind to other ArsR family proteins.
both at 10 mg/mL concentration), fails to be sensed by the MmyJ. Interestingly, in this EMSA
there is a very faint band apparent in some lanes, most noticeably those with copper and silver
added, at the same shift as previous positive results. It could therefore be interpreted that
trace amounts of these metals aid in dimer formation. However, this assay used approximately
a 20 times molar excess of metal ions to MmyJ, and so if this was truly the case then a large
amount of metal ions would need to be present to aid MmyJ dimer formation in vivo.
This split between the previous shift and the reduced shift can be seen clearly in Figure 5.17,
which shows an attempted EMSA investigating the effect of reducing the concentration of MmA
added to the reaction mixture. A shift close to the 200 bp band on the ladder could be observed,
as in previous figures, in addition to the shift lower down the lanes. It is interesting to note that
the top band is removed to a greater extent by the addition of MmA, and only conclusively at a
concentration of 10 mg/mL. This indicates that whatever MmyJ species is binding to the DNA
and causing the band labelled as ‘Half Shift’ to appear only weakly senses MmA, explaining
the comparative failure of the positive controls in Figures 5.15 and 5.16. The degree of shift
between the unbound band and the Half Shift band seems to be approximately the same as
Metal Salt Used
Arsenic As2O3
Bismuth Bi(NO3)3.5H2O
Zinc ZnCl2
Cadmium CdSO4
Cobalt Co(NO3)2.6H2O
Nickel NiSO4.6H2O
Copper CuSO4.5H2O
Silver AgNO3
Table 5.2: Salts used as source of metal ions used in EMSA shown in Figure 5.16.
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Figure 5.17: 6% Native PAGE EMSA showing the increase in preserved MmyJ:DNA complex
as MmA concentration is reduced. Two distinct shifts are apparent; only one of which appears
to be removed effectively by the addition of MmA. Note: only 5 µL of protein was added to
each lane in this assay, so as to increase the effect of lower concentrations of MmA.
the degree between the Half Shift band and MmyJ-DNA complex band, with a slight deviation
due to the non-linear nature of gel electrophoresis. This implies the previous suggestion, that
this could be the result of either monomer/dimer or dimer/tetamer binding, may have some
truth to it. Of these scenarios, the monomer/dimer equilibrium is perhaps most likely, as only
one ArsR family protein has thus far been reported to exist in a tetrameric state, requiring two
pairs of 12-2-12 dyads for DNA binding [67], where this system only has one full 13-1-13 dyad.
If this is the case, then the lack of MmA sensing by what would be the monomeric band implies
that the site sensitive to MmA lies in or around the dimeric interface of MmyJ, requiring both
monomers for maximum sensitivity. At present, however, this is just speculation.
5.3 Functional Analysis in vivo
In an attempt to complement the in vitro results reported above, Reverse Transcription PCR
was utilised and two distinct in vivo systems were also designed.
5.3.1 Reverse Transcription PCR
Reverse Transcription PCR (RT-PCR) is a method that can be used for quantifying the
transcription of mRNA in cells, and hence determine whether certain genes are expressed
[167, 168]. This procedure involves the production of complementary DNA (cDNA) of the
RNA using a reverse transcriptase enzyme and random primers, which amplify all RNA within
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Strain Genotype Description
W81 [162] ΔmmfL ΔmmfH ΔmmfP No MmF signalling molecules produced, hence no
methylenomycin production
W89 [165] ΔmmyR Overproduces MmF signalling molecules and
methylenomycin A
W95 [162] ΔmmyR ΔmmyD MmF signalling molecules produced, but no
methylenomycin or intermediates
M145 [165] SCP1- SCP2- Methylenomycin cluster absent, no MmF, MmA
or intermediates.
Table 5.3: Genotype and description of S. coelicolor strains used in RT-PCR assay. M145 is
included for use as a positive control only.
the cell lysate [169]. This mixture of cDNA of different expressed genes can then be amplified
with primers specific to the genes under scrutiny to determine whether they are indeed expressed
in the cellular system. In order to ensure that no chromosomal DNA is present, which would
lead to false positives, the cell lysate must first be processed to remove this DNA. Also, extra
sterilisation procedures must be followed to remove any trace amounts of RNase which would
disrupt results. In this instance, Life Technologies RNaseZap® was used to wash all equipment
and work areas.
In order to investigate the expression of mmyJ and mmr genes, cultures of S. coelicolor
strains W81, W89 and W95 (see Table 5.3) were grown and cDNA was obtained. It was
expected that if the MmFs were binding ligands, then an increase in mmr and mmyJ expression
would be seen in strains W89 and W95. However, increased expression of mmr and mmyJ in
W89 only would indicate that just methylenomycin A and/or its intermediates bind to MmyJ,
causing dissociation of the MmyJ:DNA complex.
Oligonucleotide pairs 16-18 from Section 8.1.3 were used to amplify the hrdB, mmr and
Figure 5.18: 1% agarose gel with results of RT-PCR assay. + and - indicate presence or absence
of cDNA, with strains of origin indicated. Ladder was included but has overpowered the camera
due to the high acquisition time required for PCR products to be visible. Dark bands at the
bottom of each lane corresponds to primers. Leakage of ladder into W81- mmr lane is noted.
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mmyJ genes present in the cDNA from each of the three W strains. hrdB was included as
a positive control, as all strains would express this gene. Other positive controls were also
included, using genomic DNA from strain M145 [165] with the hrdB primers and C73 genomic
DNA with the mmr and mmyJ primers. Negative controls were also run using extracts that
did not contain cDNA, to ensure no chromosomal DNA was present.
The result of this assay can be seen in Figure 5.18. Initial observations include the presence
of bands corresponding to the hrdB negative control for W95, along with all three negative
controls using the mmyJ primers. This indicates that there is some chromosomal DNA present
in at least the W95 cDNA, if not all three strains, unfortunately invalidating any results. It
is also apparent that the C73 positive control for the mmr primers failed, although the same
primers did amplify the gene in all three experimental cDNA samples.
While this method shows promise, it was decided that other methods would be more efficient,
especially in light of the previous EMSA results which indicate MmyJ does bind to DNA in
such a way that transcription of mmr and mmyJ is repressed. Hence, this work was not taken
any further.
5.3.2 Luciferase Reporter System
A reporter system has previously been developed for use in bacteria with a high GC content
utilising the bioluminescent protein luciferase [170]. In this system, a promoter containing a
transcriptional repressor binding site can be inserted upstream of the luxCDABE operon, such
that the binding and release of the transcriptional repressor can be monitored by the level
of bioluminescence, corresponding to the amount of luciferase produced. The pMU1 plasmid,
containing this system as well as an apramycin resistance cassette, can be seen in Figure 5.19.
This plasmid had previously been obtained from the Nodwell group at the University of
Toronto for use investigating the binding of MmfR to the mmfL promoter region. As such
the plasmid was easily accessible for this current work, with the intention of manipulating
the system to mimic the expression of mmr under the control of MmyJ. Once constructed,
the plasmids containing the mmr promoter would then be conjugated from E. coli into a
Streptomyces coelicolor M145 host, which does not contain the SCP1 linear plasmid on which
the methylenomycin gene cluster is located [165].
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Figure 5.19: Plasmid pMU1 containing luciferase system controlled by specific promoter that
can be inserted upstream of luxCDABE operon. aac(3)IV is an apramycin resistance gene. int
and attP are the integrase gene and attachment site of ΦBT1 phage, allowing insertion of this
plasmid into Streptomyces chromosomal DNA.
Primers were designed to amplify regions of C73 containing just the intergenic region
between mmyJ and mmr (designated LmJ1) and also containing the intergenic region plus
the mmyJ gene (LmJ2), as shown in Figure 5.20. These were designed such that the resulting
PCR products would have the addition of a BamHI restriction site at the mmr end and an
EcoRV restriction site at the mmyJ end. In this way they would be the correct orientation to
simulate mmr expression via the lux genes when inserted into the plasmid. Primer pairs 19 and
Figure 5.20: Plasmids LmJ1 and LmJ2, based on pMU1. Inserts were designed such that
LmJ1 should express luciferase and LmJ2 should have the transcription of luciferase regulated
by MmyJ binding to the promoter site. mmyJ-mmr intergenic region is orientated so as to
simulate mmr expression, i.e. with the mmr promoter at the same end of the insert as the
BamHI digestion site.
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Figure 5.21: 1% agarose gel containing PCR products from amplification of LmJ1 and LmJ2
inserts. Each amplification was repeated in triplicate.
20 shown in Section 8.1.3 were used to create these inserts, which were amplified using Roche
High Fidelity polymerase. The PCR products were then run on a 1% agarose gel as shown in
Figure 5.21 to confirm they were the correct size. BamHI and EcoRV were then added to the
PCR products so as to digest the ends ready for ligation. The digested inserts were then gel
purified.
Alongside this amplification and purification of the insert sequences, cells containing plasmid
11NY were grown in overnight cultures. This plasmid is a pMU1 derivative containing an 838 bp
EcoRV/BamHI insert designed to investigate MmfR binding. The 11NY plasmid was extracted
and digested using BamHI and EcoRV to remove this previous insert, giving a linearised version
of pMU1 with digested BamHI and EcoRV sites at each end. The result of this digestion is
shown in Figure 5.22, demonstrating that the 11NY insert was successfully removed. The
digested plasmid was then purified from the gel.
Ligation of the LmJ1 and LmJ2 inserts into the linearised pMU1 backbone was then
attempted in triplicate with NEB T4 ligase. As EcoRV digestion leaves a blunt end, ligation
was left to continue overnight in accordance with the manufacturer’s recommendations. Colony
number was small, with only 5 colonies appearing. Cells were taken from each colony to innoc-
ulate 10 mL liquid cultures and were grown overnight at 37 oC with shaking at 180 rpm. The
plasmids were then extracted and sent for sequencing, however all came back negative, with the
Figure 5.22: 1% agarose gel showing removal of 11NY insert from pMU1 plasmid after digestion
with BamHI and EcoRV.
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pMU1 plasmid apparently recircularising without the inserts in all cases. The transformation
was repeated with freshly digested plasmid and an altered insert:plasmid molar ratio of 20:1
in an attempt to compensate for the small size of the insert. However, this time there was no
colony growth at all.
The experiment was then repeated using Quick Ligase, again from NEB [171]. Also, this
time only 0.025 mg/mL apramycin was added to the LB plates in order to reduce the amount
of stress on the freshly transformed cells. In this instance there was good colony growth,
and cells were picked from 48 colonies for overnight liquid cultures; 24 each of LmJ1 and
LmJ2. These 10 mL cultures contained 0.05 mg/mL apramycin as before, as it was thought
that the cells would be resistant to this level of antibiotic, so as to act as a further screen
against unsuccessful transformations. Indeed, of the 48 overnight cultures, only 8 each of LmJ1
and LmJ2 grew, and so these then had their plasmids extracted for analysis. Each of these
possible hits was then sent for sequencing. In this case primer pair 21 was used, which had
been specifically designed to check for any inset between the BamHI and EcoRV restriction
sites, and had been successfully used previously by other group members investigating 11NY
insertion. Unfortunately, sequencing again indicated no positive results, with no insert present
in any plasmid.
At this point, this line of investigation was halted in favour of using a specially designed
reporter system for use in E. Coli instead of Streptomyces, as described in the next section.
5.3.3 ‘Tinsel Purple’ Reporter System
After the above negative results, it was decided that it would be more efficient to purchase
a custom reporter system already containing the mmr -mmyJ intergenic region. As such, a
Tinsel Purple reporter system, named pJ251, was purchased from DNA 2.0. This contained the
intergenic region and a kanamycin resistance cassette as seen in Figure 5.23. In this case, it was
intended that the plasmid would be transformed into BL21 star E. coli cells; both empty and
already containing the pET151 His6-MmyJ expression plasmid. As such, it was expected that
on the addition of IPTG, expression of the T7 RNA polymerase would be derepressed and the
cells containing just pJ251 would express Tinsel Purple, while those containing both pJ251 and
pET151 His6-MmyJ would not due to MmyJ repressing transcription from the mmr promoter.
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(a) (b)
Figure 5.23: (a) Plasmid pJ251, designed to express a purple protein via the mmr promoter.
The green region is the 218 bp mmr -mmyJ intergenic region, with -10 and -35 sites indicated
for both promoters. The region labeled ‘NealChater’ is the 13-1-13 inverted repeat indicated
in [100], since shown to be the MmyJ binding site. (b) Image taken from DNA 2.0 website
showing colour of expressed protein after 24 hours in LB media [172].
The pJ251 plasmid was transformed into empty BL21 star cells, with resulting colonies
being used to inoculate 10 mL cultures of LB media containing 0.1 mg/mL kanamycin and
1 mM IPTG. While the cells grew well, turning the culture distinctly cloudy, no Tinsel Purple
was expressed. A sample of pJ251 was at this point sent for sequencing using primer pair 4,
and was shown to contain the complete mmr -mmyJ intergenic region upstream of the gene
encoding for Tinsel Purple as designed.
One possible explanation for this failure in expression stems from the initial design consul-
tation, where it was decided that the kanamycin resistance cassette should be antisense to the
expression gene for Tinsel Purple. It was mentioned that this may reduce expression, but it was
desired so as to reduce the risk of read-through from the resistance cassette to the expression
system, and hence prevent false positives. As there are unique restriction sites at either end
of the expression system, it would be possible to design primers to amplify the region between
XhoI and BamHI sites such that it could be reinserted the other way around in order to test this
hypothesis. Another possibility is that the mmr promoter may not be compatible with E. coli
RNA polymerase, and so the insertion of a strong E. coli promoter site upstream of the inserted
intergenic region may be required. In this way, the mmr promoter would be circumvented, but
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MmyJ binding could still be investigated as it would obstruct the progression of the RNA
polymerase along the DNA sequence. However, there has not been time to realise either of
these experiments, and so further work must be done in order to attempt this and carry on the
in vivo aspect of the investigation into the functionality of MmyJ.
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6 Structure
While a structure based on homology modelling has already been generated and presented in
Section 2.3, a 3D structure determined by experimental methods would give a more reliable
insight into the properties of MmyJ.
6.1 Secondary Structure Analysis by Circular Dichroism
As already proven in Section 4.1.2, MmyJ has been found to have a high degree of α-helical
characteristics, as befitting an ArsR family protein. Subsequent work has stemmed from this
assertion, however the exact degree of α-helical character has not previously been alluded to.
A Circular Dichroism (CD) spectrum of His6-MmyJ in sodium phosphate buffer, obtained
as described in Section 4, was uploaded to the DichroWeb [173, 174, 175] server for analysis
with SELCON3 [176, 177], CONTIN/LL [178, 179] and CDSSTR [180, 181, 182] algorithms,
as recommended in [182]. In all cases, Reference Set 4 [182] was used, which is optimised for
data between 190 and 240 nm, corresponding to the range containing characteristic peaks for
α-helical and β-sheet secondary structure, as discussed in Section 4.1.1.
6.1.1 SELCON3 Analysis
SELCON3 is the latest iteration of the SELCON algorithm, which is a self consistent method for
the determination of secondary structure of proteins from CD data [176]. It works by including
the experimental data in the basis set, which it then uses to create an initial guess of the protein
secondary structure. This initial guess is based heavily on the reference spectrum found to be
most similar to the experimental data, and is used to predict a second approximation of the
predicted structure. This then replaces the initial guess in the next iteration of the algorithm,
which continues until it converges on a model most suited to the experimental data. Figure 6.1
shows the resulting modelled spectrum alongside the experimental spectrum submitted. From
the plot of deviation, it can be seen that this model does not perfectly replicate the experimental
data. However, as the three algorithms featured are optimised for different aspects of secondary
structure, it is recommended to perform all three analyses and evaluate the results together
[182].
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Figure 6.1: Comparison of CD spectrum expected from SELCON3 fit of predicted secondary
structure of His6-MmyJ to normalised experimental data. Deviation is shown as purple lines.
Model predicts 57% helical, 5% strand, 19% turn and 20% disordered secondary structure.
6.1.2 CONTIN/LL Analysis
CONTIN/LL is a modification of the CONTIN algorithm, which uses a ridge progression
procedure to minimise the sum of differences between the experimental spectrum and the
reference set, with weighting added according to a linear combination of iterations of the
algorithm [178, 179]. The CONTIN/LL modification reduces the reference set to exclude
proteins with a high RMSD when compared to the experimental data, thus reducing the
Figure 6.2: Comparison of CD spectrum expected from CONTIN/LL fit of predicted secondary
structure of His6-MmyJ to normalised experimental data. Deviation is shown as purple lines.
Model predicts 68% helical, 6% strand, 13% turn and 13% disordered secondary structure.
102
6.1 Secondary Structure Analysis by Circular Dichroism 6 STRUCTURE
Figure 6.3: Comparison of CD spectrum expected from CDSSTR fit of predicted secondary
structure of His6-MmyJ to normalised experimental data. Deviation is shown as purple lines,
which in this instance are nearly dot-like. Model predicts 53% helical, 21% strand, 9% turn
and 18% disordered secondary structure.
expected error in the final model [182]. Figure 6.2 shows the modelled spectrum for this
algorithm compared to the experimental result, and it can instantly be seen that it offers a
better fit that the SELCON3 algorithm.
6.1.3 CDSSTR Analysis
The final method used to fit the experimental data is CDSSTR, which randomly selects just
8 proteins from the reference set, with iterations of different combinations of these reference
proteins compared to the experimental data so as to satisfy the algorithm’s selection rules [182].
Figure 6.3 displays the resulting approximated spectrum. It can be seen in this instance that
the fit is near perfect, with no observable deviation between it and the experimental data. It
should be noted that due to the random nature of the reference selection, this result may not
be stable to attempts to reproduce it [182]; however the analysis presented here was repeated
and there seemed to be no noticeable deviation.
6.1.4 Comparison of Models
While an initial visual comparison implies that CDSSTR is the best algorithm and SELCON3
is the worst at modelling His6-MmyJ (assuming the homology model is accurate), the resulting
modelled characteristics need to be examined more closely and compared to other models
103
6.2 Nuclear Magnetic Resonance Spectroscopy Characterisation 6 STRUCTURE
Model % Helical % Strand % Turn % Disordered
SELCON3 57 5 19 20
CONTIN/LL 68 6 13 13
CDSSTR 53 21 19 18
Mean of CD Models 59 11 14 17
Phyre2 62 10 - 24 (28)
Table 6.1: Comparison of secondary structures predicted by previously discussed models based
on CD data as well as the new Phyre2 modelling of His6-MmyJ. It should be noted that 4%
of the residues in the Phyre2 model are unassigned, and have therefore been added to the
% Disordered column to give the value in brackets.
of predicted features; namely, in this instance, the homology model of MmyJ discussed in
Section 2.3. It should be noted that this model is of MmyJ as it occurs in vivo, rather than
the His tagged fusion protein on which the above analyses were carried out. As such, a new
Phyre2 [112] model was created8 with the addition of the His tag and V5 epitope [124].
The comparison between these four models is shown in Table 6.1. It can be seen that
while no individual model matches the homology model, the mean across all three models is
in good agreement with the homology model when considering the helix and sheet content of
His6-MmyJ. There is less obvious agreement between the % Turn and % Disordered, but that
is largely because Phyre2 does not assign residues as being part of a turn structure, and hence
many of the residues assigned as disordered may in fact be parts of an unrecognised turn. For
example, one of the residues between helices α3 and αR in the new Phyre2 model is classed
as disordered, despite it being one of the three residues that comprise the turn in the HTH
motif. As such, if the mean % Turn and % Disordered values from the CD models are summed
together, the total value of 31 can be seen to be close to the adjusted Phyre2 value of 28. In
this way the Phyre2 model is somewhat validated by the CD analyses; at least as far as relative
percentage composition of helical, strand and turn/disordered is concerned.
6.2 Nuclear Magnetic Resonance Spectroscopy Characterisation
In an attempt to obtain more complex structural information, Nuclear Magnetic Resonance
(NMR) spectroscopy was performed with 15N labelled protein samples.
8The new Phyre2 model is not shown here as it deviates from the previous model only in the addition of an
extra α-helix within the V5 epitope, which is only relevant when comparing to the CD data.
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6.2.1 Quantum Mechanical Theory - A Brief Overview
The basis of NMR lies in the possession of intrinsic angular spin momentum by all nuclei.
While orbital angular momentum has both a classical and quantum mechanical interpretation
of an electron orbiting a nucleus, spin angular momentum can not be thought of in terms of
classical physics, and can only be understood through quantum theory.9 Subatomic particles
can be classified as either bosons (such as photons) or fermions (such as neutrons, protons and
electrons) by their intrinsic integer or half-integer spin quantum number respectively. This is
denoted m, and is given in units of h¯ = h/(2pi), where h is Planck’s Constant [183]. As such,
atomic nuclei can have a range of spin values, calculated as the sum of spin values of their
constituent protons and neutrons. These spin values give the magnitude of the spin angular
momentum, usually represented by I = |m|. However, due to the Heisenberg Uncertainty
Principle, only the total magnitude and one component, typically taken to be that in the z
direction, can be known definitively. This can then be scaled by the gyromagnetic ratio γ, a
unique nuclear property that varies with isotope, to give the magnetic moment µ as follows
[184]:
µz = γIz (6.1)
This is the source of the NMR signal, and so it can be seen that in the case of nuclei with a zero
spin there is no magnetic moment. This includes 12C, the most abundant isotope of carbon,
hence NMR can not be performed on these nuclei. Another isotope of carbon, 13C, has a spin
value of 12 , and, as such, can be detected by NMR [185]. However, this isotope only has a
natural abundance of 1%. This is enough to generate a useable signal for small molecule NMR,
but for complex molecules such as proteins, labelling strategies must be employed to increase
the presence of 13C.
Some nuclei have a spin number whose magnitude is greater than 12 , and so their electro-
magnetic profile contains higher order functions, such as a quadrupole moment [184]. This adds
extra complexity to the acquisition and processing of NMR data, and so labelling strategies are
again employed to enhance the presence of half-spin nuclei. For example the most abundant
isotope of nitrogen is 14N, for which I = 1, leading to quadrupolar interactions. Molecules
9The name spin angular momentum is in fact misleading, and originates from early theories when it was
thought to stem from the spin of an atom on its axis. This has since been proven not to be the case.
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Figure 6.4: Illustration of precession of a magnetic moment µ around an external magnetic field
B0 at frequency ω0.
are therefore often enriched with 15N, for which I = 12 [185], allowing NMR experiments to be
performed without extra complication.
In order to understand an NMR experiment, it is also necessary to be aware of the interaction
of µ with an external magnetic field, B0. All nuclei possessing a non-zero magnetic moment
will align with an external magnetic field. However, as it is impossible to know all components
of I, and hence µ, the dipole moment cannot completely align with B0, and as such it precesses
around the magnetic field as demonstrated in Figure 6.4. The frequency of precession is defined
by the gyromagnetic ratio and magnetic field strength as follows, and so is different for all
isotopes [184]:
|ω0| = γ|B0| (6.2)
This precession frequency, ω0, is called the Larmor frequency and is a characteristic property
of each isotope in a given magnetic field. As such, NMR spectrometers are often named by
the Larmour frequency of a 1H nucleus in the magnetic field produced, for example a 14.1 T
magnet would cause 1H nuclei to precess at approximately 600 MHz, and so this is defined as
the field strength of such a spectrometer.
In an NMR spectrometer there is also an additional, weaker magnetic field B1, which is
applied perpendicular to B0. This field oscillates at a tuneable frequency ωrf , corresponding
roughly to the frequency of radio waves, such that the field at any given time can be defined
as [184]
B1 = |B1| cos(ωrf t+ φ) (6.3)
where φ is the phase of the oscillation. When ωrf = ω0 for a given isotope (defined as the
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resonance condition), the magnetic moment nutates about the B1 pulse, out of alignment with
B0. As the magnetic moment returns to equilibrium (i.e. aligned with B0), its precession
is recorded as a Free Induction Decay (FID), which can be Fourier Transformed to give the
frequency corresponding to the nuclei perturbed by the B1 pulse [186]. As this frequency is
inherently dependant on the strength of the magnetic field used, it is typically quoted as a
Chemical Shift in units of parts per million (ppm), usually denoted as δ. This allows the direct
comparison of values obtained from different spectrometers, using the conversion as follows
[184]:
δ(ppm) =
ω0 − ωref0
ωref0
(6.4)
where ωref0 is the Larmor frequency of the isotope being investigated, taken from a known
reference sample, e.g. 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) or tetramethylsilane
(TMS). It should be noted that NMR signals are inherently weak; the detected signal is actually
the difference between nuclei which align with B0 and those that align against it; a difference
of only one nucleus in 10,000, as defined by Boltzmann statistics at standard temperature and
pressure [184]. As such, multiple scans are typically carried out and summed together. As
signal occurs at the same frequency each time whereas noise occurs randomly; summing N
repeated experiments causes the signal to noise ratio to increase by a factor of 1/
√
N [184].
The power of NMR as a tool for structural characterisation of molecules comes from the fact
that individual molecules do not necessarily experience the full B0 field due to local shielding
by electrons and other effects of intermolecular interactions and bonds [184]. By this fact, the
resonance frequency of nuclei varies with the local environment, and as such a spectrum of
frequencies can be obtained where each peak corresponds to a unique electronic environment.
For simple molecules, this can be done for just one or two atomic species in order to determine
the local environment of each atom and therefore solve its structure. If investigating multiple
nuclei, a combination of pulse sequences can be used that allow interactions between atoms of
the same (homonuclear), or different (heteronuclear), species to be explicitly measured [184].
This sort of data is usually displayed as a two dimensional topographic map indicating coupled
nuclei. However, for larger molecules such as proteins, more complex experiments are also
required, leading to three-, four- or five-dimensional data. This can be visualised as an ensemble
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of topographic cubes and maps, allowing interactions to be tracked between molecules either
directly bonded or close in space, from which interatomic spacing can be computed. Some
experiments implemented in this work are two dimensional, however their design requires a
deeper understanding of quantum mechanics that is beyond the scope of this thesis.
6.2.2 Protein NMR in the Solution State
Protein NMR in the solution state has led to the elucidation of many protein structures, however
there are inherent limitations in this method. The main issue lies with the restraints of averaging
the anisotropic interactions stemming from the orientation of interatomic bonds with respect
to the external magnetic field, many of which have the general form [184]
C = CAniso
1
2
(3 cos2 θ − 1) (6.5)
where CAniso denotes the interaction due to anisotropic coupling of nuclei and θ denotes the
angle between the inter-atomic bond and the external magnetic field. These interactions, when
taken over an ensemble of molecules in a sample, lead to broadening of the peaks within the
NMR spectrum, reducing resolution and sensitivity of the method. However, in the solution
state these interactions are averaged by molecular tumbling (the rotation of molecules within
the solution), such that they are effectively cancelled out as follows:
∫ pi
0
1
2
(3 cos2 θ − 1) sin θ dθ = 0 (6.6)
Hence the anisotropic interactions tend to zero so long as molecular tumbling occurs within
a shorter timeframe than the measurement of the FID. However, tumbling speed reduces
as molecular size increases, and as such there is an upper limit in the size of molecule that
can effectively be studied by solution NMR [184]. There are exceptions, as complex labelling
strategies or pulse sequences can be implemented to raise this upper limit, but these add more
expense, time and complexity to the experiments.
A 2D 1H-15N Heteronuclear Single Quantum Coherence (HSQC) experiment [187] was
performed on a sample of MmyJ uniformly labelled with 15N, prepared to a concentration of
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Figure 6.5: 1H-15N HSQC spectrum of uniformly 15N labelled MmyJ in 50 mM Tris-HCl pH 7.
Summed spectrum of 256 scans.
approximately 1 mM in 50 mM Tris-HCl pH 7 containing 10% D2O and 0.1 mM DSS reference.
The experiment comprised 256 scans, which were summed together to increase the signal to
noise ratio as described above. The resulting spectrum can be seen in Figure 6.5. Ideally this
spectrum would contain a peak corresponding to every N-H interaction within MmyJ, of which
there should be at least 111 (one for each amine bond). It is apparent that this is not the
case, as at most only 10 individual peaks can be identified. It was suspected that the pH was
too high, and so pH was lowered to approximately 5.6 to reduce the rate of proton exchange
between the backbone amides and water/deuterium in the solvent [188]. The spectrum for
MmyJ in this altered solvent can be seen in Figure 6.6 where, in an effort to further increase
signal, 896 scans were acquired and summed. However, it can be seen that while a couple more
peaks are apparent, there is not a great deal of improvement upon the previous spectrum.
It was noted during sample preparation that aggregates were forming and dropping out of
solution which, after attempts to observe the phenomenon via gel filtration, was found to be
the direct result of removing MmyJ from an environment containing glycerol. Unfortunately,
glycerol could not be retained in the solution used for NMR analysis as the increased viscosity
would have much the same effect as if studying a much larger protein; the rate of molecular
tumbling would be drastically reduced to such a point that an NMR spectrum would not
109
6.2 Nuclear Magnetic Resonance Spectroscopy Characterisation 6 STRUCTURE
Figure 6.6: 1H-15N HSQC spectrum of uniformly 15N labelled MmyJ in 50 mM Tris-HCl pH 5.6.
Summed spectrum of 896 scans.
Figure 6.7: 1H-15N HSQC spectrum of uniformly 15N labelled MmyJ in 50 mM H2KPO4 pH 7
with 50 mM arginine and glutamine added to improve stability. Summed spectrum of 616 scans.
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be obtainable. An alternative was found in the addition of arginine and glutamine at a
concentration of 50 mM in place of glycerol, as this has been shown to give an approximately 9
times increase in protein stability [189]. As well as this, phosphate buffer was used rather than
Tris-HCl, containing just H2KPO4 at a concentration of 50 mM so that the arginine acted as
a base in this solution.
Figure 6.7 displays the results of performing the same HSQC experiment as before using
the new buffer at pH 7. It is immediately evident that there are many more peaks present,
indicating that stability was indeed likely to be a contributing factor to the previous issue.
However, there still are too few peaks present to attempt to assign them to residues within
MmyJ. It was thought that the absence of further peaks was likely due to the size of the
MmyJ dimer, as the upper limit on proteins observable via simple 15N labelling is considered
to be approximately 150 residues [190], whereas the MmyJ dimer would be the equivalent of
a 222 residue protein. Full peak assignment would require at least a three-dimensional data
set, and the data shown in Figure 6.7 required over 15 hours of acquisition time just for two
dimensional data. As it was not thought that lowering the pH would improve signal drastically,
it was decided that other experiments should be investigated. Uniform 13C, 15N labelling
was attempted to reduce acquisition time, but unfortunately protein overproduction failed
when attempted. Also, other solution state methods such as Transverse Relaxation-Optimised
Spectroscopy (TROSY) experiments were considered, but, as this would require deuteration, it
was decided that attempting solid state NMR would be a better alternative.
6.2.3 Solid State NMR
As previously mentioned, the main limitation on the size of molecule that can effectively be
characterised by solution state NMR is due to the slowing down of molecular tumbling to
timescales longer than the acquisition of the FID. In the solid state, there is no molecular
tumbling and so there is no averaging of the anisotropic interactions at all, leading to catas-
trophic line broadening with stationary samples [184]. However, by spinning the sample at high
speed, molecular tumbling can be approximated such that anisotropic interactions are again
averaged out, with increasing speed used to replicate increased molecular tumbling. This is
not a perfect solution, however, as the interactions that lie along the axis of rotation are not
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Figure 6.8: Illustration of so-called Magic Angle Spinning (MAS), with rotor containing sample
rotating at 54.7o to B0. The spinning frequency νr must be sufficiently large so as to replicate
molecular tumbling.
averaged, leaving some anisotropic contribution present in the recorded signal. The solution to
this lies in Equation 6.5, where it can be seen that if the 3 cos2 θ−1 term in brackets is equal to
zero, the contribution to anisotropic coupling along that specific angle will also be zero. This
is easily solved as follows
θM = cos
−1 1√
3
= 54.7o (6.7)
where θM is classed as the so-called magic angle. In this way, if the sample is spun
10 at sufficient
speed at an angle of 54.7o to the external magnetic field, as illustrated in Figure 6.8, then all
anisotropic effects are averaged out with the exception of those along the axis of rotation, which
also go to zero as an artefact of quantum mechanics [191].
In order to prepare a sample for solid state NMR, a newly developed method was utilised,
wherein an almost saturated solution of protein is spun in an ultracentrifuge, resulting in
forces approaching 106 × g, causing a protein concentration gradient across the sample. If
concentrated enough, this gradient will lead to super-saturation and precipitation, which can
be collected directly into the NMR rotor. It has been shown that this preparation method
results in enough short range order for NMR data to be acquired, comparable to as if the
sample was crystalline [192].
A solution of MmyJ in 50 mM phosphate buffer containing 10% glycerol11 was concentrated
to approximately 1 mM. This was then added to a vessel with a funnel leading to a 1.3 mm solid
state NMR rotor and spun in a Beckman SW41 Ti Rotor at 25,000 rpm, corresponding to a
force of approximately 100, 000× g. A precipitate was observed to form within the rotor, and a
simple one dimensional pulse sequence was used in an effort to observe cross polarisation (CP),
10Due to the required absence of any mechanical parts, spinning is achieved via high pressure air flow over
curved flanges built in to the sample rotor.
11As molecular tumbling is not an issue in solid state NMR there is likewise no issue regarding the retention
of glycerol in the sample buffer.
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Figure 6.9: 1H-15N CP spectrum of uniformly 15N labelled MmyJ precipitated from 50 mM
phosphate buffer containing 10% glycerol. Summed spectrum of 2048 scans.
i.e. the transfer of magnetisation [193], between 1H and 15N nuclei, with magic angle spinning
(MAS) carried out at 60 kHz. The resulting spectrum, summed over 2048 scans, can be seen in
Figure 6.9. It is apparent that even with this many repeated spectra summed together, there is
no visible spectrum demonstrating 1H-15N interactions. The sample preparation was repeated
with fresh MmyJ, and again the same results were observed. It is thought that even though
the MmyJ dimer was massive enough to form a precipitate, it may have been too small for said
precipitate to form cohesively, with short range order present to the degree required to generate
a detectable NMR signal.
Further solid state NMR experiments were planned using crystallised 15N MmyJ (see Sec-
tion 6.3.2 below for growth conditions), however the yield of crystals was insufficient to be
of use in NMR. As such, X-ray diffraction of crystallised MmyJ became the main focus for
determining its structural characteristics, as discussed in the remainder of this chapter.
6.3 X-Ray Diffraction
Further to the above attempts at NMR, X-Ray Driffraction was also utilised in an attempt to
solve the structure of MmyJ.
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6.3.1 A Brief Introduction to Crystallography
Diffraction occurs when a wavefront bends as it passes through a gap, with the most noticeable
effects occurring when the wavelength is of a similar magnitude to the dimension of the gap.
If more than one gap is present, then a distinct diffraction pattern is observed, formed of
constructive and destructive interference between the multiple new wavefronts [194]. The typical
classical example of this is the Young’s Double Slit experiment, where light is shone through
two adjacent slits on the order of 100 nm wide and onto a screen. On the screen a repeating
pattern of light and dark bands is visible where the wavefronts interact [195]. The properties
of this pattern, such as the width of the bands and distance between them, can be measured
and, along with known information such as the distance between the slits and the screen, can
be utilised to calculate the width and spacing of the slits. This principle also works for more
complex two dimensional patterns, although the amount of computation involved obviously
scales with the complexity of the pattern.
The theory holds for all wavelengths of light, and so X-rays can be diffracted by passing
through gaps on the order of 0.1-100 A˚. As the typical interatomic distances in molecules
and ionic compounds fall within this range, X-rays can be tuned to approximately match
these distances, allowing diffraction patterns to be observed. This type of diffraction, where a
pattern arises through constructive and destructive interference of waves reflected from planes
in a crystal lattice of atoms or molecules, is called Bragg Diffraction and is based upon Bragg’s
Law:
2d sin θ = nλ (6.8)
where d is the distance between crystal planes, θ is the angle between the crystal plane and
incident light beam that maximises constructive interference, n is a positive integer and λ is
the wavelength of the incident wave [196].
When diffracting from a three dimensional crystal lattice, the above equation is insufficient
on its own, and so theory has been developed to incorporate a reciprocal lattice, containing
coordinates corresponding to the diffraction pattern [197]. This, along with Bragg’s Law, was
incorporated into a geometrical construction called an Ewald Sphere, from which the angle
required to form a specific diffraction pattern from a crystal lattice can be calculated [198, 199,
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197]. In this manner, the unit cell of a crystal may be calculated and defined. This is the
smallest repeating volume which is then repeated through symmetry throughout the crystal;
hence if a crystal is pure, then the contents of the unit cell are mirrored throughout its volume,
and can be said to contain the structural information of the entire crystal [200]. In this way, it
can be seen that if the unit cell is defined as containing a protein, and the protein is suspended
within a crystal lattice such that the unit cell is repeated over and over, then the resulting
diffraction pattern can be solved to give the structure of the unit cell, and so the protein itself
[197].
Protein crystals are typically formed by either sitting or hanging drop methods. In both
instances a small drop containing protein in solution and crystallisation buffer, also referred to
as mother liquor [201], is sealed in an air tight well or compartment along with a large reservoir
of the mother liquor, either directly below (hanging drop) or adjacent to (sitting drop) the
protein solution. Vapour diffusion from the droplet to the reservoir causes the concentration of
both protein and any added precipitants to increase slowly, such that eventually crystals start
to form [200]. These can then be left to grow; however, if the well is not completely air tight
then the reservoir and droplet will both dry out, usually destroying the crystals [200].
6.3.2 Crystallisation Screen
As proteins are a broad and diverse class of molecules, there is no one buffer solution that will
lead to the correct conditions for crystallisation for all proteins. As such, screening assays are
used in order to determine the conditions required for a specific protein to crystallise. In this
work, four such 96 component screens were investigated:
• Morpheus - optimised to include ligands and buffers that were noted to have a high
occurrence in crystallisation conditions listed alongside solved structures on the Protein
Data Bank (PDB) [202].
• ProPlex - designed by screening over 600 conditions from published crystallised protein-protein
complexes and optimising the mixtures of significant additives [203].
• JCSG+ - an updated extension of the JCSG screen, which itself contains the best 67 of
480 previously published screen conditions [204].
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• PACT - a systematic test of pH, anions and cations with polyethylene glycol (PEG) added
as a precipitant [204].
In all cases, cleaved MmyJ was purified and concentrated to approximately 10 mg/mL in
20 mM Tris-HCl pH 8.8 with 10% glycerol added by weight. Screening plates were then prepared
as sitting drops containing 100 nL of MmyJ added to 100 nL of each screening condition, along
with a 75 µL buffer reservoir for each sample. The screening plates were then sealed and left
in a cool, dry room.
After approximately 3 weeks, it was noted that some of the screening conditions had led to
the formation of small, rock-like crystals, while others had caused MmyJ to aggregate. It was
noticed that PACT D3 (0.1 M Malic acid, MES and Tris + 25% PEG 1500, pH 6.0) contained
large angular crystals, while PACT D5 (as D3, but pH 8.0) had small crystals. As this was
the first pattern discovered, hanging drops were set up to screen around this condition, with
a pH between 5 and 8 and PEG 1500 concentrations of 17.5-30% in 2.5% increments. These
drops contained 1 µL MmyJ plus 1 µL screen condition suspended above a 200 µL reservoir.
Crystals were observed to grow after several weeks, with an example shown in Figure 6.10, but
unfortunately the in-house X-ray diffractometer was out of service for a prolonged period, and
so these hanging drops dried up before they could be investigated.
During the time when the diffractometer was out of use, the initial screening plates were
checked regularly in order to identify further conditions warranting investigation once possible.
After three months, photos were taken of all hits from the initial screen, which can be seen in
Figure 6.11 (NB: a photograph of PACT D5 is not included as the crystals grew at the edge
Figure 6.10: Photograph of crystals grown in 0.1 M Malic acid, MES and Tris + 17.5% PEG1500
pH 8.0. Taken approximately 2 months after hanging drop was set up.
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(a) JCSG+ A8 (b) JCSG+ C12 (c) JCSG+ E2 (d) JCSG+ G10
(e) Morpheus B12 (f) Morpheus C1 (g) Morpheus D12 (h) Morpheus E12
(i) Morpheus F12 (j) PACT A3 (k) PACT A4 (l) PACT A5
(m) PACT A6 (n) PACT B3 (o) PACT B7 (p) PACT B8
(q) PACT B9 (r) PACT D3 (s) PACT E1 (t) ProPlex B4
(u) ProPlex B6 (v) ProPlex D3 (w) ProPlex E8 (x) ProPlex H10
Figure 6.11: Photographs of crystals grown from original screens. Corresponding JCSG+,
Morpheus, PACT and ProPlex conditions can be found in [202, 203, 204].
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of the drop of solution and as such cannot be seen due to contrast issues). Upon comparing
these hits to the conditions in which they grew, several other patterns were discovered. For
instance, Morpheus B12, D12, E12 and F12 all contain 0.1 M Tris and bicine + 37.5% mix
of 2-methyl-2,4-pentanediol (MPD), PEG1000 and PEG3350 at pH 8.5, with the addition
of a mix of sodiated halides (B12), ionic salts (C12), short alcohol chains (D12) or di- to
penta-ethyleneglycol (E12). All of these conditions led to crystal formation, with the sodiated
halides giving the best crystals. Another pattern is PACT A3-6, which all contain 0.1 M succinic
acid, phosphate and glycine with pH varying from 6.0 to 9.0, and all of which leading to similar
shaped crystals. A third pattern is PACT B7-9, which all contain 0.1 M MES + 20% PEG6000
with the addition of 0.2 M sodium, ammonium or lithium chloride. It is interesting to note, in
this case, that the lithium chloride appears to change the shape of the crystal from rhombic to
hexagonal, although this could be an artefact of the angle from which the crystal is viewed.
It can be seen that there are some common features across the three groups of crystallisation
conditions. For example, Morpheus B12 contains sodiated halides, whereas PACT B7-9 contain
different chloride salts, one of which is sodium chloride. Hence there is some cross over between
these conditions. Likewise, Morpheus B12, D12, E12 and F12 and PACT B7-9 all contain high
levels of PEG polymerised with between 1000 and 6000 monomers per molecule. Nucleation
and crystal formation depends on pH and the presence of precipitants or additives as well as the
protein concentration reaching saturation as vapour diffuses from the drop into the reservoir
[205]. As such it can be thought that the overlap between these multiple patterns alludes to the
key components that lead to the most favourable conditions for MmyJ crystallisation; namely
high PEG content, mid to high pH and the presence of halide salts.
6.3.3 Diffraction Data
Once the diffractometer was operational, one of the crystals from the initial PACT B8 screen
was extracted from the drop and coated in a 70:30 mixture of PACT B8 mother liquor and
glycerol as a cryoprotectant [201] before being inserted into the X-ray diffractometer. As well
as the size and quality of the crystal (which was over 100 µm having been growing for close to
9 months), this condition was chosen as several crystals had grown, giving the opportunity to
optimise cryoprotection if insufficient in the first instance. However, the crystal survived freezing
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Figure 6.12: MmyJ crystal diffraction pattern with resolution of 2.1 A˚, forming part of a
complete set obtained over 300o.
well, and gave a good initial diffraction pattern. Repeated 15 minute exposures were then
taken at 1o intervals until a coverage of 300o was obtained, giving multiple data redundancies.
These data were acquired to 2.1 A˚ resolution, an image of which can be seen in Figure 6.12.
Unfortunately, molecular replacement strategies12 failed to solve the diffraction pattern due to
a lack of protein structure in the PDB with high enough homology. The most homologous
sequence as determined by BLAST analysis against the PDB was RHA00566, entry 3F6O (full
name RHA1 ro06925) [118]; a suspected ArsR family protein from Rhodococcus species RHA1
which has had its structure solved but no functionality analyses have as yet been reported.
However, this protein only has a 31% identity to MmyJ over just 54% of its sequence, and
although molecular replacement was attempted, it has proved insufficient to solve the MmyJ
structure.
6.3.4 Labelling Stratergies
In a further attempt to solve the diffraction data obtained, protein was expressed labelled with
selenomethionine (Se-Met) in place of methionine (only occurring at M84 in MmyJ) [206]. It
was hoped that this would allow the phase of the MmyJ crystal data to be determined, from
12Wherein attempts are made to alter the structure of a previously solved protein to match the unsolved
experimental data [200].
119
6.3 X-Ray Diffraction 6 STRUCTURE
which the previously acquired data could be solved [207, 208]. Unfortunately, Se-Met labelled
MmyJ failed to form cohesive crystals under the same conditions as unlabelled MmyJ. This was
despite the expectation that the same conditions should still yield high quality crystals.
Further experiments were set up to grow unlabelled crystals to be soaked in mercuric acetate
in order to directly identify the crystal phase, which was the method used to solve the SmtB
crystal structure [80]. However, these crystals failed to form, and only small, multifaceted
crystals grew. It was thought that these could be ground up and used to seed nucleation of
freshly expressed Se-Met labelled protein, but, unfortunately, there was not time to realise this
experiment during the final stages of this project. As such, the obtained data remains unsolved
pending the crystal phasing being identified.
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7 Conclusions
7.1 Summary
7.1.1 Identification of MmyJ as an ArsR Family Transcriptional Repressor
Through bioinformatic analysis of the MmyJ amino acid sequence by BLAST, Prosite and
MEME algorithms, it has been conclusively shown that MmyJ can be classified as an ArsR
family transcriptional repressor. BLAST analysis identified that residues 25-83 contain an
ArsR-like Helix-Turn-Helix (HTH) motif with high significance, calculating the expected value
of this assignment to be 1.10× 10−6. By proxy, this also identified MmyJ as containing a HTH
DNA binding domain, usually associated with transcription factors. It was also found that,
when comparing to other amino acid sequences in the NCBI database, 80 of the 100 closest
matches were ArsR family proteins, with the other 20 being hypothetical proteins of unproven
function. Furthermore, of the 80 ArsR family hits, all but one had 50% identity or higher
over 90 or more amino acids. This degree of similarity to proven ArsR family proteins adds
significant confidence to the assignment of MmyJ as an ArsR family protein. This was further
confirmed by Prosite analysis, in which it was revealed that MmyJ contains the conserved 24
residue ArsR HTH DNA binding motif, which gave good agreement when aligned against a
range of 9 other ArsR family proteins. MEME analysis of the presence of this motif when
compared to the same test set of 9 proven ArsR family proteins indicated that its presence in
MmyJ has an expected value of 1.9× 10−13, granting it high significance.
Homology modelling was then undertaken using Phyre2, which predicted a structure for
MmyJ containing 5 α-helices and one β-sheet. In this way, residues 49-70, corresponding to
α3 and α4, along with the 3 residues between them, comprise the HTH DNA binding motif in
agreement with the PROSITE assignment. This model was calculated to have high confidence
throughout, with the only significant areas of disorder being at each terminus, which is not
unexpected. This model was heavily based on the solution NMR structure of NmtR, a nickel
and cobalt sensing transcriptional repressor of the ArsR family. HADDOCK was then used
to predict the structure of the suspected MmyJ dimer based on the Phyre2 monomeric model.
This dimeric model was aligned with solved crystal structures of ArsR family proteins SmtB
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and RHA00566, as well as NMR structures of NmtR and CzrA, all of which aligned with an
RMSD of between 4.5 and 7.4 A˚ over 130 atoms or more. This degree of alignment lends
confidence to the predicted structure.
7.1.2 Protein Overproduction
The mmyJ gene was cloned into a pET151/D-TOPO expression vector for expression and
overproduction of MmyJ in E. coli. The protein was then successfully overproduced and was
found to be soluble, leading to its purification from the cell free extract (CFE) by immobilised
metal affinity chromatography (IMAC) through use of the 6xHis tag incorporated by the
expression vector. A tobacco etch virus (TEV) construct was obtained, with the enzyme being
overproduced and purified so as to cleave the 6xHis tag from the recombinant MmyJ. It was
found that the protein responsible for a band visible on an SDS-PAGE gel previously thought
to be an impurity was also cleaved upon the addition of TEV. This led to the identification
of a covalent dimer of MmyJ being present via the formation of a disulphide bridge between
cysteines in adjacent monomers, as confirmed by assay with the reducing agent DTT. As ArsR
family proteins are known to form dimers via hydrogen bonds, site directed mutagenesis was
utilised to engineer a C49S mutant of MmyJ, containing no cysteines. The same DTT assay
proved that there was no covalent dimer formation in this instance. However, as C49 was
identified as being part of the α3-helix in the Phyre2 homology model, experiments continued
with both variants of MmyJ in case the mutation of C49 caused a reduction in functionality of
the protein.
7.1.3 Protein Stability Analysis
The thermal stability of MmyJ was investigated, and it was found that the secondary struc-
ture of the protein appeared to remain intact at temperatures below 40oC, with unfolding
apparent at higher temperatures. The protein was also found not to refold upon cooling, as
expected. However, it was noted during subsequent experiments that visible aggregates of
MmyJ were forming, hence work was carried out to investigate their formation. Gel filtration
chromatography identified the presence of aggregated MmyJ with a molecular weight greater
than 70 kDa, equivalent to 5 or more monomers, along with a peak suspected to correspond
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to the expected dimeric state. Analytical ultracentrifugation was then attempted, and a broad
peak corresponding approximately to octameric oligomers of MmyJ was identified. Gel filtration
chromatography was then used to investigate this oligomer formation, where it was discovered
that the observed chromatagram could be replicated using boiled protein, indicating that the
oligomer formation was due to unfolding of the recombinant MmyJ.
Investigations into the stability of MmyJ at high concentration found that it was stable to
at least 10 mg/mL, and cryo stability experiments indicated that it was stable for a month
or more under different storage conditions. However, it was found that MmyJ was extremely
sensitive to multiple freeze/thaw cycles, and almost completely unfolded when frozen twice. It
was thought that previous issues with oligomerisation and aggregation were the product of poor
sample handling, in part due to a faulty freezer. Appropriate steps were then taken to reduce
the presence of aggregates in future experiments.
7.1.4 Functional Analysis of MmyJ
Due to the genetic arrangement of mmyJ divergent to the mmr gene, itself encoding for an eﬄux
pump that removes the antibiotic methylenomycin A (MmA) from the cell, it was suspected
that MmyJ regulates expression of this gene, and hence triggers the self-resistance mechanism
to MmA. Analysis of the intergenic region between mmyJ and mmr had previously revealed
a 13-1-13 semi conserved inverted repeat sequence, which was found to be protected by DNA
fingerprinting. Electrophoretic mobility shift assays (EMSAs) with MmyJ and fragments of
the intergenic region identified this 13-1-13 motif as being the site to which MmyJ binds. As
this site encompasses the -35 regions of both the mmyJ and mmr promoter regions, it can
tentatively be concluded that MmyJ regulates its own expression, as well as that of mmr. This
sequence was found to have close similarity to the typical 12-2-12 inverted repeats to which
ArsR-like family members usually bind. There was no such similarity with the 12-2-12 inverted
repeat to which SmtB-like family members typically bind, indicating that MmyJ is likely to
bind to just a single strand of DNA, rather than both strands.
Further EMSAs were then employed in an attempt to identify the ligands sensed by MmyJ
and cause the dissociation of the MmyJ:DNA complex. It was found that a mixture of MmC,
D1 and D2 caused partial dissociation when present in a 20 times molar excess over MmyJ,
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with the bulk of this effect found to be caused by the MmC constituent of the mixture. MmA
was then found to cause total dissociation when present in the same excess. As such, it can be
surmised that MmyJ regulates expression of both itself and the mmr gene until methylenomycin
production is initiated by the cell. As methylenomycin levels increase, MmA and C are sensed
by MmyJ, causing it to dissociate from the mmr promoter, thereby triggering production of
the eﬄux pump and removing MmA from the cell. As methylenomycin levels then fall, new
MmyJ is produced and again forms a complex with DNA at the binding site, preventing further
expression and production of the MmA resistance mechanism until needed.
7.1.5 Structural Analysis of MmyJ
Secondary structural analysis of MmyJ was carried out by circular dichroism (CD) spectroscopy,
and it was found that the results gave good agreement to the α-helical and β-sheet content of the
homology model predicted by Phyre2. Nuclear magnetic resonance (NMR) spectroscopy was
then utilised in an attempt to obtain structural information by experimental means. Although
some peaks were visible in the resulting solution state spectra, it was decided that solid state
NMR would be required in order to acquire data pertaining to the full, three dimensional
structure of MmyJ. However, attempts at solid state NMR failed to give useable signal.
Growth conditions for the crystallisation of MmyJ were screened and hits were investigated.
X-ray diffraction data was obtained to a resolution of 2.1 A˚ over 300o, but unfortunately these
data could not be solved by molecular replacement analysis due to the absence of any suitably
homologous structures in the PDB. Attempts were made to grow crystals of MmyJ labelled with
selenomethione in order to determine the phase of the crystals, thus allowing the previously
collected data to be solved. However, efforts in this were not successful during the timescale of
the project.
7.2 Recommendations for Future Work
7.2.1 Structure Determination
Further effort should be made to grow crystal labelled with selenomethionine, utilising crushed
unlabelled crystals in order to seed nucleation and crystal growth. In this way it is hoped
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that the phase of the crystals can be determined, leading to the solution of the crystal data
previously obtained. Once solved, this would provide conclusive structural information, to be
compared to both the previously constructed homology model as well as other solved ArsR
structures in order to gain deeper insights into the function of MmyJ.
It would also be desirable to continue work using NMR; either utilising more advanced pulse
sequences and labelling strategies in solution state, or by growing isotopically labelled crystals
for solid state. Even if the solution by X-ray diffraction is possible, complementary information
from NMR, including peak assignments, would offer information into the kinetics and innate
flexibility of parts of the protein.
7.2.2 DNA Binding Site
It would be advantageous to further confirm the target region of DNA to which MmyJ binds by
repeating the attempted 29-mer EMSAs as detailed in Section 5.1.4, possibly with slightly longer
oligonucleotides in case interactions with the β-sheets is required to stabilise the bond. This
should ideally be done in a higher percentage Native-PAGE gel in order to increase retardation
of the smaller DNA fragments. More work would need to be carried out to optimise the
DNA:MmyJ ratio under these conditions. It is hoped that this would conclusively prove that
only the single iteration of the 13-1-13 dyad is needed, without the extra half repeat shown
in Figure 7.1. Also, EMSAs should be repeated using both wild type and C49S variants of
MmyJ so as to investigate the significance of C49 within the α3-helix, and determine whether
it improves stability of the DNA:MmyJ complex once formed.
Once the minimal length of DNA required for binding has been identified, it would be
desirable to attempt co-crystallisation of MmyJ with the target DNA region in order to identify
key residues required for DNA binding. This would also allow the determination of the αR-αR’
distance required for DNA binding, which can be compared to that known for other ArsR family
Figure 7.1: Identified DNA motif bound by MmyJ, as Figure 5.8. Red arrows indicate 13-1-13
semi conserved inverted repeat, with adjacent extra 13 bp repeat.
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proteins. In this way it can be determined whether a bend in the DNA is required for complex
formation, and whether MmyJ is an example of a winged HTH transcription factor, such as
HlyU.
If co-crystallisation is not possible, then solution NMR titrations should be carried out,
monitoring the interactions between nuclei in the protein and the 31P nuclei in DNA. Assuming
that a fully assigned spectrum of MmyJ can be obtained, a series of spectra taken as DNA is
titrated into the NMR sample would lead to shifts in peak positions for those nuclei involved
in DNA binding. In this way it would be possible to identify key residues involved in forming
the complex with DNA, as well as accessing some of the binding kinetics of the interaction.
7.2.3 Ligand Identification
EMSAs attempted with MmF compounds, as well as metal ions known to bind to ArsR
family proteins, should be repeated once the cause of the inconclusive positive controls has
been identified and compensated for. This would provide conclusive evidence whether or not
the signalling molecules that trigger methylenomycin production also trigger the resistance
mechanism, or whether it is just the methylenomycins themselves that are sensed by MmyJ.
Work should also continue with proven ligands MmA and C in order to determine the molar
ratio needed for complete dissociation of MmyJ and DNA, from which the number of molecules
of ligand required per MmyJ dimer could be determined.
Once fully tested, and all ligands have been identified, co-crystallisation and NMR titration
should be attempted as described above for the interactions with DNA. In this way the ligand
sensing site of MmyJ can then be determined, as well as the αR-αR’ distance of the inhibitted
protein, which would show how the conformation of MmyJ is changed such that DNA binding
is impaired. This would allow the structural impact on the functionality of MmyJ to be fully
explained. Also, co-crystallisation could lead to the conclusive identification of the method of
sensing of the ligands by MmyJ; i.e. whether they physically bind to the protein or alter its
structure another way, such as through a redox reaction.
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7.2.4 Binding Kinetics
It was originally intended that surface plasmon resonance (SPR) would be used to determine
binding kinetics of MmyJ to both DNA and binding ligand, however there has not been time to
realise this. It was intended that a streptavidin SPR chip would be prepared, with biotinylated
fragments of DNA immobilised on its surface. In this way, MmyJ could then be washed over
the immobilised DNA, allowing the association and dissociation constants to be determined. If
sufficient ligand could be produced, this could then be repeated with ligand washed over the
bound MmyJ, such that the increase in dissociation upon ligand binding could be quantified.
This could then be performed for all identified binding ligands, complementing the data obtained
by NMR titration.
7.2.5 In vivo Reporter Systems
While the above in vitro work would lead to the full determination of the structure and function
of MmyJ, the further development in vivo reporter systems discussed in Section 5.3.2 and 5.3.3
should not be neglected. If perfected, these systems could be utilised to engineer a novel
inducible expression system for use in either Streptomyces or E. coli cultures, similar to the lac
system used in this work. Due to its high GC content, this could provide a useful system to be
used when investigating secondary metabolite or protein production in Streptomyces species.
In this instance, MmA would be used to induce expression, requiring the inclusion of the mmr
gene as well to provide resistance to this antibiotic.
One possible route for further developing the Tinsel Purple reporter system lies in the
mutation of the mmr -10 site included in the intergenic region cloned into plasmid pJ251. Site
directed mutation of this site as shown in Figure 7.2 would result in a stronger E. coli promoter,
which could enable the system to be developed for use in E. coli. The primers required to do
Figure 7.2: Proposed mutation of mmr -10 site for stronger expression in E. coli.
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this have been designed in the same way as those used for the C49S mutation, and are included
as oligonucleotide pair 22 in Section 8.1.3.
7.3 Concluding Remarks
In respect to the work that was carried out, there are several comments that could be made
about the approaches used. It could be considered that any one of the biophysical techniques
attempted; either solution or solid-state NMR or X-ray diffraction, could have been used to
elucidate a completely solved structure of MmyJ if they had been the sole focus of the work.
However, by attempting to gain complementarity between the different techniques, the final
result was hindered somewhat due to efforts being split between these methods. It should be
noted that this is not necessarily a criticism, as it would be preferable to obtain full data sets
from at least one of the NMR methods as well as X-ray diffraction in order to fully understand
not just the structure of MmyJ but also its dynamic properties, and the ground work done here
will make that easier in the future. Indeed, once the final step is taken to solve the crystal
data obtained here, that information can then be fed back into an optimised NMR experiment
(utilising more sophisticated labelling strategies, as well as more complex pulse sequences),
allowing peaks to be assigned to the correct nuclei more readily. From this, it would then be
possible to identify flexible regions of MmyJ and understand the motions and dynamics from
which functionality of the protein is derived via the change in configuration. As such, these
two techniques together would provide a powerful combined method of gaining insight into this
system, and so it can be understood why both avenues were pursued.
Looking closer at some of the other aspects of the work, it can be seen that a lot of informa-
tion was obtained from relatively few experiments using circular dichroism. This technique often
seems underused, and it can be argued that most of the data obtained could be acquired through
other means, such as NMR. However, the ease of sample preparation and short experimental
time has meant that some properties of the secondary structure of MmyJ, as well as practical
information about its stability, have been identified regardless of the difficulties experienced
with other, more powerful techniques. In this way, it can be seen that there was merit in using
this technique to obtain some of the more basic information about MmyJ, with the possibility
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of further complementarity being obtained had more data had been acquired from the other
approaches.
Further to this, the validity of the work carried out to create in-vivo reporter systems
should be considered. While the processes of amplifying, digesting and ligating DNA prior
to transforming and propagating cell lines, then extracting the inserted plasmids and sending
for sequencing, can be thought of as a lengthy process, the skills and understanding needed
for this work can be seen as fundamental to work in this field. As such, while the techniques
ultimately offered no direct benefit to the project, it could be considered that by undertaking
this work a greater understanding and appreciation of this corner of the scientific community
has been achieved. Having said that, the ground work for these reporter systems should not
be neglected, and further efforts should be made to complete this work not only to add further
complementarity to any other data obtained, but to continue to work towards the secondary
goal of the development of a novel inducible expression system.
It is also worth noting that the bioinformatic analyses presented here were done both
thoroughly and succinctly, utilising a range of algorithms to obtain a near complete picture
of how it is expected that MmyJ should look and behave. It has been mentioned at several
points throughout the work that no one bioinformatic technique alone is adequate, and the
complementarity strived for in the experimental work can be seen to be matched by these
analyses. However, it could be said that a larger test set would improve results when comparing
directly to other ArsR family proteins, specifically comparing to a greater range of family
members that do not interact with metallic ligands as it was suspected, and later proved,
that MmyJ interacts in some way with a non-metallic molecule. Of course, the author was
limited by the data available elsewhere, and it was felt that there was not enough known about
other non-metal sensing family members to form a reliable comparison between a statistically
significant number of these proteins.
With reference to the aims and objectives outlined in Section 1.4, most targets have been at
least partially met. It would have been satisfying to either solve the crystal structure of MmyJ or
to prove ligand binding of MmA via co-crystallisation or mass spectrometry, but these results
unfortunately could not be realised in the life of this project due to the allocation of time
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elsewhere. The only aim not realised at all was the hope of investigating binding properties,
kinetics and dynamics using a mix of NMR and SPR. However, even if MmyJ-MmA binding
had been proven, there would likely not have been time to fully realise these experiments as
well, and so it is perhaps the case that the initial project aims were too ambitious given the
projected length of the project.
With regard to the literature review carried out in Chapter 1, this work has raised several
interesting points. Firstly, as stated several times, this is the first instance of an ArsR family
protein being demonstrated to sense a non-metallic ligand. It would be interesting to carry
out experiments using reducing agents to investigate whether the interaction between MmyJ
and MmA could be due to the epoxy ring in MmA allowing MmyJ to function as a redox
switch, but this is not thought to be the case for two main reasons. Firstly, inhibition of
DNA binding by MmyJ is also demonstrated in the presence of MmC, which does not have an
epoxy ring nor any other functional group that is thought to easily lead to a redox interaction
with MmyJ. Secondly, compared to other ArsR family proteins MmyJ is severely lacking in
cysteine residues, possessing only one in helix α3. It is reported in many cases that not only is
metal binding governed by cysteine residues, but so are redox sensing mechanisms such as the
one demonstrated by BigR. Furthermore, if it is assumed that the homology model created is
accurate, the single cysteine at residue 49 is not in a position to easily impact on the tertiary
folding of MmyJ, being as it is on the outside of the α3 helix facing away from the rest of
the protein. Once the crystal structure is fully elucidated, this may prove incorrect; however
at present it is thought that the method of interaction between MmA and MmyJ could be
based elsewhere. As such, it is felt that further experimentation as outlined in Section 7.2
would lead to the possible establishment of MmyJ as the first in a new sub-class of ArsR
family proteins which sense non-metallic ligands through interactions that are not dependant
on cysteine residues.
In closing, the author would like to conclude this work by stating that it is hoped that the
projects are carried forward as suggested, leading to the determination of a fully resolved crystal
structure as well as identifying the method of interaction (and possible binding site) of MmA
with MmyJ. It is expected by the author that this will then lead to the identification of a new
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class of ArsR family proteins as described above, which could lead to further understanding of
the factors which trigger antibiotic resistance mechanisms, with possible lateral translation to
medically relevant systems. It is also hoped that the in vitro reporter work can be completed,
leading to the development of a novel inducible expression system for wider use within the
scientific community.
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8.1 Materials
8.1.1 Bacterial Strains
Plasmid Engineering/Storage StarGateTop10 competent E. coli cells
Protein Overproduction Invitrogen BL21 Star competent E. coli cells
RT-PCR Expression Assay Streptomyces M145 (SCP1- SCP2-)
Streptomyces W81 (ΔmmfL ΔmmfH ΔmmfP)
Streptomyces W89 (ΔmmyR)
Streptomyces W95 (ΔmmyR ΔmmyD)
8.1.2 Plasmids
pET151-mmyJ Expression vector for His6-MmyJ (amp)
pET151-mmyJC49S Expression vector forHis6-MmyJ C49S (amp)
LmJ1 Luciferase reporter system, mmyJ-mmr intergenic
region (apr)
LmJ2 Luciferase reporter system, mmyJ + mmyJ-mmr
intergenic region (apr)
pJ251 Tinsel Purple reporter system, mmr-mmyJ inter-
genic region (kan)
8.1.3 Oligonucleotide List
1. T7 Universal Primer
F: TAATACGACTCACTATAGGG
2. mmyJ pET151 cloning
F: CACCGTGGCGGCACGGATCACG
R: TGGAGCGCCGTGCGGGCG
3. mmyJ C49S Mutation
F: CGAAGGTGCCGCTGGCGATGTCC
R: GAGGACATCGCCAGCGGCACCTT
4. mmyJ -mmr Intergenic Region
F: TGCTGTTCTGCTCCTGTG
R: CGGCTGTCCGCCTCCTCG
5. mmyJ IG 110mer 1-110
F: TGCTGTTCTGCTCCTGTGGG
R: CGCACGGTAATTCCGGCG
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6. mmyJ IG 110mer 111-218
F: TTCTCACTGAAGCTCATATGACG
R: CGGCTGTCCGCCTCCTC
7. mmyJ IG 50mer 101-150
F: TTACCGTGCGTTCTCACTGAAGCTCATATGACGACGGCTGTCAAACTTTG
R: CAAAGTTTGACAGCCGTCGTCATATGAGCTTCAGTGAGAACGCACGGTAA
8. mmyJ IG 50mer 131-180
F: ACGACGGCTGTCAAACTTTGATGGCCGTCAACATTTGATGGCTGTCGTAC
R: GTACGACAGCCATCAAATGTTGACGGCCATCAAAGTTTGACAGCCGTCGT
9. mmyJ IG 50mer 151-200
F: ATGGCCGTCAACATTTGATGGCTGTCGTACCATGGTGGAACGACACGCGA
R: TCGCGTGTCGTTCCACCATGGTACGACAGCCATCAAATGTTGACGGCCAT
10. mmyJ IG 50mer 169-218
F: TGGCTGTCGTACCATGGTGGAACGACACGCGACGAGGAGGCGGACAGCCG
R: CGGCTGTCCGCCTCCTCGTCGCGTGTCGTTCCACCATGGTACGACAGCCA
11. mmyJ IG 29mer 101-129 (Self Annealing)
GCTTACCGTGCGTTCTCACTGAAGCTCATATGCGAGGCATATGAGCTTCAG
TGAGAACGCACGGTAAGC
12. mmyJ IG 29mer 117-145 (Self Annealing)
GCCTGAAGCTCATATGACGACGGCTGTCAAAGCGAGGCTTTGACAGCCGTC
GTCATATGAGCTTCAGGC
13. mmyJ IG 29mer 131-159 (Self Annealing)
GCACGACGGCTGTCAAACTTTGATGGCCGTCGCGAGGCGACGGCCATCAAA
GTTTGACAGCCGTCGTGC
14. mmyJ IG 29mer 147-176 (Self Annealing)
GCTTTGATGGCCGTCAACATTTGATGGCTGTCGCGAGGCGACAGCCATCAA
ATGTTGACGGCCATCAAAGC
15. mmyJ IG 29mer 161-189 (Self Annealing)
GCACATTTGATGGCTGTCGTACCATGGTGGAGCGAGGCTCCACCATGGTAC
GACAGCCATCAAATGTGC
16. hrdB
F: GATTGGGCGTAACGCTCTTG
R: TGTCCCTGCTGGTCTTCTC
17. SCP1.237c (mmr)
F: AGGTTGGCTCCCGTGAATC
R: TGTCCCTGCTGGTCTTCTC
18. SCP1.238 (mmyJ )
F: GCACGGATCACGACAGAG
R: GTCGACGATCGCGGTGAG
19. LmJ1 Insert (EcoRV → IG region → BamHI)
F: CCGGATATCGATGCGCTCTGTCG
R: CCGGGATCCCGCCTGTTCGGACAGTGG
20. LmJ2 Insert (EcoRV → mmyJ + IG region → BamHI)
F: CCGGATATCTACGGCTGTCCTCCGCAACC
R: Same as 19R
21. LmJ1/2 Insert Check
F: AAGCCACTGAGCGGGAGCTTG
R: GACGCTGTTGTCGCCGAAGTTG
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22. pJ251 mmr -10 Promoter Mutation
F: CCGGAATTACCGTGCGTTCTATTATAAGCTCATATGACGACGGCTGTCAAA
CTTTG
R: CAAAGTTTGACAGCCGTCGTCATATGAGCTTATAATAGAACGCACGGTAAT
TCCGG
8.1.4 Kits
Gel Extraction Thermo Scientific GeneJET Gel Extraction Kit [209]
Plasmid Extraction Thermo Scientific GeneJET Plasmid Miniprep Kit
[210]
Reverse Transcription PCR QIAGEN RNeasy Kit [211], Turbo DNA-free Kit
[212], Superscript II Reverse TRanscriptase Kit [213],
QIAquick Kit [214]
Site Directed Mutagenesis Agilent QuikChange Lightning SDM Kit [215]
8.1.5 Gel Markers, Dyes and Stains
DNA Gel Stain GelRed
DNA Molecular Weight Ladder Thermo Scientific FastRuler Low Range Ladder,
Thermo Scientific GeneRuler Low Range Ladder
Native PAGE Loading Dye Expedeon DNA/Native Loading Buffer
Protein Gel Stain Expedeon InstantBlue
Protein Molecular Weight Ladder Spectra Multicolor Low Range Protein Ladder
SDS-PAGE Loading Dye Expedeon LDS Loading Buffer
8.1.6 Buffer Exchange/Concentration Filters
Centrifuge Filters Amicon Ultra-15 (10 kDa MWCO)
Dialysis Thermo Scientific SnakeSkin Tubing (7 kDa MWCO)
Microcentrifuge Filters Amicon Ultra 0.5 mL (10 kDa MWCO)
8.1.7 Purification Columns
Gel Filtration Superdex 75 5/150 GL
IMAC GE Healthcare HisTrap HP 1 mL
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8.2 Instruments
Analytical Ultracentrifugation Beckman XLI
Cell Lysis Constant Systems Cell Disruptor (one-shot mode)
Circular Dichroism Spectroscopy Jasco J-720
Crystallography Screen Setup TTP Labtech Mosquito LCP
FPLC A¨KTApurifier 10 and A¨KTA Pure 25
Mass Spectrometry Bruker MaXis Plus
NMR (Solid State) Bruker Avance II 600 MHz
NMR (Solution State) Bruker Avance II 700 MHz
X-Ray Diffraction Genix Xenocs mar 345dtpµX
8.3 Experimental Methods
8.3.1 PCR Protocols
Taq Polymerase:
• 5.0 µL 10 × Taq buffer (+
(NH4)2SO4).
• 2.0 µL dNTPs (10 mM).
• 1.0 µL each primer.
• 0.5 µL Template.
• (3 µL MgCl2 if needed).
• 2.5 µL DMSO (100%).
• 1.0 µL Taq polymerase.
• Water up to 50 µL total (37 µL if no
MgCl2).
1. 94oC, 2 minutes.
2. 94oC, 45 seconds.
3. 55oC, 45 seconds.
4. 72oC, 90 seconds, Go to 2. × 30.
5. 72oC, 5 minutes.
6. 4oC, hold.
QuikChange Site Directed Mutagenesis Kit:
• 5.0 µL 10× Reaction Buffer.
• 1.0 µL Template.
• 1.0 µL each primer (0.1 mM).
• 1.0 µL dNTPs (from kit).
• 3.0 µL QuikSolution.
• 38.0 µL Water.
1. 95oC, 1 minute.
2. 95oC, 50 seconds.
3. 60oC, 50 seconds.
4. 68oC, 1 minute/kb, Go to 2. × 18.
5. 68oC, 7 minutes.
6. 4oC, hold.
Roche High Fidelity Polymerase:
• 37.0 µL Water.
• 2.5 µL DMSO.
• 2.0 µL dNTPs (10 mM).
• 5.0 µL Buffer 2 (with MgCl2).
• 1.0 µL Each Primer.
• 0.5 µL Template.
• 1.0 µL Polymerase.
1. 95oC, 5 minutes.
2. 95oC, 45 seconds.
3. 55oC, 45 seconds.
4. 72oC, 2 minutes, Go to 2. × 30.
5. 72oC, 15 minutes.
6. 4oC, hold.
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8.3.2 Sterilisation Procedure
All work with live cells was carried out using solutions, plastics and growth media sterilised
either by autoclaving or using 0.22 µm syringe filters. Cell work was carried out in a sterile
environment created by first disinfecting the bench with 1% by weight Virkon solution. A
bunsen burner with roaring flame was then placed in the centre of the sterilised work area in
order to maintain a sterile surface.
8.3.3 Chemical Transformation of Cells
After gently thawing, 2 µL of plasmid containing solution was added to 20 µL competent cells.
This mixture was kept on ice for 30 minutes, before being heat shocked at 42oC for 30 seconds,
after which 500 µL of pre-warmed LB was added and the resulting cell culture was incubated
at 37oC for an hour while shaking at 180 rpm. This was then split in a 1:9 ratio between two
25 mL LB plates containing 0.1 mg/mL ampicillin or other antibiotic as appropriate and left
to grow at 37oC overnight.
8.3.4 Glycerol Stock Preparation
A vial of 10 mL liquid LB containing 0.1 mg/mL ampicillin or other antibiotic as appropriate
was inoculated with a picked colony from a solid culture plate. This was then incubated at
37oC overnight while being shaken at 180 rpm. After incubation, 1 mL of culture was taken
and added to 1 mL 50% glycerol solution for long term storage at -80oC.
8.3.5 Culture Preparation for Plasmid Extraction
A vial of 10 mL liquid LB containing 0.1 mg/mL ampicillin or other antibiotic as appropriate
was inoculated either from glycerol stock or culture plate. This was then incubated at 37oC
overnight while being shaken at 180 rpm. The resulting cell culture was then spun down at
4,000 rpm for 20 minutes and the supernatant discarded. The pellet was then resuspended and
the plasmid extracted.
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8.3.6 DNA Sequencing
20 µL of plasmid preparation was submitted according to the guidelines supplied by GATC
Biotech, along with 20 µL of each primer required for SUPREMERUN analysis. Sequenced
data was analysed using Clone Manager™ 9 Professional Edition.
8.3.7 Protein Expression
A BL21 star colony was picked and used to inoculate 10 mL LB media containing 0.1 mg/mL
ampicillin, which was then grown overnight at 37oC, shaking at 180 rpm. A proportion of
this starter culture was then added to a large conical flask no more than 25% full of LB (also
containing 0.1 mg/mL ampicillin) such that 1% of the final liquid volume was added from the
starter culture (i.e. if growing a 800 mL culture in a 5 L flask, 8 mL of the starter culture
was added). This was then left in an incubator at 37oC shaking at 180 rpm until an optical
density at 600 nm (OD600) of about 0.6 was reached, after which time protein overproduction
was initiated using IPTG at a final concentration of 1 mM. This was then incubated overnight
at 15oC, shaking at 180 rpm to allow the BL21 star ample time to overproduce the protein.
The following morning, the cell culture was split into 500 mL flasks and spun down in a
Sorvall RC6 Plus ultra-centrifuge at 5,000 rpm for 20 minutes. The resulting cell pellet(s) were
then resuspended in IMAC wash/binding buffer (see Section 8.3.9) such that the total volume
of all resupsended cells from a single culture was approximately 50 mL. This was placed in a
50 mL Falcon Tube and refrigerated until purification.
If expressing isotopically labelled proteins, the above procedure was modified as follows,
using M9 minimal media. Once the cell cultures had reached OD600 of approximately 0.6,
they were spun down at 5,000 rpm for 20 minutes, before being washed by resuspending in
approximately 100 mL M9 salts. They were then centrifuged again and were resupsended in
M9 media, using half the volume of the original LB culture. This was done to minimise the cost
of labelled carbon and nitrogen sources used, as it has been shown that when expressing labelled
proteins using M9 the yield of expressed protein is similar whether the cells are transferred into
the same volume as they had been grown in LB or half that volume [216]. These cultures
were then induced with IPTG and from this point onwards were handled the same as natural
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abundance expression in LB.
If expressing proteins labelled with specific amino acids, such as selenomethionine in place of
methionine, the above protocol for expressing isotopically labelled proteins was followed with
a few minor alterations. Firstly, natural abundance carbon and nitrogen sources were used,
so no isotopic labelling was introduced. Secondly, M9 media was used containing 20 mg/L of
each amino acid individually, with the necessary substitution made. Finally, if required 1 mM
tris(2-carboxyethyl)phosphine (TCEP) was added to all media and buffers as a reducing agent.
In the case of selenomethionine labelling, this prevented aggregation via interactions between
selenium in adjacent molecules.
Long Term Storage Buffer:
• 100 mM NaCl
• 20 mM TRIS (pH 8)
• 30% Glycerol
Phosphate Buffer:
• Makes 0.1 M Potassium Phosphate Buffer at desired pH using the following volume (mL)
of 1 M stocks and diluted to 1 L:
pH K2HPO4 KH2PO4 pH K2HPO4 KH2PO4
5.8 8.5 91.5 7.0 61.5 38.5
6.0 13.2 86.8 7.2 71.1 28.3
6.2 19.2 80.8 7.4 80.2 19.8
6.4 27.8 72.2 7.6 86.6 13.4
6.6 38.1 61.9 7.8 90.8 9.2
6.8 49.7 50.3 8.0 94.0 6.0
8.3.8 Cell Lysis
Once resuspended, cells were lysed at approximately 20 kPsi using a cell disruptor. Once the
entire sample had been lysed, the cell debris was then pelleted by spinning down in a Sorval
RC6 Plus ultra-centrifuge at 18,000 rpm for 20 minutes. The supernatant was then passed
through a 0.22 µm syringe filter to remove any remnants of cell debris or unlysed cells. This
cell free extract (CFE) was then either further purified or refrigerated until needed.
8.3.9 Protein Purification
A His-Trap column was washed and allowed to equilibrate with 10 mL of wash/binding buffer
as per the column’s instruction booklet. A Superloop™ system was then used to pass up to
50 mL of CFE through the column, loading it with His6-MmyJ. After this, more wash/binding
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buffer was passed through the column to remove any last unbound proteins and return the UV
absorbance trace to close to the baseline. The His6-MmyJ was then eluted from the column
by gradual introduction of elution buffer containing 200 mM imidazole. 3 mL fractions were
collected throughout the purification process.
Ni2+ IMAC Wash/Binding Buffer:
• 100 mM NaCl
• 20 mM TRIS (pH 8)
• 0-10 mM Imidazole
• 10% Glycerol
• Degas before use
Ni2+ IMAC Elution Buffer:
• 100 mM NaCl
• 20 mM TRIS (pH 8)
• 200 mM Imidazole
• 10% Glycerol
• Degas before use
8.3.10 Protein Visualisation via SDS-PAGE
Gels were cast using either a 10 or 15 well comb depending on requirements, and were pre-run
for up to 2 hours at 200 V to ensure all remaining monomeric acrylamide had been drawn out
of the gel. 15 µL of each sample was then loaded and the gel was run at 200 V until the loading
dye could be seen to be nearing the bottom of the gel. Gels were then stained for between 15
minutes and an hour before being de-stained in cold water overnight.
SDS-PAGE Gels:
(Makes 60 mL) 15% 12% 4% 4% (2 mL)
1.5 M TRIS (pH 8.8) 15.0 mL 15.0 mL 15.0 mL 0.5 mL
20% SDS 0.3 mL 0.3 mL 0.3 mL 30 µL
10% Acrylamide 30.0 mL 24.0 mL 7.5 mL 0.25 mL
Water 14.7 mL 20.7 mL 37.2 mL 1.25 mL
• For 5 mL gel, add 100 µL APS and 5 µL TEMED
SDS-PAGE Running Buffer (10 × ):
• 250 mM TRIS-HCl pH 8.8
• 2 M Glycine
• 1 % SDS
8.3.11 Cleavage by TEV Protease
TEV protease was added to His6-MmyJ at an approximately 1:100 TEV:His6-MmyJ molar
ratio, which was then incubated at room temperature overnight on a rocking plate oscillating
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approximately once every 10 seconds. This mixture was then purified via FPLC similar to CFE
purification. However in this case the TEV protease was retained by the HisTrap column, along
with the cleaved 6xHis tags and other protein impurities. This allowed the collection of pure,
cleaved MmyJ as a non-specific binding protein by elution with 20 mM imidazole.
TEV Buffer:
• 50 mM TRIS (pH 8).
• 0.5 mM EDTA.
• 1 mM DTT.
8.3.12 Site Directed Mutagenesis
Primer pair 3 were designed using the online QuikChange Primer Design tool [217]. PCR
was carried out using the protocol 8.3.1 and XL10-Gold competent cells supplied with the
QuikChange Kit were transformed with the PCR product according to [215] and solid LB
plates containing 0.1 mg/mL ampicillin were inoculated with the transformed cells as usual.
8.3.13 Mass Spectrometry Sample Preparation and Analysis
Protein sample was buffer exchanged into 50 mM ammonium acetate and diluted to a final
concentration of approximately 1 µM . This was then loaded by direct infusion. Data was anal-
ysed using Bruker DataAnalysis, and spectra were deconvoluted using the maximum entropy
algorithm.
8.3.14 Buffer Exchange by Dialysis
Protein solution was put into an appropriate length of dialysis tubing. This was then sealed
and submerged in 2 L of new buffer and left for at least 6 hours, before the buffer was replaced
and it was left for another 6 hours. In cases where more than 10 mL of protein solution was
to be dialysed, a 5 L reservoir of new buffer was used, such that the ratio of new buffer to old
never dropped below 200:1.
8.3.15 Circular Dichroism Spectroscopy
Protein samples were prepared to a concentration of 0.5 mg/mL in phosphate buffer pH6.5
unless otherwise stated. In order to minimise the amount of sample needed, a 1 mm quartz
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cuvette was used, and 3 acquisitions were run in order to reduce noise. As N2 used to purge
the instrument and H2O in the sample buffer both absorb strongly at less than 180 nm [146]
and natural amino acids do not give rise to CD bands at wavelengths above 300 nm [144], only
wavelengths between these values were scanned. Unless otherwise stated, all spectra were taken
at 25oC.
8.3.16 Gel Filtration Chromatography
A column was used with an optimum protein separation range of 3 kDa to 70 kDa and a 50 µL
maximum sample volume. As each His6-MmyJ monomer has a mass of approximately 15 kDa,
this mass range was thought to be suitable for investigating the protein oligomeric state. Also,
the small sample volume meant that analytical work could be carried out quickly without using
up large quantities of protein, as would be the case in a larger column which would be more
appropriate for purification. The UV absorption at 280 nm was recorded as a function of
cumulative volume passed through the column.
A series of solutions containing proteins of known mass was run in order to calibrate the
column in the configuration used. These proteins were from the Gel Filtration Molecular Weight
Markers Kit for Molecular Weights 6,500-66,000 Da produced by Sigma-Aldrich ®, which were
dissolved in gel filtration buffer as per the kit’s instructions. These solutions were then run
through the FPLC machines as 50 µL samples in order to calibrate the column (see Figure 4.4,
Section 4.2.1).
Gel Filtration Buffer:
• 100 mM NaCl
• 20 mM TRIS (pH 8)
• 10% Glycerol
• Degas before use
8.3.17 Analytical Ultracentrifugation
Protein samples were prepared in 50 mM TRIS pH 8.8 + 0.5 mM EDTA with 10% glycerol by
weight added for stability. This was then sent to the Birmingham Biophysical Characterisation
Facility (BBCF) to be run. The data from this was then analysed using Sedfit [218] alongside
theoretical parameters for buffer density (ρ) and viscosity (η) calculated using Sednterp [219],
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as well as partial specific volume (V¯ ) calculated from the amino acid sequence.
8.3.18 Agarose Gels
Agarose was weighed out to either 1.0 g/L or 1.2 g/L depending on size of DNA fragment and
TBE buffer was added as required. Mixture was then heated in a microwave at 450 W until
melted, after which it was held under cold running water for approximately a minute. This
cooled the gel enough to add DNA intercalating stain at 5 µL per 100 mL of gel. Gel was then
poured into the casting tray with an appropriate comb and allowed to set.
TBE Buffer (5 × ):
• 27 g TRIS.
• 14 g Boric Acid.
• 3.4 g EDTA.
• (HCl to pH 8-8.3.)
• Water to 0.5 L.
8.3.19 Electrophoretic Mobility Shift Assay (No Ligand)
Unless otherwise stated, 1 µL DNA was incubated with 10 µL MmyJ in IMAC wash/binding
buffer (or 10 µL of buffer for negative controls) plus 1 µL EMSA buffer and 8 µL dH2O for 15
minutes at room temperature. After this time loading dye was added and the assay was loaded
into a Native PAGE gel and run at 100 V until the stain neared the bottom of the gel. NB: If
using annealed oligonucleotides, DNA was first diluted by a factor of 10
Native PAGE Gel (6%):
• 2 mL 5× TBE Buffer
• 2 mL 30% Acrylamide
• 6 mL dH2O
• 200 µL APS
• 10 µL TEMED
• Pre-run gel for 2 hours at 120 V before use.
8.3.20 Electrophoretic Mobility Shift Assay (Ligand Added)
As above, but after the 15 minute incubation 1 µL of suspected ligand was added (or 1 µL
solvent for negative control) and the mixture was then left to incubate for a further 15 minutes.
Loading dye was then added and the gel was loaded and run as above.
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8.3.21 Reverse Transcription PCR: cDNA Production
Streptomyces strains were grown in SMM media for 3 days at 30oC while undergoing shaking
at 200 rpm. These cells were then pelleted, resuspended and lysed on a vortex using tubes
containing Lysing Matrix E from the FastDNA™ SPIN Kit for Soil by MP Biomedicals [220].
cDNA was then purified using the QIAGEN RNeasy Kit [211], Turbo DNA-free Kit [212] and
SuperScript II Reverse Transcriptase [213], before using the QIAquick Kit [214] to clean up the
resulting cDNA. This was then used as a template for PCR under normal conditions.
8.3.22 BamHI and EcoRV Double Digestion
1 µL each of NEB BamHI and EcoRV enzyme was added to 16 µL DNA along with 2 µL
CutSmart buffer. Alkaline phosphatase was added to the reaction mixture to prevent religation
where required. The resulting mixture was then incubated at 37oC for 30 minutes. Digested
DNA was then gel purified as needed.
8.3.23 Plasmid Ligation
Ligase was used in accordance with the protocol supplied with the enzyme. Resulting ligated
plasmid was transformed into Top10 cells and plated onto LB media containing 0.05 mg/mL
apramycin and incubated at 37oC overnight
8.4 Growth Media
LB Media:
• 10.0 g Bactatryptone.
• 5.0 g Yeast extract.
• 10.0 g NaCl.
• (15.0 g Agar for solid medium).
• 0.1% Antibiotic (add after autoclaving).
• Water up to 1.0 L.
M9 Salt Solution (5 × ):
• 32.0 g Na2HPO4 · 7H2O, or 17.0 g Na2HPO4
• 6.0 g KH2PO4
• 2.5 g NaCl
• 5.0 g NH4 salt, unless adding label, in which case add after mixed
• Water up to 0.5 L
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M9 Media:
• 100 mL 5 × M9 salt solution.
• 1 mL 1 M MgSO4 solution.
• 50 µL 1 M CaCl2 solution.
• 0.5 g Nitrogen source (add after autoclaving).
• 1 g Carbon source (add after autoclaving).
• 1% 100× BME vitamins (add after autoclaving).
• Tap Water up to 0.5 L.
Soya Flour Media:
• 10.0g Mannitol.
• 10.0 g Soya flour.
• 10.0 mM CaCl2.
• (10.0 g Agar for solid medium).
• Water up to 0.5 L.
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